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Abstract 
Porous silicate substituted hydroxyapatite (SiHA) as synthetic bone graft substitute 
(BGS) shows excellent bone repair in vivo. It is accepted that the mechanical 
environment to which cells are exposed regulates cellular differentiation. One 
mechanism by which BGS architecture may regulate bone formation could be 
through influencing the shear stress distribution of interstitial fluid. The aim of this 
study was to investigate the combined influence of BGS architecture and fluid shear 
environment on human mesenchymal stem cells (hMSCs) responses.  
hMSCs were cultured on SiHA BGS with defined porosity. A 3D in-house perfusion 
bioreactor system was established, and two shear stress profiles were applied in this 
study: 1) continuous basal perfusion rate (BPR) at 0.07 ml/min; 2) BPR with a period 
of high perfusion rate (pHPR) every day at 2.5 ml/min. The cytoskeleton of hMSCs 
was reorganized under perfusion conditions compared with under static condition. 
Shear stress induced both ERK1/2 and pEKR1/2 translocation from the cytoplasm to 
nucleus. hMSCs cultured in BPR profile differentiated towards osteogenic lineage, 
while pHPR induced hMSCs to differentiate towards chondrogenic lineage. Gene 
expression of osx, sox9, runx2 and col ii was not dependent on BGS micro-porosity 
under static condition. However, the expression of osteogenic transcription factor 
osx increased significantly with increasing BGS micro-porosity under BPR condition, 
whereas the expression of chondrogenic markers like sox9, runx2 and col ii decreased 
with increasing BGS micro-porosity under pHPR condition after 3 days.  
Nifedipine was used to block L-type voltage-sensitive Ca2+ channel (VSCC) activity. 
The translocation of ERK1/2 and pEKR1/2 from the cytoplasm to nucleus was found 
to be dependent on L-type VSCCs. Both BPR induced osteogenic differentiation and 
pHPR induced chondrogenic differentiation were found to be modulated by L-type 
VSCCs. The findings of this PhD thesis demonstrate that the future evaluation of 
porous BGS bioactivity should be conducted under carefully selected perfusion 
conditions, and the results of this thesis suggest that chondrogenic markers should 
also be used as one of the indicators for BGS performance in addition to conventional 
osteogenic markers, as early chondrogenic activity may denote the onset of 
osteochondral bone formation.  This would also argue for longer term culture to 
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further monitor cell fate and the development of any extracellular matrix (ECM) 
produced. 
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Chapter 1 Review of the Literature 
1.1 Bone Composition and Structure 
Bone is a highly organized tissue that has four major functions: maintain blood 
calcium levels, support skeletal haematopoiesis, provide mechanical support for soft 
tissue and provide protection to internal organs. It is important to understand the 
fundamental characteristics of bone composition and bone structure to develop and 
evaluate synthetic bone graft substitute (BGS) materials for clinical use. 
1.1.1 Bone Cells 
The bone cells make up 10% of the total volume of bone. There are three major types 
of cells: osteoblasts, osteocytes and osteoclasts in bone and they are responsible for 
the bone formation, bone maintenance and bone remodelling. 
Osteoblasts originate from mesenchymal stem cells. Active osteoblasts have a 
cuboidal morphology and are found on the surface of new bone. Osteoblasts 
accomplish their bone formation function through three stages: synthesis of collagen, 
matrix maturation and matrix mineralization. During the proliferation of osteoblasts, 
matrix proteins, especially type I collagen are deposited onto the bone surface to 
form unmineralised matrix termed osteoid. This is followed by the precipitation of 
inorganic minerals forming the mineralized bone matrix. After the formation of bone 
matrix, some osteoblasts are entombed in the bone and subsequently differentiate 
into osteocytes or transform into resting, or quiescent osteoblasts and become bone-
lining cells if not buried. 
Osteocytes are the end cell phenotype in the osteoblastic lineage, constituting the 
most abundant cell type of bone. Although osteocytes lie within lacunae in 
mineralized tissue, they have long dendritic extensions through which they can 
communicate with other osteocytes or osteoblasts. It is the communication that 
enables osteocytes to perform the role of modulating the exchange of mineral ions, 
the supply of oxygen and nutrients throughout the bone. Another function of 
osteocytes is mechanotransduction, potentially because they are well placed to 
sense the magnitude and direction of mechanical forces within the tissue. It is well 
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documented that osteocytes are responsive to mechanical forces both in vivo and in 
vitro (Lanyon, 1993). 
Osteoclasts are derived from the hematopoietic macrophage/monocyte lineage. The 
main function of osteoclasts is to resorb bone. The capacity of osteoclasts to resorb 
bone depends on their ability to synthesise a series of electrolytes and degradative 
enzymes (Teitelbaum, 2007). Once attached to bone, osteoclasts create an isolated 
microenvironment between itself and the bone surface. Osteoclasts secreted 
hydrogen ions via H+-ATPase proton pumps and chloride channels to lower the pH to 
as low as 4.5 within the isolated environment. The acidity within the degradative 
space resorbs the mineral phase exposing the organic matrix of bone, which is 
subsequently degraded by cathepsin K (Saftig et al., 1998). 
1.1.2 Bone Matrix 
Bone matrix consists of both an organic component and an inorganic component, 
resulting in a well-engineered composite structure which delivers the mechanical 
strength and toughness of bone with a relatively low density. 
The organic component of bone matrix is primarily constituted of collagenous 
proteins (85 - 90%). Type I collagen is the major collagenous protein found in bone. 
Type I collagen is a unique triple helical molecule, which is made up of three parallel 
polypeptide chains. These triple helices assemble to form fibrils. Fibrils then combine 
with other molecules, such as proteoglycans, to form fibril bundles and fibres, which 
then assemble with each other and form bone tissue (Varma et al., 2016). 
The remain 10 - 15% of organic component consists of non-collagenous proteins. 
Several non-collagenous proteins, including osteonectin (ON), osteopontin (OPN), 
bone sialoprotein (BSP) and osteocalcin (OC), serve crucial functions in matrix 
organization and bone mineralization. Osteonectin plays a key role in bone by 
initiating formation of mineral, as it binds collagen I to form a complex, which in turn 
act as nucleator of hydroxyapatite formation (Termine et al., 1981). Osteonectin was 
also found to support bone remodelling, regulate cell proliferation and cell-matrix 
interaction (Delany et al., 2000). Osteopontin is a multifunctional protein. On one 
hand, as an extracellular matrix component, it can regulate mineral crystal formation 
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and growth. On the other hand, it is involved in physiological and pathological 
processes including cell proliferation, migration, survival and inflammation (Sodek et 
al., 2000). Bone sialoprotein acts as a hydroxyapatite nucleator, and its secretion 
regulated precisely during the initiation of mineralization (Hunter and Goldberg, 
1993). Because of its restricted secretion, bone sialoprotein provides a valuable 
marker for osteogenic differentiation and bone formation (Ganss et al., 1999). 
Osteocalcin is the most abundant non-collagenous protein of bone extracellular 
matrix. Osteocalcin is known to limit bone formation by regulating mineral crystals’ 
growth and controlling the size of growing crystals (Ducy et al., 1996; Hoang et al., 
2003). Osteocalcin also plays a role in bone remodelling through cell signalling and 
the recruitment of osteoblasts and osteoclasts, which have active roles in bone 
deposition and resorption, respectively (Bodine and Komm, 1999; Chenu et al., 1994). 
Apart from these bone extracellular matrix related proteins, another group of non-
collagenous proteins are the growth factors, including the transforming growth 
factor-β family, insulin like growth factor-1, insulin like growth factor-2 and the bone 
morphogenic proteins. These growth factors play a crucial rule in cellular growth, 
differentiation, survival, and cell cycle progression (Lawrence, 1996; Jones and 
Clemmons, 1995; Bragdon et al., 2011). 
The inorganic component of bone, known as bone mineral, accounts for ~60-70% dry 
weight of bone (LeGeros, 2002). Bone mineral has a similar crystallographic structure 
to hydroxyapatite, Ca10(PO4)6(OH)2, but is a multi-substituted form, with cations such 
as Mg, Na, Mn, Zn substituted for Ca and ionic groups such as CO3 substitute for PO4 
and OH. High resolution AFM studies find that the bone crystals are very small, with 
widths and lengths ranging from 30 to 200 nm (Hassenkam et al., 2004). Non-
stoichiometry and small size of the crystals were believed to give inorganic 
component the solubility needed for resorption of the bone by osteoclasts, which is 
compulsory for the continuous remodelling and repair of bone (Olszta et al., 2007). 
The mineral phase of bone, as stiff and brittle reinforcement of the organic matrix, 
strongly influences the stiffness of bone. By comparing the moduli and fracture strain 
of the matrix component of bone (mineral: 135 GPa and 0.1%, collagen: 1 GPa and 
10% respectively) with that of bone (10-25 GPa and 1- 1.5%), it can be seen that bone 
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achieves a compromise, making bone stiff (like mineral) but also tough (like collagen) 
(Wainwright et al., 1982; Fratzl et al., 2004). 
1.1.3 Bone Structures 
Bone exists mainly in two structural types, cortical bone and trabecular bone, on a 
macrostructure level depending on the location and function of the osseous tissue. 
Cortical bone and trabecular bone have the same matrix composition and ultra-
structure, but they have different porosity and micro-structure which gives them 
different mechanical properties. 
 
Figure 1-1 Bone structure diagram showing cortical osteons and trabeculae bone. (Marieb 
and Hoehn, 2007) 
Cortical bone is dense (porosity 5-10%), constituting the diaphysis of adult long bones 
and the external surfaces of flat bones. It provides maximum resistance to torsion 
and bending. Cortical bone is composed of cortical osteons, also known as a 
Haversian system, which is the fundamental unit of compact bone (Figure 1-1). A 
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typical Haversian system is cylindrical in shape and runs parallel to the long axis of 
the diaphysis. At the centre of a Haversian system is the Haversian canal, which is 
surrounded by 4-20 concentric lamellae. The Haversian canal contains blood vessels, 
nerves, loose connective tissue and interstitial fluid. Each osteon connects with other 
osteons, the marrow cavity, and the periosteum through perpendicular or oblique 
canals namely the Volkmann’s canal. 
Cancellous bone or trabecular bone is the spongy, porous (porosity 50-90%) type of 
bone found at the ends of long bones, i.e epiphysis (Figure 1-1). The matrix forms 
struts called trabeculae which enclose a three-dimensional, interconnected porous 
space. The pores are filled with bone marrow which contains blood, and therefore 
the nutrients needed by the bone cells inside the trabeculae as well as on the surface 
of trabeculae. The trabecular macrostructure is typically oriented depends on the 
load distribution, which gives its anisotropy mechanical properties (Keaveny et al., 
2001). 
1.2 Bone Mechanobiology 
Cells in the human body are constantly exposed to a variety of mechanical forces 
through the actions of muscle forces, gravity, blood flow and other physical processes. 
It is well recognized that cells can sense and respond to mechanical forces, it can 
integrate and analyse this information and change its morphology, dynamics, 
behaviour and fate. The interactions between cells and mechanical forces are critical 
to the development and functionality of various tissues and organs of the body. For 
example, bone changes its shape, density and stiffness when its mechanical loading 
conditions are altered (Turner and Pavalko, 1998; Mullender et al., 2004). 
Mechanobiology is a multi-disciplinary field that encompasses biology, biophysics 
and bioengineering, which focuses on how cells sense mechanical signals and 
translate mechanical signals into a cellular response. 
1.2.1 Mechanically Responsive Bone Cells 
The mechanical response of bone cells including osteocytes, osteoblasts, MSCs, 
osteoclasts, have all been documented. Osteocytes are pervasively distributed 
throughout bone and connected through a network of canaliculi, so they are well 
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placed to sense the magnitude and direction of mechanical force within the tissue 
(Rubin et al., 2006). Osteocytes are indeed able to respond to a period of 6 min  
intermittent compressive load that varied sinusoidally from 0 to 600 N at 1 Hz in vivo 
as shown by increased number of cells displaying glucose 6-phosphate 
dehydrogenase (G6PD) activity (Skerry et al., 1989). Forearm compression loading at 
2.25 N, which represents a global strain of 2250 µƐ for 100 cycles at 2 Hz, of mice 
showed the rapid activation of β-catenin through the early release of prostaglandin 
in osteocytes (Lara-Castillo et al., 2015). It is likely that these signals that orchestrate 
bone homeostasis by regulating both bone-forming osteoblasts and bone-resorbing 
osteoclasts (Lanyon, 1992; Nakashima, 2011; Baron and Rawadi, 2007). 
Many studies have demonstrated osteoblasts are mechanoresponsive both in vitro 
and in vivo. Osteoblasts respond to intermittent strain (majority of the cells on the 
plate received less than 5000 micro strain, three cycles per min for 1, 2, and 4 days) 
as shown by increased transcription and secretion of matrix proteins, including type 
I collagen, osteopontin, osteocalcin (Harter et al., 1995). Osteoblastic like cells on 
polyurethane (PU) open cell foam BGS exposing to short bouts of cyclic compressive 
loading using a sine wave at 1 Hz, 5% strain also has a strong rise in mineralised matrix 
production (Sittichockechaiwut et al., 2009). Osteoblasts in intact rat tibiae 
demonstrated the expression of cyclooxygenase (COX)-1 and COX-2 after subjected 
to 300 cycles of bending or sham loading at 2 Hz with an applied load of 65 N 
(Forwood et al., 1998).  Osteoblastic cell lines were observed to respond to cyclic 
strains (500 – 5000 µƐ) at 1 Hz and produced nitric oxide (NO) and prostaglandin 
(Smalt et al., 1997).  
MSCs share the hematopoietic niche with blood stem cells and respond to the 
mechanical environment of the marrow by altering output of differentiated cell types 
(David et al., 2007; Sen et al., 2008). MSCs subjected to oscillatory fluid flow for 2 
hours at 1 Hz with peak shear stress of 10 dyn/cm2 exhibited increased proliferation 
and increased gene expression of osteogenic markers (Li et al., 2004). It has been 
demonstrated that various forms of mechanical forces can regulate MSCs fate. For 
example, sinusoidal fluid flow for 1 hour at 1 Hz with peak shear stress of 10 dyn/cm2 
has been proved to upregulate the expression of transcription factors involved in 
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differentiation into osteogenic lineage (Arnsdorf et al., 2009). While both sinusoidal 
compressive loading with 10% magnitude at 1 Hz for 4 hours and intermittent 
hydrostatic pressure of 0.1, 1 or 10 MPa at 1 Hz for 4 hour/day have been found to 
enhance chondrogenesis of MSCs as evidenced by increases in sox9 expression, type 
II collagen and aggrecan gene expression (Huang, 2004; Miyanishi et al., 2006). 
Mechanical control of osteoclast function occurs typically through regulation of 
osteoclast recruitment, which is achieved by regulation of osteoclastogenesis via 
soluble signals. Rubin et.al have shown that dynamic mechanical strain can decrease 
osteoclast formation by around 50% in primary marrow cultures through a decrease 
in RANKL mRNA expression (Rubin et al., 1999; Rubin et al., 2002). Kim et al. also 
reported that oscillatory fluid flow induced decreased osteoclasts formation in a co-
culture system of MSCs and osteoclast precursors by decreasing the RANKL/OPG 
mRNA ratio (Chi Hyun Kim et al., 2006). 
1.2.2 Candidate Mechanoreceptors 
The ability of cells to sense the mechanical forces from the environment requires that 
mechanoreceptors either directly contact with the extracellular space, or that a 
mechanoreceptor can distinguish changes in a physical intermediary such as pressure 
or fluid shear on the plasma membrane (Thompson et al., 2012). 
1.2.2.1 Integrin 
Integrins contain heterodimers of non-covalently associated α and β subunits. Each 
subunit has a large ECM domain, a single membrane-spanning helix, and usually a 
short unstructured cytoplasmic domain (Campbell and Humphries, 2011). On the 
ECM domain, integrins bind to a specific amino acid sequence (RGD ligand) found 
from ECM proteins like OPN and fibronectin. On the cytoplasmic domain, integrins 
associate with the peripheral domains of the cytoskeleton and a range of accessory 
proteins, including vinculin, paxillin, talin and α-actinin to form large, highly dynamic 
multiprotein complexes. The binding of extracellular ligands to integrins may initiate 
intracellular signalling events (outside-in signalling), while modification of 
intracellular domains also regulates the binding affinity of extracellular receptors 
(inside-out signalling). 
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Mechanical forces can alter the conformation of integrin-associated proteins, which 
could affect the exposure of binding sites, consequently modulating the recruitment 
of additional components. Integrins, together with a range of associated signalling 
proteins (for example kinases, phosphates), respond to mechanical forces by 
initiating a cascade of events. Such cascades include the activation of 
phosphorylation and G-protein mediated pathways, which result in local alterations 
in cytoskeletal dynamics. These, in turn, lead to alterations in cell shape, 
transcriptional regulation or other cellular behaviours (Geiger et al., 2009). 
Integrins have a primary role in sensing the environmental signals. Numerous studies 
that have been summarized in a series of reviews (Bershadsky et al., 2006; Delon and 
Brown, 2007) show that integrin-based molecular complexes are involved in the 
sensing and processing of mechanical stimuli, such as fluid shear stress and substrate 
stretching. Integrins have been demonstrated as mechanoreceptors in a variety of 
cells including osteocytes, osteoblasts, mesenchymal stem cells and chondrocytes 
(Aderem, 1992; Mobasheri et al., 2002; Klein-Nulend et al., 2013; Liyue Liu et al., 
2012). For example, integrin β1 plays predominant roles in shear induced signalling 
and gene expression in osteoblast like cells (Lee et al., 2008). Integrin β1 play 
important roles in triggering the outside-in signalling and condensing precartilage 
during chondrogenesis of MSCs (Raghothaman et al., 2014; Jin et al., 2007; Zhang et 
al., 2015). Mechanical stimulation and nanotopography led to significant 
upregulation of gene expression for integrin α1, as well as runx2 in osteoblast like 
cells (Prodanov et al., 2010). 
1.2.2.2 Cell Cytoskeleton 
The cell cytoskeleton is an interconnected network of filamentous polymers and 
regulatory proteins, by which cells can resist deformation, transport intracellular 
cargo and change shape during movement (Fletcher and Mullins, 2010). The 
interconnected and viscoelastic nature of the cytoskeleton together with its 
interaction with extracellular environment via receptor-ligand complexes is suited to 
the detection and transmission of mechanical signals to biochemical signals (Janmey, 
1998). Fluid shear stress has been demonstrated to induce reorganization of actin 
filament into contractile stress fibres in osteoblasts (Pavalko et al., 1998). While 
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inhibition of actin stress fibre development altered the response of osteoblasts to 
fluid shear stress (McGarry et al., 2005). 
1.2.2.3 Plasma Membrane Structure 
The plasma membrane provides cells with a stable internal environment. Plasma 
membrane lipid rafts are known to have a significant role in the signalling facilitation 
system. Lipid rafts are highly organized and dynamic assemblies of cholesterol and 
sphingolipid. This structure creates a complex association of signalling molecules, 
including GTP-binding proteins, kinases, and calcium. The accumulation of these 
molecules in one location gives lipid rafts the capability to spread signals to 
downstream targets rapidly and specifically (Rizzo et al., 1998). Lipid rafts have been 
demonstrated to be essential for responding to hydrostatic pressure and fluid shear 
stress and activation of ERK1/2 in osteoblasts (Ferraro et al., 2004). Apart from lipid 
rafts, mechanical forces also have other effects on the plasma membrane, such as 
generating strong strain and inducing conformational changes, thus altering protein 
binding and cell structure. 
1.2.2.4 Cell-Cell Connections  
Cadherins are a family of integral membrane glycoproteins, composed of a long 
extracellular domain, a single-pass transmembrane domain, and a small, intracellular 
tail. A widespread view for many years was that cadherin-based adhesion involved a 
single binding interface between the cadherin extracellular domains. This adhesive 
connection intrinsically conveys mechanical information to cells by resisting 
mechanical forces. The intracellular domain anchors the cadherins to the 
cytoskeleton by associating with a variety of protein complexes, including β-catenin, 
α-catenin and vinculin. Therefore, cadherins act as mechanoreceptor that senses 
fluctuations in tensile force owing to dynamic cytoskeletal deformation. In 
osteoblasts, the intracellular domain of cadherins associates with β-catenin. Fluid 
shear stress decreased this association, which result in an increase in the cytoplasmic 
pool of β-catenin. The increase in unbound β-catenin in conjunction with the 
activation of glycogen synthase kinase 3 beta (GSK3β) induced by shear stress has 
been proposed as a potential upstream regulator of β-catenin nuclear translocation 
(Norvell et al., 2004). 
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Gap junctions are membrane-spanning channels, composed of connexin subunits, 
that allow rapid and direct diffusion of small molecules (< 1 kDa), such as ionized 
calcium, from the one cell to another cell (Genetos et al., 2007). Gap junction 
intercellular communication has been demonstrated as a mechanoreceptor in 
response to fluid flow (Alford et al., 2003). 
1.2.2.5 Primary Cilia 
Primary cilia are microtubule-based organelles that project from the cell surface. As 
the cilia bends in response to fluid flow, increased tension on the membrane result 
in opening of mechanosensitive ion channels, such as an influx of intracellular Ca2+, 
causing membrane depolarization and activation of auditory nerve fibres (Ingber, 
2006). There is evidence that primary cilia deflection is required for fluid shear stress 
induced osteogenic responses (Malone et al., 2007). Damage or removal of primary 
cilia of osteoblasts have been shown to inhibit oscillatory fluid flow(OFF)-induced 
PGE2 release and mineral deposition (Delaine-Smith et al., 2014).  
1.2.2.6 Ion Channels 
Bone cells express several different ion channels involved in mechanosensitive 
pathways, including stretch-active cation channels, voltage-sensitive calcium 
channels (VSCC), and transient receptor potential (TRP) channels. The application of 
different forms of mechanical forces have been shown to activate different 
mechanosensitive ion channels. Oscillatory fluid flow was shown to induce 
intracellular Ca2+ mobilization via the Inositol trisphosphate (IP3) pathway and the L-
type VSCC (You et al., 2001). Membrane stretch induced intracellular Ca2+ 
mobilization via T-type VSCC, which regulates downstream adenosine triphosphate 
(ATP) release and ERK1/2 activation (Thompson et al., 2011). Fluid shear stress 
increased intracellular Ca2+ mobilization via mechanosensitive cation-selective 
channel and L-type VSCC, which together with a resultant release of ATP was found 
to activate the ERK1/2 phosphorylation (Liu et al., 2008). 
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1.2.3 Intracellular Signalling Pathways 
1.2.3.1 Kinase Activation 
Mitogen activated protein kinase (MAPK) is a family of serine/threonine protein 
kinases including Extracellular Signal-regulated Kinase (ERK1/2), c-Jun N-terminal 
Kinase (JNK) and p38 kinase. Many studies have shown that ERK1/2 is activated by 
fluid shear in both osteoblasts and MSCs (Liu et al., 2008; Glossop and Cartmell, 2009). 
The MAPK members have been demonstrated to be essential in cell growth, 
differentiation and apoptosis. For example, the activation of ERK1/2 is necessary for 
mechanical strain induced positive bone remodelling by inhibiting osteoclastic 
potential of bone marrow stromal cells (Rubin et al., 2002).  
Focal adhesion kinase (FAK) is a non-receptor cytoplasmic protein tyrosine kinase 
(PTK), which is concentrated near focal adhesions. FAK interacts with various 
signalling proteins, including Src family PTKs, phosphatidylinositol 3-kinases (PI3K), 
Shc, Grb2 and paxillin. This enables FAK to function within a network of integrin-
stimulated signalling pathways resulting in the activation of downstream targets such 
as the MAPK cascades (Schlaepfer et al., 1999). The fluid flow induced activation of 
FAK has been demonstrated to be critical for activation of ERK1/2 and JNK, and for 
the shear stress induced expression of c-fos, COX-2, OPN,  and PGE2 release (Young 
et al., 2009; Wang et al., 2011). 
1.2.3.2 β-Catenin 
β-catenin plays a significant role in bone mass regulation (Case and Rubin, 2010). 
Studies have shown that loading activates the β-catenin signalling pathway both in 
vitro (Sunters et al., 2010; Case et al., 2011) and in vivo (Robinson et al., 2006; Lara-
Castillo et al., 2015). Researchers have demonstrated that activation of β-catenin in 
response to load through the prostaglandin, and protein kinase (Akt) signalling 
pathways (Kamel et al., 2010). It has been shown that uniform biaxial strain through 
focal adhesion induced mammalian target of rapamycin complex 2 (mTORC2) 
activation and phosphorylation of Akt, which caused the inactivation of GSK3β (Case 
et al., 2011). The inactivation of GSK3β then resulted in the preservation of β-catenin 
by protecting it from degradation (Sen et al., 2009). Preserved β-catenin is believed 
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to target genes like runt-related transcription factor 2 (runx2), osterix (osx) and oc, 
to promote osteoblast differentiation of MSCs (Day et al., 2005). 
1.2.3.3 GTPases  
GTPases are a large family of enzymes that bind and hydrolyse guanosine 
triphosphate (GTP), in turn switching on a variety of physiological processes. Studies 
have indicated that Rho family of GTPases were activated in response to oscillatory 
fluid flow (Arnsdorf et al., 2009), which in turn regulated cell shape via its effects on 
ROCK-mediated cytoskeletal tension, and guiding MSCs differentiation into the 
osteogenic lineage (McBeath et al., 2004; Xu et al., 2012). 
1.2.3.4 Calcium Signalling 
A rapid increase in intracellular calcium ([Ca2+]i) levels is the earliest detected 
response in mechanically stimulated bone cells (Rawlinson et al., 1996). Intracellular 
Ca2+ mobilization was initiated by variety of  mechanical forces, including membrane 
stretch (Walker et al., 2000), oscillatory flow (You et al., 2001) and steady flow (Liu 
et al., 2008). Intracellular Ca2+ mobilization subsequently initiated downstream 
signalling including ATP, prostaglandin (Genetos et al., 2005),  MAPK (You et al., 2001; 
Katz et al., 2006), c-fos, COX-2, (Chen et al., 2000) and matrix protein production 
(Walker et al., 2000). For example, it has been demonstrated that intracellular Ca2+ 
mobilization through the L-type VSCC in response to shear stress was compulsory for 
ATP release, which in turn mediated prostaglandin release (Genetos et al., 2005). 
Bone mechanobiology is a complicated area. A significant amount of research has 
been conducted to investigate bone mechanical signalling pathways. Bone grafts 
could potentially function through interacting with local mechanical environment, 
however, aside from the complexity of deconvolution of the multiple pathways 
involved, there are ethical considerations and high costs to study in vivo. Therefore, 
there is a clear need to develop an in vitro system to study mechano-biologic 
responses to changes in BGS structure and chemistry. 
1.3 Bone Formation and Bone Healing 
Intramembranous and endochondral ossification are two mechanisms through which 
bone formation occurs. Both processes start with stem cell proliferation and 
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condensation. During intramembranous ossification, condensed MSCs differentiate 
directly into osteoblasts and secrete organic matrix, after which the crystal apatite 
deposits. This process mainly forms flat bones, like craniofacial skeleton. Long bones 
are formed by endochondral ossification, during which MSCs first differentiate into 
chondrocytes and form the initial cartilage templates. Chondrocytes in the centre of 
these cartilage templates further differentiate into hypertrophic chondrocytes and 
form cartilage. The hypertrophic cartilage is then invaded by blood vessels and 
eventually replaced by bone and marrow.  
Bone healing is a regenerative process that is initiated in response to injury. The 
process of bone healing can be divided into four overlapping stages: hematoma 
formation and inflammation, soft callus formation, hard callus formation, and bone 
remodelling (Figure 1-2).  
 
* Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings. 
Figure 1-2 Diagram of bone healing process.  
Following damage to the bone, disruption of local soft tissue integrity, blood vessels 
and marrow structure leads to the formation of a hematoma, which encloses the 
fracture area. Hematoma acts as the scaffold in which a callous is developed in the 
later stages of bone repair. Removal of the hematoma significantly attenuates bone 
repair (Grundnes and Reikerås, 1993). The correct inflammation response is also 
essential for bone repair. The inflammatory response is associated with the secretion 
of several cytokines and growth factors, including interleukin-1 (IL-1), interleukin-6 
(IL-6), tumour necrosis factor-alpha (TNF-α), transforming growth factor-beta (TGF-
β), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) 
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and bone morphogenetic proteins (BMPs) (Mandracchia et al., 2001; Gerstenfeld, 
Cullinane, et al., 2003; Barnes et al., 1999; Cho et al., 2002). These cytokines and 
growth factors have important roles in bone healing. For example, TNF-α promotes 
the recruitment of mesenchymal stem cells (MSCs) and osteoclasts, and plays a 
regulatory role in bone healing (Gerstenfeld, Cho, et al., 2003). VEGF promotes 
angiogenesis, which is crucial for blood supply to the injury site and bone healing 
(Street et al., 2002). 
The soft (cartilaginous) callus formation is an endochondral bone formation process. 
Release of the correct cytokines and growth factors aid the recruitment of 
mesenchymal stem cells (MSCs) from periosteum, endosteum, bone marrow and 
adjacent soft tissues, proliferation of MSCs and the their differentiation into 
chondrocytes (Bigham-Sadegh and Oryan, 2015). Chondrocytes proliferate and 
synthesise cartilaginous matrix and then undergo hypertrophy, mineralizing the 
cartilaginous matrix before undergoing apoptosis (Schindeler et al., 2008). This 
cartilaginous callus provides initial stabilization of the fracture site. Meanwhile, the 
periosteum undergoes intramembranous ossification to create an external callus. 
Hard callus formation represents the active period of osteogenesis process. The 
formation of new vascular structure is critical for formation of the hard callus, which 
increases oxygen tension in the local region necessary for osteoblasts differentiation 
(Schindeler et al., 2008). Osteoblasts have prominent levels of activity at this stage 
and form mineralized bone matrix. Soft cartilaginous callus is gradually replaced by 
new formed hard callus of woven bone, which is typically irregular and under-
remodelled. 
Bone remodelling begins with an initiation phase that includes recruitment of 
osteoclast precursors, osteoclast differentiation, formation of sealing zones beneath 
osteoclasts and bone tissue resorption in these zones. After the resorption phase is 
completed, osteoclasts undergo apoptosis whilst osteoblasts are recruited and begin 
to lay down new bone.  
Mechanical factors have been demonstrated to modulate bone healing. For example, 
in a controlled metaphyseal fracture model in sheep, low interfragmentary strain led 
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to intramembranous bone formation, whereas higher strains additionally provoked 
endochondral ossification (Claes et al., 2011). The difference between remodelling in 
cortical bone and cancellous bone is that in cortical bone osteoclasts move along the 
length of a Haversian canal, progressively eroding away the whole osteon, whilst in 
cancellous bone, osteoclasts begin resorption at a designated surface of a piece of 
trabecular bone (Burr et al., 1985; Huiskes et al., 2000). Apart from fracture healing, 
healthy bone is also continuously remodelled, shaped and repaired, to maintain its 
structural integrity, strength and to fulfil its role in mineral homeostasis (Kular et al., 
2012). The presence of microcracks in bone and the osteocyte apoptosis in these 
areas is currently considered a crucial driver of the remodelling response (Cardoso et 
al., 2009). Mechanical force is a key regulator of bone remodelling and therefore 
bone architecture (Carter, 1984; Lanyon, 1993; Jacobs et al., 2010).  
Spontaneous fracture healing is the natural way for bone to regenerate. However, 
for critical-sized defects, bone fails to self-repair which leads to musculoskeletal 
disorders. This is the situation where surgical intervention is required via application 
of graft materials or metal implants. 
1.4 Bone Grafting and Evaluation of Synthetic BGS Performance 
Bone grafting, a surgical procedure, involves transplantation of a bone tissue from 
patient’s own body, bone tissue from another individual or species, a natural 
substitute or synthetic substitute to augment and regenerate bones that are lost due 
to a disease or injury. Although autograft accounts for the largest proportion of the 
global BGS market to date, its requirement of double incision and the post-surgery 
pain on both sites have drawn increasing interests of scientists and manufactures in 
synthetic BGS. The world market of BGS is expected to reach over $5031 million by 
the end of 2027, and this market is projected to grow at a compound annual growth 
rate of ~ 6.52% during the period of 2017 – 2027 due to aging population 
(IndustryToday, 2017). There are several types of BGS, including autologous graft, 
allogenous grafts and synthetic bone graft. 
Autologous grafts, or autografts are bones harvested from the patient and 
transplanted to injured site. It is considered as the “gold standard” by clinicians and 
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accounts for the largest market of the global BGS so far. The advantage of autografts 
includes minimal risk of immunogenic response, osteoinductive and osteoconductive 
abilities (Cypher and Grossman, 1996; Giannoudis et al., 2005). However, autografts 
can result in donor site morbidity (Silber et al., 2003) and their availability is limited 
by the limited volume of bone that can be harvested from the donor site. Although 
autograft accounts for the largest market of the global BGS so far, its requirement of 
double incision and the post-surgery pain on both sites have drawn increasing 
interests of scientists and manufactures in synthetic BGS. 
Allogenous grafts, or allografts, represents bone harvested from one individual and 
transplanted into another individual of the same species. Xenografts represents bone 
harvested from one individual and transplanted into another individual of a distinct 
species. Although allografts and xenografts are natural bone tissue, having risk of 
immunogenic response together with reduced osteoinductive ability make them less 
attractive choices. 
Synthetic BGS have gained increasing interest in bone repair. They are available in 
different forms and materials, including calcium phosphates (Gauthier et al., 1998), 
Bioglass (Jones, 2015), polymers (Thomson et al., 1996) and their combination (Sang-
Soo Kim et al., 2006). The ideal BGS must satisfy a series of strict demands: 
appropriate surface chemistries encouraging cell adhesion, proliferation and 
differentiation; appropriate levels and sizes of porosity allow for cell migration; 
promoting biological processes such as the production of extracellular matrix and 
vascularisation; good mechanical properties; and a degradation rate that matches 
the regeneration rate of natural tissue (Lannutti et al., 2007).  
Porous hydroxyapatite (HA) has a close resemblance to the composition of bone 
mineral and has been suggested as promising BGS (Hing et al., 2002). Silicon is crucial 
for bone growth and development because collagen and proteoglycans are 
crosslinked by it, and silicon has also been show to act in the bone mineralisation 
process (Pietak et al., 2007). The incorporation of silicon into HA BGS induced several 
changes: release of soluble silica species, increased negative surface charge and 
higher solubility (Porter et al., 2003; Hing et al., 2006). These changes are important 
to enhance the osteoconductivity of hydroxyapatite by improving cell adhesion, 
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because the adhesion is highly dependent on composition, microstructure, 
wettability and surface charge of the material. Silicate substituted hydroxyapatite 
(SiHA) has demonstrated earlier organised collagen fibrils formation and more 
apatite crystallites at the bone-implant surface than pure HA in vivo, suggesting the 
promoted bone remodelling process (Porter et al., 2004). Ovine defect model also 
showed significantly higher percentage of bone ingrowth and bone coverage for SiHA 
than pure HA, indicating the incorporation of silicon highly improves the bioactivity 
of hydroxyapatite (Patel et al., 2005). Experiment results validated the response of 
healing response to Si level and suggest the optimal bone healing is obtained when 
SiHA is substituted with 0.8 wt% Si (Hing et al., 2006).  
Pore structure (such as macro-pore size, macro-porosity, interconnectivity of macro-
pores, micro-porosity (the volume fraction of micro-pores in the struts of porous 
BGS)) has been demonstrated to have a strong impact on bone ingrowth in vivo 
(Mastrogiacomo et al., 2006; Hing et al., 2004; Hing et al., 2005; Campion et al., 2011; 
Coathup et al., 2012). For example, in vivo study of hydroxyapatite (HA) BGS with 
different macro-pore structure has demonstrated that macro-porosity and pore 
interconnection of the BGS influenced the amount of deposited bone and kinetics of 
bone formation (Mastrogiacomo et al., 2006). Increased levels of micro-porosity in 
HA BGS was found to facilitate earlier neovascularization (Hing et al., 2004), thicker 
trabeculae of new bone (Hing et al., 2005), and a greater volume of bone formation 
(Coathup et al., 2012) in vivo. One explanation that micro-pore structure promoted 
BGS performance is micro-pores allow cellular infiltration, which increases biological 
fixation and thereby results in improved mechanical interlock between the cells and 
the surface of the substrate (Bignon et al., 2003; Annaz et al., 2004a). However, many 
in vitro studies were carried on BGS discs under static condition (Marra et al., 1999; 
Liao et al., 2004; Ghorbani et al., 2015). Under these conditions, some BGS still 
perform quite good and it may be possible to screen for variation in chemistry or 
structure. But it is unknown that how/even if the cellular response to a BGS disc 
under static condition in vitro translates to the bone formation response to porous 
BGS in vivo. 
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1.4.1 Cells Used in Evaluation of Synthetic BGS Performance 
Osteoblasts are an obvious choice for evaluation of synthetic BGS performance, 
because of their capacity to synthesise bone-specific proteins and deposit 
mineralized matrix. Many studies have used osteoblasts combined with various of 
BGS and demonstrated bone nodule formation in vitro, new bone formation in vivo 
and favourable healing efficacy (Xynos et al., 2000; Wang et al., 2014). However, the 
disadvantage associated with osteoblasts is that they have relatively limited 
proliferative capacity and short lifespans. Immortalized osteoblast cell lines, like 
MG63, SaOs2, MC3T3-E1, are often used in evaluating the performance of BGS 
because of their ease of access and repeatability.  The osteoblast cell lines have some 
features of osteoblasts, however it is clear that these cells do not fully reflect the 
behaviour of primary osteoblasts and must be used with caution. For example, by 
characterizing osteosarcoma cell line MG-63, Saos-2 in comparison to primary human 
osteoblasts, Pautke found that no ALP activity could be detected in MG-63 cells 
(Pautke et al., 2004). Czekanska also observed that the maximum level of ALP activity 
of MG-63 by day 28, was ~ 26 fold lower compared to human osteoblasts at the same 
point, while both SaOs2 and MG-63 cells demonstrated a higher proliferation rate 
than human osteoblasts (Czekanska et al., 2014).  
MSCs have been considered as attractive choice for evaluating BGS performance 
because of their high proliferation and multipotent differentiation capability. Bone 
repair process in vivo is initiated by MSCs recruitment, differentiation into 
chondrocytes and cartilaginous intermediate formation (Phinney and Prockop, 2007). 
The capacity of MSCs to repair skeletal defects has been proven in animal tests, and 
subsequently in human patients with osteogenesis imperfecta (Horwitz et al., 2002). 
Minimal criteria for the characterization of MSCs were defined by the International 
Society of Cellular Therapy position statement: plastic-adherent; having the potential 
to differentiate into chondrogenic, osteogenic and adipogenic lineage in vitro; 
positive expression for CD105, CD73, CD90 surface markers; and negative expression 
for CD14, CD19, CD34, CD45 and HLA-DR surface markers (Dominici et al., 2006). 
MSCs reside in a diverse host of tissues throughout the adult organism, including 
bone marrow, adipose tissue, periosteum, skeletal muscle, synovium membrane, 
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blood and dental pulp. Currently, bone marrow derived MSCs and adipose tissue 
derived MSCs are considered as the most accessible source of MSCs. Their bone 
regenerative capacity has been demonstrated in vivo (Cowan et al., 2004; 
Karageorgiou and Kaplan, 2005). 
1.5 Bioreactors 
Mechanical forces are known to affect cellular behaviour, including morphology, 
proliferation, differentiation into specific lineages, and functions. Therefore, 
mechanical forces play  important roles in bone healing (Lanyon and Rubin, 1984; 
Lanyon, 1993; Robling et al., 2002; Boerckel et al., 2012). However, studies of in vitro 
BGS efficacy evaluation and mechanism investigation have been traditionally carried 
out in a static environment which does not represent the mechanical environment 
that cells are exposed to in vivo. Researchers have designed a variety of bioreactors 
to apply mechanical force while evaluating the performance of BGS. The physiologic 
relevant mechanical forces are usually divided into three main categories: shear 
stress, compressive stress and strain. Several researchers hypothesized that flow of 
interstitial fluid is the most probable way of informing bone cells about mechanical 
loading (Knothe Tate et al., 1998; Sikavitsas et al., 2001). There are mainly three types 
of bioreactors: spinner flask bioreactor, rotating wall bioreactor and perfusion 
bioreactor that are used to apply mechanical forces to cell cultured on BGS. 
1.5.1 Spinner Flask Bioreactor 
Spinner flask bioreactor composes of a media reservoir, a stir bar or other stirring 
mechanism that stirs the media, side arms through which BGS and media can be 
removed and usually gas exchange system. BGS are typically suspended from the top 
of the flask using needle like apparatus. In spinner flask bioreactor, convective 
transport of nutrients to the BGS brings increased concentrations of oxygen to the 
BGS compared to diffusional transport of nutrients in static culture. Cells on the 
surface of the BGS are also exposed to shear stress which could enhance osteogenic 
differentiation. 
One of the earliest studies using spinner flask reported that spinner flask 
demonstrated a 60% increased proliferation after 7 days, 2.4 times higher alkaline 
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phosphatase (ALP) activity after 14 days, 3.5 times OC secretion after 18 days of rat 
marrow stromal osteoblasts seeded on poly (D, L-lactic-co-glycolic acid) (PLGA) 
porous BGS compared to static culture. However cell growth and mineralization were 
limited to the outside of the BGS because of limited nutrient transport in internal BGS 
(Sikavitsas et al., 2002). Another study also observed when human bone marrow 
MSCs were cultured on collagen BGS for 5 weeks in spinner flask, bone formation 
only happens in the peripheral region of the BGS (Meinel et al., 2004). Research has 
demonstrated that spinner flask could reveal the influence of BGS structure on 
cellular behaviour. For example, 200 µm pore coralline hydroxyapatite exhibited 
faster rate of osteogenic differentiation than did the 500 µm pore, whereas 500 µm 
pore coralline hydroxyapatite BGS exhibited increased proliferation rate in spinner 
flask (Mygind et al., 2007). A study reported that the extent of proliferation and 
osteogenic differentiation become higher at increased stir rate, which indicated 
increased shear stress affects the osteoblastic differentiation of rat MSCs in the study 
(Ichinohe et al., 2008). Human adipose derived stem cells (ADSCs) cultured on 
cancellous BGS in spinner flask bioreactors showed enhanced osteogenic 
differentiation compared to static environment (Song et al., 2014). Human ADSCs 
combined with cartilage biomimetic BGS, chitosan/gelatin hybrid hydrogel, in 
spinner flask bioreactors showed enhanced proliferation and chondrogenic 
differentiation compared to static environment (Song et al., 2015). 
1.5.2 Rotating Wall Bioreactor 
Rotating wall bioreactors are composed of two concentric cylinders, an inner cylinder 
that is stationary and allows gas exchange and an outer cylinder that rotates. The 
space between the two cylinders is filled with culture media which hosts cell seeded 
BGS. BGS can move freely in the media, cells on the surface of the BGS are exposed 
to shear stress caused by the centrifugal forces of the outer cylinder balance with 
gravity (Godara et al., 2008). It was first designed to aid high-density, three-
dimensional cell cultures (Schwarz et al., 1992). Many studies have used rotating wall 
bioreactor and achieved promoted cell behaviour in vitro. For example, osteoblasts 
in a rotating wall bioreactor have been reported to achieve rapid proliferation, 
increased ALP activity and differentiation (Song et al., 2006). Co-culture MSCs with 
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MSC-derived endothelial cells (ECs) within a porous BGS using a rotating wall 
bioreactor generated  bone tissue containing vascular-like structures (Nishi et al., 
2013). Primary articular chondrocytes cultured in rotating wall bioreactor were able 
to overcome the limited proliferation and their tendency to dedifferentiate in static 
culture (Mellor et al., 2014). Other studies have showed rotating wall bioreactors to 
be relatively less effective. When rat primary calvarial cells were cultured on the BGS 
in rotating wall bioreactor for 7 days, osteoblasts showed significantly increased 
mineralized matrix formation, ALP activity, oc expression and opn expression but no 
influence on cell proliferation (Yu et al., 2004). Rotating wall bioreactor culture 
yielded similar cell density, but had the lowest levels of ALP activity whereas those 
cultured in the perfusion system or in a spinner flask demonstrated enhanced ALP 
activity compared to those cultured statically (Goldstein et al., 2001). Human 
mesenchymal stem cells and rat marrow stromal cells were also observed to have 
lower ALP activity and OC secretion in rotating wall bioreactor than in spinner flask 
bioreactor and static condition (Sikavitsas et al., 2002; Tzu Wei Wang et al., 2009). 
The limited cell proliferation in rotating wall bioreactors compared with spinner flask 
bioreactor could be due to collisions of BGS with the wall of bioreactor while moving 
or the low shear stresses on cells in the bioreactor.  
1.5.3 Perfusion Bioreactor 
Spinner flask bioreactor and rotating wall bioreactor have shown effectiveness in 
some instances; however, perfusion bioreactors have shown greater positive effects 
on osteoblastic differentiation due to direct perfusion of nutrients through BGS and 
ability to stimulate the cells with greater shear stresses (Yeatts and Fisher, 2011). 
Perfusion bioreactors typically comprises of a cartridge which houses the cell seeded 
BGS, a medium reservoir, a tubing system and a pump. Cartridge must be carefully 
designed to tightly fit the BGS which must be highly porous, so that medium can be 
perfused directly through the pores of the BGS, instead of around the BGS. Many 
perfusion bioreactors have been developed and used in in vitro studies (Table 1-1).  
Table 1-1 showed that in a critical evaluation of 39 papers, it was clear that perfusion 
culture could promote cell expansion, differentiation to osteogenic phenotype, and 
mineralized matrix compared to static culture. Much of the work has been completed 
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to investigate how BGS materials, cell type, flow rate and flow mode used in a 
perfusion bioreactor system influence the outcome of cell expansion and 
development of phenotype. 48.7% of the studies (19/39) used polymer BGS and 30.8% 
of the studies (12/39) used calcium phosphate BGS in perfusion bioreactor. Apart 
from polymer and calcium phosphate, researchers also used titanium fibre mesh, 
composite and decellularized trabecular BGS in perfusion bioreactor. 
Mainly MSCs or osteoblasts have been used in perfusion bioreactor studies. Most 
(66.7%) of the studies (26/39) used MSCs from different species, like human, rat and 
sheep in perfusion bioreactor. Osteoblasts or osteoblastic cells (11/39) were the 
second favourite choice (28.2%) of cells in perfusion bioreactor. Apart from MSCs and 
osteoblasts, there was one study that used human adipose stem cells and one study 
that used stromal vascular fraction cells in perfusion bioreactor. 
Most of the perfusion rate (38/39) was from 0.01 ml/min to 4 ml/min, apart from 
one study that used 10 ml/min. However, shear stress is not only depending on flow 
rate, but also other parameters like BGS pore size, BGS diameter and BGS porosity. 
Flow rate should be used with caution when comparing the shear stress across 
different studies. Flow rate was demonstrated to have a dose effect on ALP activity, 
cell number and mineralized matrix, when rat MSCs were cultured on titanium fibre 
mesh BGS (Bancroft et al., 2002). When hMSCs on decellularized bovine trabecular 
bone were cultured in perfusion bioreactor at 400 µm/s flow velocity, radically 
increased cell numbers and the amount of bone proteins and minerals compared to 
flow velocity of 100 µm/s (Grayson et al., 2008). hMSCs on polylactic glycolic acid 
(PLGA) BGS showed induced osteogenic differentiation at 0.5 ml/min but not at 0.2 
ml/min (Yang et al., 2010).  
Apart from flow rate, studies have compared the different influence of steady flow 
and dynamic flow on osteogenic differentiation. Oscillatory perfusion has 
demonstrated increased ALP activity of MC3T3-E1 (mouse osteoblastic cells) on β-
TCP ceramic BGS compared with continuous unidirectional flow. Similarly, when 
MC3T3-E1 osteoblastic cells on collagen-glycosaminoglycan were subjected to 
continuous unidirectional flow, pulsatile flow or oscillatory flow, although all three 
types of flow configuration demonstrated increased cyclooxygenase-2 (COX-2), 
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prostaglandin E2 (PGE2) expression and OPN production, dynamic flow was found to 
be more stimulatory than continuous unidirectional flow (Jaasma and O’Brien, 2008). 
Studies have demonstrated that perfusion bioreactor is a feasible in vitro system to 
mechanically stimulate cells cultured on 3D BGS, and cells are responsive to shear 
stress generated by flow in a perfusion bioreactor. However, studies focusing on 
cellular responses to BGS parameters such as porosity, pore size, stiffness were still 
conducted in a static environment which does not represent the mechanical 
environment that cells are exposed to in vivo. Therefore, the current study intends 
to investigate the cellular responses to SiHA BGS structure in a mechanical 
environment using perfusion bioreactor. Based on perfusion configurations from 
literatures, MSCs or osteoblast, and perfusion rate between 0.01 ml/min and 4 
ml/min was used.
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Table 1-1 In vitro studies utilizing perfusion bioreactors. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Goldstein 
et al., 2001) 
Poly (DL-lactic-co-glycolic 
acid) (PLGA) foam discs  
Rat 
osteoblastic 
cells from 
marrow issue 
Continuous 
unidirectional flow, 0.03 
ml/s (0.34 dyn/cm2) 
No difference in cell number and OC activity; 
higher ALP activity 
(Bancroft et 
al., 2002) 
Titanium fibre mesh  Rat MSCs continuous 
unidirectional flow, 0.3, 
1, 3 ml/min (< 1 dyn/cm2) 
Increased mineralized matrix, ALP activity, cell 
number; dose effect 
(Sikavitsas 
et al., 2003) 
Titanium fibre mesh  Rat MSCs Continuous 
unidirectional flow, 0.3 
ml/min, culture medium 
has different viscosity 
Increased mineralized matrix, ALP activity; dose 
effect 
(Cartmell et 
al., 2003) 
Hydrated human 
trabecular bone  
MC3T3-E1 
osteoblastic 
cells 
Continuous 
unidirectional flow, 0.01, 
0.1, 0.2, and 1.0 mL/min  
Increased cell proliferation at 0.01 mL/min; increased 
runx2, oc, alp expression at 0.2 ml/min 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Meinel et 
al., 2004) 
 
Collagen discs hMSCs Continuous 
unidirectional flow, 0.2 
ml/min (35 µm/s) 
Higher ALP activity, bone rods formation in the 
direction of flow distributed throughout the 
construct 
(Wang et 
al., 2003) 
β-tricalcium phosphate  Rat MSCs Continuous 
unidirectional flow, 2 
ml/h 
Higher ALP activity, OC content both in vitro and in 
vivo, increased bone formation in vivo 
(Sikavitsas 
et al., 2005) 
Poly (L-lactic acid) (PLLA)  Rat MSCs Continuous 
unidirectional flow, 0.6 
ml/min 
Increased matrix deposition, proliferation, ALP 
activity 
(Fassina et 
al., 2005) 
Polyurethane foam  SAOS-2 
osteoblastic 
cells 
Continuous 
unidirectional flow, 3 
ml/min  
Increased proliferation, OPN, OC, decorin and COL I 
secretion, calcium deposition 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Vance et 
al., 2005) 
 
Silicon-stabilized 
tricalcium phosphate and 
hydroxyapatite 
MC3T3-E1 
osteoblastic 
cells 
Continuous 
unidirectional flow, 0.025 
ml/min; 
Oscillatory flow, 4 
ml/min, 1 Hz, 30 min 
once daily 
Enhanced PGE2 release; oscillatory flow further 
enhanced PGE2 release 
(Zhao and 
Ma, 2005) 
Poly(ethylene-
terepthalate) (PET)  
hMSCs Continuous 
unidirectional flow, 0.2 
ml/min 
Higher cell number, more even cell distribution, 
maintained multipotential differentiation of hMSCs 
(Porter et 
al., 2007) 
Polycaprolactone (PCL)  Rat MSCs Continuous 
unidirectional flow, 0.2 
ml/min 
Increased mineralized matrix 
(Manuela E 
Gomes et 
al., 2006) 
Corn starch and 
polycaprolactone (PCL)  
Rat MSCs Continuous 
unidirectional flow, 0.3 
ml/min, 1 ml/min 
Enhanced cell differentiation 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Janssen et 
al., 2006) 
Biphasic calcium 
phosphate (OsSatura™, 
IsoTis, The Netherlands), 
10 cc of granules Ø 2 ~ 6 
mm 
Goat MSCs Continuous 
unidirectional flow, 4 
ml/min 
Homogeneous and viable cell layer, dense layer of 
extracellular matrix, abundant de novo bone 
formation after 6 weeks implantation 
(Holtorf, 
Jansen, et 
al., 2005) 
Titanium fibre mesh  Rat MSCs Continuous 
unidirectional flow, 0.3 
ml/min first day, then 1 
ml/min 
Increased mineralization, cellularity, ALP activity, 
OPN secretion even in the absence of 
dexamethasone; further enhanced by 
dexamethasone 
(Holtorf, 
Sheffield, et 
al., 2005) 
60% hydroxyapatite/40% 
β-tricalcium phosphate  
Rat MSCs Continuous 
unidirectional flow, 0.3 
ml/min first day, then 1 
ml/min 
Increased cell number, ALP activity, OPN secretion 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Zhao et al., 
2007) 
Poly (ethylene 
terepthalate) (PET)  
hMSCs Continuous unidirectional 
flow, 0.1 ml/min, 1.5 
ml/min  
1.4 times higher proliferation, more fibronectin 
secretion at 0.1 ml/min; upregulated ALP activity and 
calcium matrix deposition at 1.5 ml/min 
(Grayson et 
al., 2008) 
Decellularized bovine 
trabecular bone 
hMSCs Continuous unidirectional 
flow, 100 µm/s, 400 µm/s  
Flow at 400 µm/s radically improved cell numbers, 
cell distribution, bone minerals and proteins 
(Jaasma and 
O’Brien, 
2008) 
Collagen-
glycosaminoglycan  
MC3T3-E1 
osteoblastic 
cells 
Continuous unidirectional 
flow, 1 mL/min (~235 
µm/s), 0.05 ml/min (~11.8 
µm/s);  
Pulsatile flow, 0 - 1.0 
mL/min (peak-to-peak), 2 
Hz;  
Oscillatory flow, 1 mL/min 
(peak-to-peak), 1 Hz 
All types of flow showed increased COX-2 expression, 
PGE2 expression, OPN production; dynamic fluid flow 
was more stimulatory than steady fluid flow during 
long term culture. 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Jaasma et 
al., 2008) 
Collagen- 
glycosaminoglycan GAG  
MC3T3-E1 
osteoblastic 
cells 
Continuous unidirectional 
flow, 0.1 - 2 ml/min;  
Pulsatile flow, 0 - 1 mL/min 
(peak-to-peak), 2 Hz;  
Oscillatory flow, 1 mL/min 
(peak-to-peak), 1 Hz. 
All types of flow showed decreased cell number and 
increased PGE2 
(Du et al., 
2008) 
β-tricalcium phosphate  MC3T3-E1 
osteoblastic 
cells 
Oscillatory perfusion, 0.5 
ml/min (0.04 dyn/cm2), 
1/60 Hz 
Higher seeding efficiency, homogeneous cell 
distribution, ALP activity, cellularity 
(Du et al., 
2009) 
β-tricalcium phosphate  MC3T3-E1 
osteoblastic 
cells 
Continuous unidirectional 
flow, 1 ml/min; 
Oscillatory perfusion, 0.5 
ml/min, 1 ml/min 
Increased cell number; oscillatory let to increased ALP 
activity 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Xu et al., 
2008) 
β-tricalcium 
phosphate  
Sheep MSCs Continuous 
unidirectional flow, 3 
ml/min (~0.0029-0.027 
Pa) 
Increased proliferation, non-homogenous cell 
proliferation rate and cell coverage 
(Yang et al., 
2010) 
Polylactic glycolic acid 
(PLGA)  
hMSCs or hMSCs 
transduced with 
human 
telomerase 
catalytic subunit 
(hTERT) gene 
Continuous 
unidirectional flow, 0.2 
ml/min for 9 days and 
then 0.5 ml/min for 7, 14, 
21, 28 days 
 
Homogeneous seeding, Increased viability, 
proliferation, Induced osteogenic differentiation at 
0.5 ml/min 
(da Silva et 
al., 2010) 
Hydroxyapatite (HA) 
and silicate 
substituted HA (SiHA) 
dense tablets 
SaOs-2 
osteoblastic 
cells 
Continuous 
unidirectional flow, 
through BGS surface, 2 
ml/min 
Increased cell number and ALP activity on both BGS; 
faster adhesion process, longer and thinner focal 
adhesions on SiHA 
 
Chapter 1 
31 
 
Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Janssen et 
al., 2010) 
Biphasic calcium 
phosphate 
(OsSatura™, IsoTis, 
The Netherlands), 
10 cc of granules Ø 
2 ~ 6 mm 
hMSCs Continuous 
unidirectional flow, 4 
ml/min (108 µm/s) 
Homogeneous and viable cell layer, dense layer of 
extracellular matrix; no difference in osteogenic 
markers compared with static culture; abundant de 
novo bone formation but no difference compared 
with static culture 
(Bjerre et 
al., 2011) 
HA Pro Osteon®  hMSCs Continuous 
unidirectional flow, 
0.1 ml/min 
Decreased vitality, proliferation and differentiation 
(Yu et al., 
2012) 
Polycaprolactone 
(PCL) /hydrogel 
Rat MSCs Continuous 
unidirectional flow, 
0.6 ml/min 
Increased proliferation, opn, oc, and bsp expression 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Barron et 
al., 2012) 
Calcium phosphate  MC3T3-E1 
osteoblastic 
cells coculture 
with mouse 
microvascular 
endothelial cells 
(EOMA) 
Continuous bidirectional 
flow, 0.075 mL/min 
Downregulated vegf and opn expression at early 
timepoints; Increased alp and oc expression at day 7; 
Increased cell number, cell/matrix area coverage, 
angiogenic activity at day 14 
(Kim and 
Ma, 2012) 
Poly (ethylene 
terepthalate) (PET)  
hMSCs Continuous unidirectional 
flow at BGS surface (PF), 0.2 
ml/min; 
Continuous unidirectional 
flow through bone graft 
substitue (TF),  
0.2 ml/min 
PF: retained ECM protein, and mitogenic growth 
factors, preserve hMSCs proliferation 
TF: induced osteogenic differentiation, higher ALP, 
calcium deposition, osteogenic markers 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Pisanti et 
al., 2012) 
Poly (L-Lactic acid) 
(PLLA)  
hMSCs Continuous unidirectional 
flow, 0.3 ml/min 
Increased ALP activity, bmp2 expression 
(Correia et 
al., 2013) 
 
Silk fibroin disk  Human adipose 
stem cells 
(hASC) 
Steady perfusion, 
continuous unidirectional 
flow at 400 µm/s for 5 
weeks; 
Dynamic perfusion, 
continuous unidirectional 
flow at 400 µm/s for 2 
weeks, followed by 3 weeks 
pulsatile flow, velocity 
fluctuating between 400 
and 1200 μm/s at 0.5 Hz  
Dynamic perfusion group showed increased opn 
expression, PGE2 synthase expression, OPN, BSP, COL 
I protein deposition and mineral deposition 
compared with steady perfusion group 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Yeatts et 
al., 2014) 
 
Poly (lactic-co-
glycolic 
acid)/polycaprolact
one (PLGA/PCL)  
hMSCs Continuous unidirectional 
flow, 1 ml/min 10 days then 
in vivo implantation 
Increased new bone area, bone regeneration 
(Wang et 
al., 2014) 
β-tricalcium 
phosphate  
Rabbit 
osteoblasts 
Continuous unidirectional 
flow, 0.5 ml/min for day, 
followed by 2 ml/min 
Increased cell viability, ALP activity; better bone 
formation, compression strength in vivo 
(Filipowska 
et al., 2016) 
Gelatin-coated 
polyurethane (PU) 
disc 
hMSCs Continuous unidirectional 
flow, 2.5 ml/min  
Increased oc, opn, bsp and bmp2 expression 
(Tang et al., 
2017) 
polyurethane  Rat MSCs Continuous unidirectional 
flow, 10 ml/min 
Increased viability, proliferation, type I and III 
procollagen, equilibrium modulus 
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Table 1-1 cont. 
Reference BGS types Cell types Flow regimen Observation 
(All observations were compared with static culture) 
(Ismail et 
al., 2017) 
Porous HA 
(Engipore) 
 
Stromal vascular 
fraction (SVF) 
cells 
Oscillating perfusion, 1 
ml/min  
Accelerated initial vascularization, Increased bone 
formation 
(Mitra et al., 
2017) 
PLG/HA 
composite disk  
hMSCs Continuous 
bidirectional perfusion 
3 ml/min  
Increased proliferation, Ca, OC content, neovascularization 
globally. Great bone volume fraction, bone mineral density, 
tissue ingrowth, collagen density after perfusion culture 14 
days than 1 or 7 days 
(Chen et al., 
2017) 
Collagen/HA  Rat MSCs Oscillatory perfusion, 1 
ml/min, 1/60 Hz 
Increased viability, cell distribution uniformity, ECM, COL I 
secretion and mineral deposition, osteogenic 
differentiation 
(Vetsch et 
al., 2017) 
Silk fibroin  hMSCs Continuous 
unidirectional flow, 
0.001 m/s, 0.061 m/s 
Increased metabolic activity, DNA; Increased ECM 
formation, osteogenic differentiation at 0.061 m/s; 
decreased ECM formation, osteogenic differentiation at 
0.001 m/s 
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1.6 Aims and Objectives 
A substantial number of BGS materials have been developed for clinical use, and 
some of them claim to be osteoinductive. Various theories have been proposed to 
explain the claimed osteoinductivity, such as response to modulation of local 
mechanical environment, cells response to bone graft surface roughness, increased 
bone graft surface area, increased ion exchange, or increased nutrient transfer due 
to increased pore connectivity. Bone mechanosensitivity has been extensively 
acknowledged, and mechanical stimulus have been shown to significantly influence 
cellular behaviour. However, so far, studies of in vitro BGS efficacy evaluation and 
mechanism investigation were traditionally carried out in a static environment which 
does not represent the environment that cells are exposed to in vivo. Therefore, 
there is a clear need to develop a dynamic in vitro system, which includes mechanical 
perturbation, in order to investigate how BGS work and further develop smart BGS 
materials. 
The hypothesis of this thesis is that synthetic bone graft architecture has an influence 
on osteogenic cell responses through its interaction with local mechanical 
environment. Therefore, to investigate the response of osteogenic cell responses to 
BGS macrostructure and microstructure, a test system should expose the cell seeded 
BGS to (i) direct strain and local fluid shear (ii) a local fluid shear in isolation (iii) a 
specific pattern/level of fluid shear. 
The aims of this PhD research were to incorporate these mechanical forces in a 3D 
bioreactor system, examine the influence of BGS architecture on cell responses to 
probe the mechanism behind the excellent clinical performance of hierarchical 
porosity in SiHA BGS. 
The flow diagram of this PhD research can be seen in Figure 1-3. This PhD thesis is 
composed of 7 chapters. Chapter 1 opens with studies in the literature about bone 
composition and structure, bone mechanobiology, bone healing, BGS and 
bioreactors. Chapter 2 describes the experimental procedures used in this PhD for 
the synthesis and characterization of SiHA BGS, cell culture model, 3D bioreactor 
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system and cellular response characterization. In Chapter 3, an in vitro 3D bioreactor 
system for application of direct strain and local fluid shear on cell-seeded SiHA BGS 
granules was validated. Parameters of seeding cells on SiHA BGS granules in the 
perfusion chamber were optimized. The response of osteoblastic-like MG63 cells to 
mechanical stimulation was investigated. In Chapter 4, SiHA granules consisting of 
equivalent levels of total porosity but various levels of micro-porosity, and SiHA 
granules consisting of equivalent levels of micro-porosity but various levels of total 
porosity were synthesised and characterised. The structural guidance of SiHA 
granules on human mesenchymal stem cells (hMSCs) proliferation and 
differentiation in static environment were examined. In Chapter 5, hMSCs were 
cultured on SiHA granules with defined micro-porosity in a static, basal perfusion rate 
(BPR) or a period of high perfusion rate (pHPR) environment. The synergistic effect 
of BGS micro-porosity and shear stress on responses of hMSCs was studied. In 
Chapter 6, the modulation of L-type voltage-sensitive calcium channels (VSCCs) on 
fluid shear stress induced differentiation of hMSCs cultured on 3D SiHA BGS was 
investigated. Chapter 7 describes the conclusions about the work in this PhD thesis, 
and future perspectives on BGS and 3D bioreactor systems.  
 
Figure 1-3 Flow diagram of the current PhD research. 
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Chapter 2 Materials and Methods 
2.1 SiHA Granules Synthesis 
SiHA has been successfully used as bone filler in clinic in the form of granules which 
are easy to shape to fit the defect size (Harshavardhana and Noordeen, 2015). 
Macro-porosity (the bulk of the pore fractions) and micro-porosity (fraction of 
porosity within the BGS body) (Hing et al., 2005) of BGS play important roles in 
bioactivity of SiHA BGS. SiHA granules with different macro-porosities and micro-
porosities were synthesised and their bioactivities were evaluated in in vitro 
experiments. 
Dried silicate substituted hydroxyapatite (SiHA) precipitate cakes containing 0.8 wt% 
silicon were provided by Baxter Inc. They were crushed into small pieces, using a 
pestle and mortar and passed through a 1 cm sieve. The small pieces were disc-milled 
and then calcined at 700 oC for 4 hours to reduce any moisture. 
Table 2-1 Parameters of foaming process to produce different SiHA granules. 
 SiHA-14 SiHA-22 SiHA-28 SiHA70 
SiHA powder (g) 560 ± 1 560 ± 1 490 ± 1 730 ± 1 
Deionized water (g) 867 ± 2 867 ± 2 805 ± 2 1087 ± 2 
Milling media (g) 4254 ± 5 4254 ± 5 4454 ± 5 5625 ± 5 
First ball milling time (min) 90 ± 1 65 ± 1 10 ± 1 90 ± 1 
PVA (g) 130 ± 1  130 ± 1  240 ± 1 170 ± 1 
 
Calcined SiHA power was used to produce the different porous granules samples. 
Different amount of SiHA power, deionized water (Table 2-1) were added in a milling 
pot and mixed into a paste. Milling media (ceramic milling balls) were added to this 
paste (Table 2-1) and then the pot was sealed using nuts and bolts to avoid leaking. 
The whole container was ball milled firstly at a rate of 270 rpm onto a ball mill 
machine for the different time (Table 2-1). Polyvinyl alcohol (PVA) was dissolved in 
double distilled water and used as binder solution. When the first ball mill finished, 
the pot was opened and PVA (Table 2-1) was added into the pot, which was sealed, 
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and ball milled for a further 3 hours. After 3 hours, the foam was sieved to remove 
all milling media and then transferred to plastic moulds and dried at 40 - 50 oC for 48 
hours (Genlab, drying cabinet). Once dried, the foam was demoulded and sintered at 
1250 oC in a (Lenton, AWF) for 4 hours. Large pieces of sintered SiHA foam were 
collected for total porosity and micro-porosity quantification and the rest of sintered 
SiHA foam was gently crushed and sieved using 2 mm and 1 mm sieves to achieve 1-
2 mm diameter SiHA granule fraction, which were used in cell culture experiments in 
the current thesis. 
2.2 Materials Characterization 
2.2.1 X-ray Diffraction (XRD) 
XRD was used for determining the crystal structure of SiHA samples. The 
fundamental principle of XRD is that every crystal structure has unique atomic 
spacing and inter-planar spacing. Monochromatic X-ray is generated and directed 
toward the sample, when wavelength of the incident X-ray (λ), angle of incidence (θ) 
and crystal inter-planar spacing (d) satisfy Bragg’s Law (nλ = 2dsinθ, n is the “order” 
of reflection), the interaction of the incident rays with the sample produces 
constructive interference and a diffracted ray (Figure 2-1). During scanning, sample 
and detector are rotated, so X-ray is irradiated with a range of 2θ angles, the intensity 
of reflected X-ray is recorded, converted to spectra and compared with reference 
patterns, in order to identify or verify the nature of the phases present in the sample. 
 
Figure 2-1 Schematic diagram of Bragg’s Law. 
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Small SiHA granules (φ<1 mm) were used to obtain XRD patterns using a XPERT-Pro 
diffractometer (Philips). The monochromatic Cu-Kα radiation was operated at a voltage 
of 45 KV and 40 mA, and the data were acquired at a 2θ of 20o to 40o with a step size 
of 0.02o at 2.5 s per step. Phases were identified by comparing the obtained 
diffraction patterns with International Committee for Diffraction Data (ICDD) file 
cards 9-432, 37-1497, 25-1137, 9-348 and 9-169 for HA, calcium oxide (CaO), 
tetracalcium phosphate (Ca4(PO4)2O), α and β-tricalcium phosphate (Ca3(PO4)2) 
respectively. 
2.2.2 Density and Total Porosity Measurement 
The total porosity and apparent porosity were measured by water saturation method 
based on Archimedes’ principle. SiHA pieces were weighed in a dry condition three 
times (Wdry), and then were placed in boiling deionised water for 60 mins to ensure 
all open pores were filled with water. Sample were allowed to cool before being 
weighed three times while submerged in deionised water at known temperature 
(Wsub). Then they were taken out of the water and weighed while saturated with 
water (Wsat). The apparent density (taking into account of both open pores and 
closed pores), the real density (taking into account only closed pores) and the total 
porosity can be calculated using the following equations, of which 𝜌𝐻2𝑂  is the 
density of deionised water at the measurement temperature, and an accepted 
value(Akao et al., 1981) of 3.156 g/cm3 was used for the theoretical apatite density 
(𝜌𝐻𝐴). 
𝜌𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡 =
𝑊𝑑𝑟𝑦
𝑊𝑠𝑎𝑡−𝑊𝑠𝑢𝑏
∗ 𝜌𝐻2𝑂                                           Equation 1.1 
𝜌𝑟𝑒𝑎𝑙 =
𝑊𝑑𝑟𝑦
𝑊𝑑𝑟𝑦−𝑊𝑠𝑢𝑏
∗ 𝜌𝐻2𝑂                                                    Equation 1.2 
𝑇𝑜𝑡𝑎𝑙 𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = (1 −
𝜌𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡
𝜌𝐻𝐴
) ∗ 100%                         Equation 1.3 
2.2.3 Micro-Porosity Measurement 
Micro-porosity of SiHA BGS was analysed using quantitative metallography methods 
(Hing et al., 1999). SiHA samples were embedded in resin (EpoFix, Struers), polished, 
coated with gold using sputter coater and imaged with secondary electron imaging 
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using scanning electron microscope (SEM) (FEI inspect F) at 300× magnification. Six 
images for each sample were taken and analysed to quantify the micro-porosity 
(number of pixels under and above an optically set threshold values of grey tones) in 
microporous regions by NIS element image analysis software (Nikon).  
2.3 Cell Culture Models 
Appendix 2 lists the supplier and CatLog number of all cell culture and molecular 
analysis chemicals used in this PhD study. Some key chemicals are also defined in the 
main body of the text. 
2.3.1 MG-63 Osteoblast Cell Line Culture 
Cryopreserved human MG-63 cells were seeded at a density of 4000 cells/cm2 in T-
75 flasks in basic cell culture medium (BM) (Table 2-2) at 37 oC in a humidified 
incubator with 5% CO2. 
Table 2-2 Components of basic cell culture medium (BM) for cell culture in T-75 flasks in 
CO2 atmosphere. 
 
 
 
 
 
Culture medium was replaced every two to three days. 70% to 90% confluent cells 
were detached by trypsin-EDTA solution and were subcultured at a density of 4000 
cells/cm2 in T-75 flasks in 15 ml basic cell culture medium. Passage 4-5 of MG-63 cells 
were used in the study.  
2.3.2 Human Bone Marrow Derived MSCs Culture 
Cryopreserved human bone marrow derived mesenchymal stem cells (hMSCs) 
(PromoCell, Lot: 403Z003.2.) were seeded at a density of 4000 cells/cm2 in T-75 flasks 
in 15 ml MSC growth medium 2 (PromoCell) at 37 oC in a humidified incubator with 
5% CO2. Culture medium was replaced every two to three days. 70% to 90% confluent 
Component Supplier 
CatLog 
number 
Volume 
High glucose Dulbecco's  
Modified Eagles Medium (DMEM) 
(contains NaHCO3 buffer) 
Sigma D6429 15 ml 
Fetal bovine serum (FBS) Sigma F9665 1.5 ml 
Penicillin-Streptomycin Sigma P4333 150 μl 
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cells were detached by Accutase solution, which contains proteolytic and 
collagenolytic enzymes, and is a gentle alternative cell detachment solution to trypsin. 
hMSCs were then subcultured at a density of 4000 cells/cm2 in T-75 flasks in 15 ml 
MSC growth medium 2. Passage 4-5 of hMSCs were used in the experiment.  
2.4 Perfusion Bioreactor System 
Cell seeded BGS were subjected to flow induced shear stress using an in-house 3D 
perfusion bioreactor system (Figure 2-2). The perfusion bioreactor system consists 
independent chambers and each chamber (diameter: 8 mm; height: 16 mm) 
accommodates one construct (i.e. cells were seeded on 0.47 ± 0.03 g of BGS granules 
packed in the chamber). Culture medium from the reservoir was perfused through 
the constructs vertically in a bottom-to-top direction using a peristaltic pump (IPC 
Iamatec, VWR). Experiments could be performed in both media flow to waste and 
recirculating configurations. The details of cell culture media used varied with cell 
type and experiment and are included in each chapter. 
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Figure 2-2 (a) Schematic diagram of flow to waste perfusion and compression system. (b) 
schematic diagram of recirculating perfusion bioreactor system. 
2.5 DNA Quantification 
Total DNA was quantified by using a Quant-iT PicoGreen dsDNA Assay kit (Invitrogen, 
UK). The PicoGreen dsDNA reagent is an ultrasensitive fluorescent nucleic acid stain 
for quantifying double-stranded DNA (dsDNA) in solution. Therefore, it is a very good 
indicator of DNA levels in specific samples. 
Medium from each sample was aspirated and the BGS were then washed three times 
with phosphate buffered saline (PBS) and submerged into 1 ml of 0.05% Triton TX for 
cell lysis. Cell lysates were collected, frozen at -80 oC and then thawed for 3 cycles, 
sonicated for 5 minutes and centrifuged at 4 oC at 12000 rpm for 15 mins. The 
Cell culture medium (100 ml/day 
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resultant supernatant solutions from each construct were then collected for DNA 
quantification. The DNA quantification kit provided a 100 µg/ml lambda DNA solution 
which was diluted 50-fold in premade Tris-HCL EDTA (TE) buffer (1 ml 200 mM Tris-
HCl, 20 mM EDTA, pH 7.5, mixed with 19 ml distilled DNAse-free water) to make a 2 
μg/ml stock solution of dsDNA in TE buffer. The 2 μg/ml dsDNA stock solution was 
then 2-fold serial diluted for 8 times to make standards.  
 
Figure 2-3 Calibration curve for DNA concentration. 
100 μl of each standard or sample supernatant was then incubated with 100 μl of 
PicoGreen working solution (dilute concentrated PicoGreen DMSO solution 200-fold 
in TE buffer). Then the plate was incubated for 2 to 5 mins at room temperature and 
the fluorescence was read at excitation and emission wavelength of 480 nm and 592 
nm respectively using plate reader (BMG LABTECH, FLUOstar OPTIMA). A standard 
curve of fluorescence versus DNA concentration was generated using standards, and 
DNA concentration from unknown samples was calculated from the DNA standard 
curve (Figure 2-3). 
2.6 Specific ALP Activity Assay 
ALP activity was quantified by using a highly sensitive colorimetric ALP Assay Kit 
(Abcam). The kit uses p-nitro phenyl phosphate (pNPP) as a phosphatase substrate 
which turns yellow (λmax = 405 nm) when dephosphorylated by ALP enzyme. 
Medium from each sample was aspirated and BGS granules were then washed three 
times with ice cold PBS and submerged into 1 ml of ice-cold alkaline phosphatase 
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assay buffer from the kit for cell lysis. Cell lysates were frozen at -80 oC and then 
thawed for 3 cycles, sonicated for 5 minutes, centrifuged at 4 oC at 12000 rpm for 15 
mins and the supernatant was used to test ALP activity. 10 mM 4-nitrophenol (4NP) 
(Sigma) was diluted 10 times to make 1 mM 4NP, and then 2-fold serial diluted for 8 
times to make standards. 
 
Figure 2-4 Calibration curve for ALP concentration. 
80 μl of each standard or supernatant was then incubated with 50 μl of 5.4 mM pNPP 
buffer (2 p-nitro phenyl phosphate (pNPP) tablets dissolved in 5.4 ml of assay buffer) 
in clear 96 well-plate at 37 oC for 40 mins. The reaction was stopped using 20 μl of 
sodium hydroxide, and the final absorbance was read at 405 nm using a microplate 
reader (BMG LABTECH, SPECTROstar). A standard curve of absorbance versus 4NP 
concentration was generated using standards, and 4NP dephosphorylated by ALP 
from unknown samples were calculated from the standard curve (Figure 2-4). Specific 
ALP activity was calculated by the equation below.  
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝐿𝑃 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
=
4𝑁𝑃 𝑑𝑒𝑝ℎ𝑜𝑠𝑝ℎ𝑜𝑟𝑦𝑙𝑎𝑡𝑒𝑑 𝑏𝑦 𝐴𝐿𝑃 𝑓𝑟𝑜𝑚 𝑢𝑛𝑘𝑛𝑜𝑤 𝑠𝑎𝑚𝑝𝑙𝑒 (𝑛𝑚𝑜𝑙)
 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡 𝑣𝑜𝑙𝑢𝑚𝑒(𝑚𝑙) ∗ 𝑟𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒(min) ∗ 𝐷𝑁𝐴 (µ𝑔)
 
2.7 Alizarin Red S Staining 
2 g Alizarin Red S (Sigma) was dissolved in 100 ml of ddH2O and pH was adjusted to 
4.1-4.3 with HCL or NH4OH. The solution was then filtered through 0.22 µm 
membrane and stored at 4 oC in dark. Medium from each 24 wells was aspirated, and 
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cells were gently washed with 1 ml PBS. 1 ml 4% (w/v) formaldehyde in PBS was 
applied to the cells and incubated for 1 hour at room temperature. This was followed 
by aspirating formaldehyde solution and cells were washed with 1 ml of ddH2O twice. 
1 ml of freshly made Alizarin Red S solution was added to each well and incubated at 
room temperature for 45 mins in dark. After incubation, Alizarin Red S solution was 
removed and cells in each well were washed 5 times with 1 ml ddH2O. 1 ml PBS was 
applied to each well after washing. Osteoblasts with extracellular calcium deposits 
are bright orange-red colour while undifferentiated osteoblasts without extracellular 
show slight red colour. 
2.8 Immunofluorescence Methods 
Prior to fixation, the cell culture medium was removed and the BGS granules with 
cells were briefly washed with PBS, and then cells on BGS were immediately fixed in 
4% (w/v) paraformaldehyde in PBS solution at room temperature for 10 min. BGS 
granules with cells were washed three times for 5 min in PBS then cells on BGS were 
permeabilised with 100% methanol at -20 oC for 10 mins and rinsed with PBS. Cells 
on BGS were blocked in blocking buffer (PBS with 5% (v/v) fetal bovine serum and 
0.3% triton) for 1 hour to reduce non-specific antibody interactions. The steps 
described above were all conducted at room temperature. 
Cells on BGS were incubated with primary antibody at 4 oC overnight in staining 
buffer (PBS with 1% (w/v) bovine serum albumin (BSA) and 0.3% triton at a suitable 
concentration (Table 2-3). Cells on BGS were then washed three times for 5 min in 
PBS then incubated for 2 hours with species-specific fluorescent secondary 
antibodies at room temperature (Table 2-4). Following this, cells on BGS were 
incubated with 5 μl methanolic alexa fluor 488 phalloidin (Thermo Fisher Scientific, 
UK) stock solution into 500 μl PBS at room temperature for 30 min to label F-actin 
then washed three times for 5 min in PBS. Cells on BGS were further incubated with 
1 µl of 1 mg/ml diamidino-2-phenylindole (DAPI) stock solution (Thermo Fisher 
Scientific) into 1 ml of PBS at room temperature for 5 min to label cell nuclei then 
washed three times for 5 min. Cells on BGS were imaged using a Zeiss LSM510 laser 
scanning confocal microscope, with 30-50 z-sections taken through the cells at 1.5 
µm intervals. Maximum projections of z-stacks were processed by the Zeiss ZEN 
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software. Quantification of the nucleus and cellular size were performed using Image 
J software. 
Table 2-3 Primary antibodies used in this thesis. 
Target Species Supplier Catalog 
number 
Use Dilution 
RUNX2 Mouse Abcam ab76956 IF 1:100 
ERK1/2 Rabbit Cell Signalling Technology mAb #4695 IF 1:500 
pERK1/2 Rabbit Cell Signalling Technology mAb #4370 IF 1:200 
ERK1/2 Rabbit Cell Signalling Technology mAb #4695 WB 1:1000 
pERK1/2 Rabbit Cell Signalling Technology mAb #4370 WB 1:2000 
GAPDH Mouse Abcam ab9484 WB 1:2000 
 
Table 2-4 Secondary antibodies used in this thesis. 
 
2.9 Western Blotting 
2.9.1 Cell Lysate Preparation 
Prior to lysis, cells attached to BGS granules were washed three times with ice cold 
PBS. Cells from each sample were then lysed in ice cold 500 µl RIPA lysis extraction 
buffer supplemented with 1% (v/v) Halt protease and phosphatase inhibitor cocktail 
(Life Technology), incubated on ice for 15 min, sonicated for 30 s to increase the yield, 
and then centrifuged at 14000 rpm at 4 oC for 15 min. The supernatant was collected 
either immediately subjected to total protein quantification or stored at -20 oC for 
later use. 
Target Supplier Catalog number Use Dilution 
Alexa Fluor 647 goat anti-mouse  Abcam ab150119 IF 1:500 
Alexa Fluor 594 donkey anti-rabbit  Abcam ab150064 IF 1:200 
IRDye® 680RD goat anti-mouse  Licor P/N 925-68070 WB 1:15000 
IRDye® 800CW donkey anti-rabbit  Licor P/N 925-32213 WB 1:15000 
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2.9.2 Total Protein Quantification 
Total protein was quantified by using pierce BCA protein assay kit (Thermo Fisher 
Scientific). In an alkaline environment, Cu2+ in the reagent is reduced to Cu1+ which 
chelates with protein to form a light blue complex, then bicinchoninic acid (BCA) 
reacts with the Cu1+ and forms an intense purple-coloured complex which exhibits a 
strong linear absorbance at 562 nm. The intensity of absorbance at 562 nm increases 
with protein concentration. 2 mg/ml bovine serum albumin (BSA) stock from the kit 
and lysis buffer were used to make standards as listed in Table 2-5. 
Table 2-5 BSA standard solution preparation. 
Standard BSA (µg/mL) Vol 2 mg/mL BSA (µL) Vol lysis buffer (µL) 
Blank 0 0 100 
STD1 20 1 99 
STD2 100 5 95 
STD3 250 12.5 87.5 
STD4 500 25 75 
STD5 900 45 55 
STD6 1,400 70 30 
STD7 2,000 100 0 
 
10 μl of protein supernatant from each sample or each standard was incubated with 
200 μl of working solution (made with 50 parts of reagent A and 1 part of reagent B) 
in triplicate in wells of a clear 96 well-plate. The plated was mixed thoroughly on a 
plate shaker for 30 s and then incubated at 37 oC for 30 min. After allowing the plate 
to cool down to room temperature, the absorbance was measured at 562 nm using 
a plate reader (BMG LABTECH, SPECTROstar). A standard curve of absorbance versus 
protein concentration was generated using standards, and protein concentration 
from unknown samples was determined from the protein standard curve. 
2.9.3 Electrophoretic Separation of Proteins 
Lysis buffer was used to dilute samples to get same protein concentration (20 µg/50 
µl) for each, according to the protein concentration of each cell lysate as measured 
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using BCA. Loading buffer was made by mixing 900 μl of Leammli 4* concentrate and 
100 μl of reduction reagent mercaptoethonal. 45 µl diluted protein sample was then 
mixed with 15 µl loading buffer, heat denatured by heating in a heat block at 100 oC 
for 5 min, and then chilled on ice.  
Chilled samples were centrifuged down, mixed, and 50 µl cell lysate and loading 
buffer mix was loaded to each well and run on 4 - 20% Mini-PROTEAN® TGX™ Precast 
Protein Gels in tris/glycine/SDS running buffer at 150 mV for 1 hour. Pre-stained, 
strep-tagged recombinant proteins (10 - 250 kD) standards were run alongside the 
samples. 
2.9.4 Immunoblotting and Band Quantification 
Following electrophoresis, the gels were transferred to low-auto fluorescence PVDF 
membrane by semi-dry transfer method using a Trans-Blot Turbo transfer system and 
Trans-blot SD semi-dry transfer cell (Biorad, UK). A single gel was transferred at 2.5A, 
25 V for 3 min for, but when two gels were transferred, the time was extended to 5 
min.  
Following transfer, membranes were blocked with 15 ml 5% (w/v) BSA in tris buffered 
saline (TBS) for 1 hr at room temperature. After blocking, membranes were 
incubated with the appropriate primary antibodies overnight at 4 oC (Table 2-3). 
Following this, membranes were washed three times for 5 min in TBS with 1% (v/v) 
tween20 (TBST), and then incubated with the appropriate species-specific infra-red 
secondary antibodies (Table 2-4) in 5% (w/v) BSA in TBS for 1 hr at room temperature. 
This was followed by two 5 min washes in TBST and one final wash in TBS. 
Membranes were imaged using the Licor Odyssey infrared scanner and densitometry 
was performed using Image J software to quantify band intensity. 
2.10 Quantitative Gene Expression 
2.10.1 RNA Isolation 
BGS samples with attached cells were rinsed three times with ice cold PBS, and then 
lysed in 1 ml of tri-reagent (Life Technology). The cell lysate was collected and either 
immediately subjected to RNA isolation or stored at -80 oC for later use. 0.2 ml pure 
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chloroform was added to each sample, and then centrifuged to separate the upper 
aqueous RNA phase. The RNA phase was purified using RNeasy Mini Kit (QIAGEN). 
Briefly, total RNA binds to the column and the remaining lysate which passes through 
the column upon centrifugation (12000 rpm for 15 s) was discarded. Following this, 
the bound RNA was washed once with 700 µl RW1 buffer, twice with 500 µl buffer 
RPE, and then centrifuged in a fresh collection tube to remove any remaining RPE 
buffer. The column was then transferred to a clean collection tube and the RNA was 
eluted in 30 µl of RNAse free water. 
The purity of RNA was determined using the Nanodrop ND-1000 spectrophotometer 
(LabTech). Pure RNA exhibits an A260/280 absorbance ratio of 2.0. Also RNA content 
of the sample can be quantified by measuring the absorbance of the samples at 260 
nM, and an absorbance of 1 unit at 260 nm corresponds to 40 μg/ml of RNA. 
2.10.2 cDNA Synthesis 
The process comprises two steps 1) RNA denature: 1 μl of random primer was mixed 
with 4 μl of RNA template, denatured at 70 oC and then chilled on ice for 5 min. 2) 
Reverse transcription: reverse transcription reaction mix was prepared according to 
reaction 1, and then combined with 5 μl of denatured RNA and primer mix from step 
1. Following this it was annealed in a heat block at 25 oC for 5 min, extended at 42 oC 
for 60 min and then reverse transcriptase was inactivated at 70 oC for 15 min. 
Reaction 1: 
GoScript 5* reaction buffer 4 μl 
MgCl2 (25 mM) 2.4 μl 
PCR Nucleotide Mix (10 mM) 1 μl 
Recombinant RNasin ribonuclease inhibitor 1 μl 
GoScript reverse transcriptase 1 μl 
RNeasy free water 5.6 μl 
Final Volume 15 μl 
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2.10.3 Primer Design 
Primers were designed based on the sequences published in GenBank using Primer-
BLAST tool and synthesised in Sigma. Sequence information for primers used in this 
thesis are shown in Table 2-6. 
Table 2-6 Human primers for PCR. 
2.10.4 Quantitative Real Time Polymerase Chain Reaction (qPCR) 
Levels of gene expression were measured by qPCR and was conducted using SYBR 
Green dye-based assay. SYBR Green dye is a fluorescent DNA binding dye that 
preferentially binds to double-stranded DNA (dsDNA). It has an excitation and 
emission wavelength of 494 nm and 521 nm, respectively. Excitation of DNA-bound 
SYBR Green dye produces a much stronger fluorescent signal compared to unbound 
dye. The fluorescence signal (at 521 nm) of DNA-bound SYBR Green dye is monitored 
during the annealing and extension phases of the qPCR reaction. The threshold of 
the qPCR reaction is the level of the fluorescence signal that reflects a statistically 
significant increase over the calculated baseline signal. It is set to distinguish relevant 
Gene Forward primer sequence (5’-3’) Reverse primer sequence (5’-3’) 
osx F- GAGTGGAACAGGAGTGGAGC R- GCTTGTAAAGGGGGCTGGAT 
alp F- CCGTGGCAACTCTATCTTTGG R- GCCATACAGGATGGCAGTGA 
bmp2 F- GACGGACTGCGGTCTCCTAAAG R- CTGACCTGAGTGCCTGCGATAC 
col i F- CCCCGAGGCTCTGAAGGT R- CACCAGCAATACCAGCAGCA 
dmp1 F- AGCATCCTGCTCATGTTCCTTT R- GAGCCAAATGACCCTTCCATT 
runx2 F- AGGCAAGAGTTTCACCTTGA R- CCTGGGGTCTGTAATCTGAC 
sox9 F- AAAGGCTACGACTGGACGCT R- AGATGTGCGTCTGCTCCGT 
col ii F- GTGTCACGGCCAGGATGTC R- GCAGAGGACAGTCCCAGTGT 
myoD F- GGTCCCTCGCGCCCAAAAGAT R- CAGTTCTCCCGCCTCTCCTAC 
Integrin α1 F- CGCTGCTGCGTATCATTCAA R- GGCCAACTAACGGAGAACCA 
Integrin α5 F- CCTATGAGGCTGAGCTTCGG R- GGTGCAGTTGAGTCCCGTAA 
Integrin β1 F- GCCGCGCGGAAAAGATGAAT R- TCGCAAAACCAACTGCTGTG 
gapdh F- GATCATCAGCAATGCCTCC R- ATCACGCCACAGTTTCCC 
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amplification signal from the background. The threshold cycle (Ct) is the cycle 
number at which the fluorescent signal of the reaction crosses the threshold. 
qPCR was conducted on an Applied Biosystem Quantstudio 6 Flex Real-Time PCR 
system (Thermo Fisher Scientific) and analysed using Quantstudio Real-Time PCR 
software. Gene expression as quantified according to the comparative quantification 
algorithms Ct method, which compares the gene of interest (GOI) from 
experimental samples with both a calibrator (i.e. untreated or control sample) and 
glyceraldehyde 3-phosphate dehydrogenase (gapdh) as a house keeping (hk) gene. 
gapdh is one of the most commonly used housekeeping gene with the assumption 
that it remains constant in the cells. With this method, CtGOI in both experimental 
sample (s) and calibrator (c) are adjusted in relation to Cthk from the two samples. 
The resulting Ct value is incorporated to determine the fold change in expression. 
Fold change = 2-Ct 
Ct = Ct sample - Ct calibrator 
Ct sample = CtGOI s - Cthk s 
Ct calibrator = CtGOI c - Cthk c 
The KAPA SYBR FAST Universal qPCR master mix (Sigma, UK) containing SYBR Green 
dye and passive reference dye ROX was used for qPCR. For QuantStudio System, low 
ROX from the kit was used to normalise for non-PCR-related fluctuations in 
fluorescence signal. PCR reactions were performed according to reaction 2.  
Reactions were performed on cDNA generated from 4 µg RNA and were diluted 1:10 
so that each reaction contained at least 10 ng of the original RNA. A sample 
containing nuclease-free water instead of template cDNA, the ‘no template control’ 
(NTC) is also run for each GOI to distinguish between actual gene expression and 
background contamination. All samples are run in triplicate to minimise pipetting 
error and a mean Ct value is obtained for each experimental replicate. 
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Reaction 2: 
cDNA 1 μl 
Low ROX (100*) 0.1 μl 
KAPA master mix 5 μl 
Primer (10 μM) 1 μl 
RNeasy free water 2.9 μl 
Final Volume 10 μl 
PCR reactions were performed according to the following process: firstly, the initial 
template was denatured into single-stranded DNA and polymerases were activated 
at 95 oC for 3 min. Secondly, there were 40 cycles of amplification which includes 3 
steps: 1) dsDNA was denatured to single-strands DNA at 95 oC for 10 s. 2) Primers 
attach to the specific location of template cDNA at a lower temperature (3 to 5 
degrees lower than melting temperature of primers) for 20 s. 3) A new strand of DNA 
was made by the KAPA SYBR DNA polymerase from the KAPA SYBR master mix at 72 
oC for 30 s. At last, dissociation step was conducted by denaturing all the components 
at 95 oC for 1 min, annealing at 55 oC for 30 s and then gradually increasing 
temperature to 95 oC while monitoring the fluorescence to generate a dissociation 
curve. 
While SYBR Green dye-based assay has the advantage of being more cost effective 
than other probe-based assays, its main drawback is less of specificity. Because SYBR 
Green dye binds to any amplified dsDNA product, regardless of target or non-target, 
and all such signals are summed, producing the amplification plot. It therefore 
requires primers to be accurately designed to only amplify the specific region of 
interest. Also, it is important to perform the dissociation analysis. By analysing the 
first derivative of the dissociation curve (a peak), homogeneity of the PCR product 
can be assessed, when combined with other information such as data from NTC 
sample, the specificity of the PCR reaction can be evaluated. 
2.11 Cell Morphology Characterization Using SEM 
Cell seeded BGS granules were chilled on ice for 30 min and then primarily fixed in 1 
ml of 1.5% glutaraldehyde buffered in 0.1 M sodium cacodylate (PH 7.2 - PH 7.4) and 
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incubated overnight at 4 oC. The primarily fixed granules are stained in 1% osmium 
tetroxide buffered in 0.1 M sodium cacodylate and incubated for 1 h at room 
temperature. The samples were then washed (5 mins, 3 times) with 0.1 M sodium 
cacodylate, incubated in 1% tannic acid dissolved in 0.05 M sodium cacodylate for 30 
mins at room temperature and then washed (5 mins, 3 times) with 0.1 M sodium 
cacodylate. The granules were then dehydrated by washing (5 mins, twice) in a 
graded series of ethanol (20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 96%) and 
followed by a final wash in 100% ethanol (10 mins, twice). Samples were then 
immersed in hexamethyldisilazane (HMDS) for 10 mins and air-dried. Finally, the 
samples were mounted on SEM stubs, coated with gold using sputter coater and then 
observed with secondary electron imaging at an accelerating voltage of 5 KV and a 
working distance around 10 mm using field emission (FE) scanning electron 
microscope.
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Chapter 3 Validation of an in vitro 3D Bioreactor for 
Application of Perfusion and Compression on Cells 
Cultured on SiHA BGS Granules 
3.1 Introduction 
Porous silicate substituted hydroxyapatite (SiHA) BGS have demonstrated excellent 
biocompatibility in vivo (Patel et al., 2002; Hing et al., 2006), particularly SiHA BGS 
granules which have the advantage of handling in clinic use. It has been shown that 
pore structure is critical to BGS performance in vivo (Hing et al., 2004; Hing et al., 
2005; Campion et al., 2011; Coathup et al., 2012). 
Cell seeding is generally performed under static conditions by inoculating cell 
suspensions onto BGS. Gravity action and capillary forces generated by porous BGS 
then encourage cell penetration within the BGS (Polak et al., 2013). Seeding cells 
onto BGS determines the initial cell number in the BGS, as well as their spatial 
distribution throughout the matrix. Therefore, seeding cells onto a BGS represents a 
crucial step, which is known to influence cellular viability, proliferation, migration, 
phenotypic expression and functionality of engineered tissues (Holy et al., 2000; Burg 
et al., 2000; Qi et al., 2004; Yang et al., 2010). The first aim of the current study 
concerned investigation of the seeding parameters, include cell density, cell 
suspension volume and incubation period for SiHA BGS granules to achieve optimal 
seeding. 
It is well known that mechanical loading plays an important role in bone remodelling 
and fracture healing (Lanyon and Rubin, 1984; Lanyon, 1993; Robling et al., 2002; 
Boerckel et al., 2012). Several researchers have hypothesized that flow of interstitial 
fluid is the most probable way of informing bone cells about mechanical loading 
(Knothe Tate et al., 1998; Sikavitsas et al., 2001). In BGS, fluid flow (shear stress) has 
been shown to enhance mineralized matrix deposition of marrow stromal 
osteoblasts (Bancroft et al., 2002; Sikavitsas et al., 2005; Porter et al., 2007; Chen et 
al., 2017), and benefit osteogenesis and bone formation in vivo (Wang et al., 2003). 
While shear stress has been extensively used to mechanically stimulate cells in 3D 
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BGS, mechanically stimulation from compression should also be considered, as 
compression generated BGS deformations was sufficient to regulate gene expression 
of cells (Hazenbiller et al., 2017). Several studies have used specially designed 
bioreactor systems to apply shear and compression at the same time (Bolgen et al., 
2008; Jagodzinski et al., 2008; David et al., 2008; Appelman et al., 2009; Baas et al., 
2010; C X Liu et al., 2012). Some of these bioreactors were developed and marketed 
by Bose®(Cartmell et al., 2011) and Zetos® (Davies et al., 2006; David et al., 2008), 
which were initially developed for the culture of natural tissues like bone or cartilage, 
and were not fully adaptable to stimulate cells seeded on SiHA BGS granules. 
Therefore, the second aim of this study was to develop a bioreactor that enables cell-
seeded SiHA BGS granules to be exposed to both shear stress and compression stress. 
Then cellular response to variation of BGS porosity can be investigated in the 
bioreactor. 
3.2 Method 
3.2.1 Seeding Investigation 
Irregularly shaped SiHA granules (φ: 1-2 mm) were synthesised using a slip foaming 
technique, as described in Chapter 2.1, which enabled independent control of the 
level of total porosity and the level of micro-porosity (Hing and Bonfield, 2000). SiHA 
granules with total porosity of 80.9 ± 1.9% and micro-porosity of 21.5 ± 1.4% (SiHA-
22) were used in all in vitro experiment in this chapter. A volume of 1 cm3 (0.47 ± 
0.03 g) of SiHA-22 BGS granules were gently packed in a silicone tube and sandwiched 
with a thin porous mesh, which retained granules in the tube and allowed cell culture 
medium to be perfused through the BGS. Two groups of cell suspension with 
different cell densities were prepared (Table 3-1):  
Table 3-1 Cell number and suspension volume of seeding investigation experiment. 
 1) 2) 
Cell Number 
(106 cells) 
0.2 0.08 0.1 0.175 0.25 0.5 1 
Suspension 
Volume (µl) 
400 500 600 700 500 
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1) 0.2 million of human osteoblast like cell line MG63 cells were suspended in 400, 
500, 600 or 700 μl of basic cell culture medium (BM) (high glucose Dulbecco’s 
modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin, as per Table 2-2);  
2) 0.08, 0.1, 0.175, 0.25, 0.5 or 1 million of MG63 cells were suspended in 500 μl of 
basic cell culture medium (BM, as per Table 2-2).  
Prepared MG63 cell suspensions were divided into two equal volumes and each was 
pipetted onto each construct from both ends and allowed to attach for 2 hours under 
static condition at 37 oC in a humidified incubator with 5% CO2 (Figure 3-1). After 2 
hours of attachment, BGS granules were transferred from silicone tubes to 24 well-
plates, rinsed three times with PBS to wash out the unattached cells and submerged 
into 1 ml of 0.05% Triton TX for cell lysis. Cell lysates were frozen at -80 oC and then 
thawed at room temperature for 3 cycles, sonicated for 5 minutes, centrifuged at 4 
oC at 12000 rpm for 15 mins. The resultant supernatant solutions from each BGS were 
then collected for DNA quantification as described in Chapter 2.5. 
                                    
Figure 3-1 Diagram of seeding cells on to construct and incubate for 2 hours in incubator.                                  
To visualize cell morphology on BGS with increasing lengths of time, BGS seeded with 
0.5 and 1 million cells in 500 μl of cell suspension were incubated in cell culture 
medium for up to 7 days after 2 hours of attachment, media was changed every other 
day. After 1, 3, 5 and 7 days, 3 samples from each group were used to quantify DNA, 
another 2 samples from each group were used for Scanning Electron Microscopy 
(SEM) visualization. BGS were transferred from the silicon sample tubes to 24 well-
Granules packed 
in silicone tube  Mesh 
Cell suspension 
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plates, chilled at 4 oC for 30 minutes, fixed, stained, dehydrated and visualized as 
described in Chapter 2.11. 
3.2.2 MG63 Cell Differentiation  
0.1 million MG63 cells in 1 ml basic cell culture medium were seeded in 24 well plates 
and incubated at 37 oC in a humidified incubator with 5% CO2. After one day the 
culture medium was replaced with either basic cell culture medium (BM, as per Table 
2-2) or BM enriched with osteogenic supplements (0.1 µM dexamethasone, 0.05 mM 
ascorbic acid and 10 mM β-glycerophosphate (Sigma-Aldrich)) (BMO). The medium 
was changed every 2 days thereafter. After 3, 7, 14, 25 and 38 days of incubation, 
total DNA amount and specific ALP activity of MG63 were quantified as described in 
Chapter 2.5 and 2.6. After 25 and 38 days of incubation, MG63 cells were fixed and 
extracellular calcium deposit was stained by using Alizarin Red S as described in 
Chapter 2.7.  
3.2.3 Perfusion and Compression Bioreactor 
Cell seeded BGS were subjected to mechanical stimulation using an in-house 3D 
perfusion bioreactor system (Figure 3-2). The perfusion bioreactor system consists of 
6 independent chambers and each chamber (diameter: 8 mm; height: 16 mm) 
accommodates one construct (i.e. cells were seeded on 0.47 ± 0.03 g of BGS granules 
packed in the chamber). Perfusion culture medium (Table 3-2) from 6 individual 
reservoirs was perfused through the constructs vertically in a bottom-to-top 
direction using a multichannel peristaltic pump (IPC Iamatec, VWR). The bioreactor 
system was designed to be able to be incorporated into Bose ElectroForce 5500 Load 
Frame System to allow compression and perfusion at the same time. MG63 cell 
seeded SiHA-22 BGS granules were cultured under 3 different conditions:  
1) Static culture in 24 well-plate;  
2) continuous BASAL PERFUSION RATE (BPR) at 0.07 ml/min flow rate in flow to waste 
configuration as per Figure 3-2;  
3) BASAL PERFUSION RATE + one hour daily cyclic COMPRESSION (BPR + C) of 5000 
µε at 1 HZ rate in flow to waste configuration as per Figure 3-2. 
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After 3 days of culture, total DNA, specific ALP activity, and the gene expression of 
runx2, col i and opn of MG63 cells on the BGS were quantified as described in Chapter 
2.5, 2.6, and 2.10. MG63 on BGS were visualized using Scanning Electron Microscopy 
(SEM) as described in Chapter 2.11, and RUNX2 distribution was visualized as 
described in Chapter 2.8. 
Table 3-2 Components of perfusion culture medium in CO2 atmosphere. 
 
 
 
 
 
 
 
Component Supplier 
Catalog 
number 
Volume 
High glucose Dulbecco's  
Modified Eagles Medium (DMEM) 
(without NaHCO3 buffer) 
Sigma D7777 1 g 
Ultra-pure water QMUL lab N/A 870 ml 
Fetal bovine serum (FBS) Sigma F9665 100 ml 
HEPES Solution Sigma H0887 20 ml 
Penicillin-Streptomycin Sigma P4333 10 ml 
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Figure 3-2 (a) Schematic diagram of flow to waste perfusion and compression system. (b) 
Schematic showing assembly parts of loading model (Chana, 2015). 
Cell culture medium (100 ml/day for 
each construct period) 
Peristaltic pump 
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Collected 
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3.3 Results 
3.3.1 Seeding Investigation 
 
Figure 3-3 The effect of (a) volume and (b) cell density of cell suspension on DNA amount 
of attached MG63 cells on SiHA-22 after 2 hours. (c) The effect of attachment time on DNA 
amount of attached MG63 cells on SiHA-22 granules. (d) The effect of seeding density on 
DNA amount of attached MG 63 cells on SiHA-22 for 7 days. Results are presented as mean 
± standard deviation (n>=3). Statistical analysis was performed by one-way ANOVA 
followed by Tukey's post-hoc multiple comparison with 95% confidence intervals (a, b, and 
c), or two-way ANOVA followed by Bonferroni post-tests(d). *p < 0.05, **p < 0.01 and ***p 
< 0.001. 
The quantity of total DNA from the BGS was assumed to be proportional to the 
number of cells on the BGS. So total DNA production was quantified to evaluate the 
number of cells attached on the BGS. As can be seen in Figure 3-3(a), when 0.2 million 
MG63 cells were suspended into different volume of cell culture medium, seeded on 
BGS and incubated for 2 hours, the number of cells attached on BGS was not 
dependent on the volume of cell suspension. As can be seen in Figure 3-3(b), in 500 
µl of cell suspension, the number of attached MG63 cells on BGS increased 
a b 
c d 
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significantly with increasing cell density and seeding 1 million MG63 cells generated 
the highest number of MG63 cells attached on BGS after 2 hours. As can be seen in 
Figure 3-3(c), attachment time had a positive effect on the attachment of MG63 cells 
on BGS. There was a trend that the number of attached cells increased with 
increasing attachment time until 8 hours then dropped after 8 hours. However, it was 
interesting to note that there was no significant difference in the number of attached 
cells from 2 - 4, 4 - 6 and 6 - 8 hours of attachment, and standard deviation were 
large at 6, 8 or 24 hours. There was no significant difference in the number of 
attached cells between 2 hours and 24 hours of attachment, while a significant 
difference was detected between 2 hours and 8 hours. As can be seen in Figure 3-3(d), 
when 1 million MG63 cells (500 µl cell suspension, at a concentration of 2 × 106 
cells/ml) were seeded on SiHA-22 BGS and incubated for 7 days, MG63 cells 
attachment and proliferation on SiHA-22 BGS was significantly higher compared with 
0.5 million MG63 cells (500 µl cell suspension, at a concentration of 1 × 106 cells/ml) 
seeded on BGS, irrespective of the time points. There was a trend that the number 
of MG63 cells on SiHA BGS increased with time, for both initial seeding number of 
0.5 million and 1 million MG63 cells. 
As can be seen in Figure 3-4, there were more cells observed on the BGS for initial 
seeding number of 1 million cells compared with initial seeding number of 0.5 million 
cells at any time point. There was a trend that the number of cells increased with 
time throughout 7 days of incubation, irrespective the initial number of cells seeded 
on the BGS. These observations were consistent with the result of DNA quantification. 
Chapter 3 
63 
 
 
Figure 3-4 The effect of initial cell seeding number, i.e (a, c, e, g) 0.5 million of MG63 cells 
and (b, d, f, h) 1 million of MG63 cells on cell numbers and cell morphology (white arrow) 
on SiHA-22 BGS granules after (a, b) 1 day, (c, d) 3 days, (e, f) 5 days and (g, h) 7 days, 
visualized by SEM. 
a b 
c d 
e f 
g h 
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3.3.2 3D Bioreactor System 
As can be seen in Figure 3-5, both continuous basal perfusion rate (BPR) and basal 
perfusion rate + compression (BPR + C) significantly increased the DNA amount of 
MG63 cells on the BGS compared with static condition. The specific ALP activity of 
MG63 cells was higher under static condition compared with BPR and BPR + C, 
however, there was no significant difference of specific ALP activity between culture 
conditions. 
 
Figure 3-5 (a) DNA amount and (b) Specific ALP activity of MG63 cells cultured on SiHA-22 
BGS under static condition, basal perfusion rate (BPR), basal perfusion rate with one hour 
daily cyclic compression (BPR + C) after 3 days. Statistical analysis was performed by one-
way ANOVA followed by Tukey's post-hoc multiple comparison with 95% confidence 
intervals. *p < 0.05, **p < 0.01 and ***p < 0.001. 
As can be seen in Figure 3-6, the expression of runt-related transcription factor 2 
(runx2) was significantly increased by BPR + C compared with static culture. The 
expression of type I collagen (col i) was significantly higher under BPR than both static 
culture and BPR + C conditions. The expression of osteopontin (opn) was significantly 
higher under BPR + C than both static culture and BPR, with the expression of opn 
being significantly higher under static than BPR.  
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Figure 3-6 The gene expression of runx2, col i and opn of MG63 cells cultured on SiHA-22 
BGS under static condition, basal perfusion rate (BPR), basal perfusion rate with one hour 
daily cyclic compression (BPR + C) after 3 days. Statistical analysis was performed by two-
way ANOVA followed by Bonferroni post-tests. *p < 0.05, **p < 0.01 and ***p < 0.001. 
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Figure 3-7 Cell populations under scanning electron microscopy (SEM). (a) 3 days of static 
culture, (b) 3 days of basal perfusion rate (BPR) culture, (c) 3 days of basal perfusion rate 
with one hour daily cyclic compression (BPR + C) culture. 
From SEM images, the cell population was higher under basal perfusion rate (BPR) 
compared with static culture, with cell population being the highest under basal 
perfusion rate + compression (BPR + C), as can be seen in Figure 3-7. 
500 µm 
a 
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   b 
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Figure 3-8 Runx2 expression (a, c, e) and nuclei (b, d, f) examined by immunofluorescence 
and confocal microscopy. (a, b) 3 days of static culture, (c, d) 3 days of basal perfusion rate 
(BPR) culture, (e, f) 3 days of basal perfusion rate with one hour daily cyclic compression 
(BPR + C) culture. 
RUNX2 was observed to have a very faint expression, and BPR culture showed a 
stronger signal of RUNX2 than static culture (Figure 3-8(a, c)). RUNX2 was 
demonstrated to be more concentrated under BPR + C than BPR. 
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3.3.3 MG63 Cells Differentiation 
As can be seen in Figure 3-9, the specific ALP activity of MG63 cells under static 
culture condition was very low between day 3 and day 14, and it increased 
significantly from day 25. 
                   
Figure 3-9 Specific ALP activity of MG63 cells (0.1 million cells/well in 24 well-plate) after 
3, 7, 14, 25 and 38 days of incubation in 24 well plates in basic cell culture medium. 
Statistical analysis was performed by one-way ANOVA followed by Tukey's post-hoc 
multiple comparison with 95% confidence intervals. *p < 0.05, **p < 0.01 and ***p < 0.001. 
The specific ALP activity of MG63 cells was not dependent on the supplement of 
osteogenic induction medium at both day 25 and day 38, which can be seen in Figure 
3-10 (a). As can be seen in Figure 3-10 (b), there was small amount of extracellular 
calcium deposits after both 25 days and 38 days in basic cell culture medium. The 
extracellular calcium deposition was higher in osteogenic medium compared with 
basic medium.  
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Figure 3-10 Specific ALP activity of MG63 cells (0.1 million cells/well in 24 well-plate) after 
25 and 38 days of incubation in 24 well plates in basic cell culture medium (BM) or BM 
supplemented with osteogenic induction medium (BMO).  
3.4 Discussion 
It is important that enough cells are seeded onto a BGS, so cells can colonise the 
materials surface and interact with each other to proliferate and differentiate. 
Absolute cell number and ECM deposition have been shown to be significantly larger 
in high initial seeding density groups than their low initial seeding density control 
groups (Limin Wang et al., 2009). However, high initial seeding densities might have 
negative repercussions on nutrient availability, cellular metabolism, and cell viability 
(Issa et al., 2011). Therefore, it is crucial to optimize initial seeding density to achieve 
optimal cell attachment and growth. When conducting seeding investigation, it 
should also be borne in mind that once seeded the BGS granules need be compatible 
with a 3D bioreactor system. 
a 
b 
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A previous study has shown that seeding cells on to SiHA-22 BGS granules in a 24 
well-plate first, allowing to attach for 2 hours and then transferring the granules into 
perfusion chamber was a very abrasive approach which led to a substantial degree 
of cell injury (Chana, 2015). However, seeding cells directly onto SiHA-22 BGS 
granules packed in the perfusion chamber and then allowing cells to attach for 2 
hours was able to support cell proliferation, and the highest seeding cell number 
tested i.e. 0.112 million cells (700 µl of cell suspension at a concentration of 1.6 × 105 
cells/ml) provided the most supportive environment for cell proliferation after 3 days 
(Chana, 2015). Considering the large specific surface (0.26 ± 0.05 m2/g) area of the 
porous SiHA-22 BGS, it is worth investigating if increased initial seeding cell numbers 
could further increase cell attachment and proliferation. The experimental results 
demonstrated that increasing the initial number of seeding cells significantly 
increased absolute number of cells attached on the BGS. Initial seeding number of 1 
million cells (500 µl of cell suspension at a concentration of 2 × 106 cells/ml) could 
continuously proliferate over 7 days. This suggests that porous SiHA-22 BGS was able 
to provide enough surface for cells to attach and the porous structure was beneficial 
for nutrient transfer and encourage cell colonisation. Seeding density in excess of 2 
× 106 cells/ml may be suitable, however practical difficulties encountered in when 
working with cells at higher concentration prohibited this and a concentration of 2 × 
106 cells/ml were used for each construct (0.47 ± 0.03 g of SiHA granules) for all of 
the further experiments. 
The volume of cell suspension and attachment time should also be carefully 
considered when seeding cells directly onto BGS granules packed in the perfusion 
chamber. Limited volume of cell suspension cannot cover all BGS granules, while too 
much cell suspension cannot be held by the BGS granules, which makes the actual 
cell number seeding on the BGS uncontrollable. The results of the current study 
indicated when same number of cells were in cell suspension, the number of 
attached cells was not dependent on cell suspension volume. As handling 600 µl and 
700 µl of cell suspension had a higher risk of overflowing the chamber when 
conducting the experiments, 500 µl of cell suspension was chosen for practical 
reasons. Interestingly, prolonging the attachment time (2 hours) for another 2 hours 
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or 4 hours did not significantly increase cell attachment, which indicated that 2 hours 
of attachment time was sufficient for cells to attach on SiHA-22 BGS granules. 
Although 8 hours of attachment time led to significantly higher number of attached 
cells compared with 2 hours of attachment, standard deviation was large suggesting 
a degree of variability. Moreover, it was not possible to finish the sample preparation 
and bioreactor construction continuously in a day. Therefore, it was decided that, for 
later experiments, 2 hours of attachment time would be used. 
The response of osteoblastic cell to mechanical stimulation has been widely studied 
using various forms of load application. It is well established that a perfusion-based 
bioreactor is the most efficient culture system in terms of nutrient transport 
homogenization, waste elimination, cell distribution, cell growth and differentiation 
(Szpalski et al., 2013). A great number of studies has proven that cell proliferation 
was stimulated by perfusion (Bancroft et al., 2002; Sikavitsas et al., 2005). Bioreactor 
systems for applying mechanical loading and shear stress at the same time have also 
shown beneficial effects of mechanical loading on proliferation, osteogenic 
differentiation and mineral matrix deposition (Table 3-3). In this current study, MG63 
osteoblast-like cells seeded on 3D SiHA-22 BGS granules responded to changes in 
mechanical environment. Basal perfusion rate (BPR) was proven to promote MG63 
cells proliferation compared with static culture. Basal perfusion rate + compression 
(BPR + C) further improved the proliferation compared with basal perfusion rate (BPR) 
condition. However, perfusion through BGS requires a tight fit between construct 
chamber and tubing, which creates friction resistance for compression and results in 
the compression force on BGS granules cannot be quantified. 
It is well accepted that osteoblast differentiation can be characterized by specific ALP 
activity, osteogenic genes expression like runx2, opn, oc and col i, and in vitro 
mineralization capacity. RUNX2 transcription factor is a key regulator of osteoblast 
differentiation and bone formation (Harada and Rodan, 2003). OPN is a glycosylated 
bone phosphoprotein secreted during osteogenesis, before the onset of 
mineralization. BPR + C led to concentrated distribution of RUNX2, upregulated runx2 
expression and upregulated opn expression, agreeing with previous research that 
mechanical loading and shear stress supported osteogenic differentiation 
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(Jagodzinski et al., 2008; David et al., 2008). BPR upregulated col i expression, 
agreeing with previous research (Fassina et al., 2005). While BPR downregulated the 
expression of opn after 3 days, which is contradictory to previous studies (Holtorf, 
Jansen, et al., 2005; Jaasma and O’Brien, 2008). A Long-term study will need to be 
carried out to confirm the stimulatory effect of perfusion. 
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Table 3-3 Perfusion and mechanical loading of cell-seeded BGS: models and effects. 
Reference 
 
BGS Cell type Perfusion Compression Observation  
(Bolgen et 
al., 2008) 
 
Cryogel, 2-hydroxyethyl 
methacrylate (HEMA)–
lactate–dextran, cylindric (Ø 
= 8 mm, H = 4 mm) 
MG63  Continuous 
0.1 ml/min 
1.5% strain, 1Hz 
1 h daily for 2 weeks 
Perfusion + compression: increased cell 
ingrowth, ECM, ALP activity 
(Jagodzinski 
et al., 2008) 
bovine acellular matrix, 
Tutobone® discs, cylinder (Ø 
= 20 mm, H = 4mm) 
hMSCs Continuous 
10 ml/min 
10% strain, 0.5Hz, 
(24h, 1, 2, and 3 weeks) 
Perfusion: increased proliferation, runx2 
expression, OC content; 
Perfusion + compression: increased 
proliferation, runx2 expression 
Further increase OC content 
(David et 
al., 2008) 
Bovine cancellous bone, 
cylinder (Ø = 10 mm, H = 5 
mm) 
Bone cells in 
bovine 
cancellous bone 
Continuous 
10 µl/min 
0.4% strain, 1 Hz, 300 cycles 
daily for 3 weeks 
Perfusion + compression: increased 
osteoblast differentiation, trabecula, 
Young’s Modulus, ultimate force 
(Appelman 
et al., 2009) 
PEG-Proteoglycan (PP), PEG-
Fibrinogen (PF), PEG-
Albumin (PA), and PEG BGS 
Primary articular 
chondrocytes 
Not 
mentioned 
1 day of free swelling, then 
15% strain, 1 Hz, 3 times for 1 
hr on and 2 hrs off each day 
for 27 days stimulation  
Increased BGS compressive modulus 
(Baas et al., 
2010) 
Poly (l-lactic acid) porous 
BGS, porosity: 90%  
Primary rat 
bone cells 
Continuous  
0.1 ml/min 
1.5% strain, 1 Hz, 3 times for 1 
hr on and 2 hrs off per day for 
28 days 
Perfusion + compression: increased 
mineralized nodules, average of 
absolute principal strain at nodule sites 
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pore size: 250 - 350 µm, 
cylinder (Ø = 9 mm, H = 4 
mm) 
(C X Liu et 
al., 2012) 
polyurethane (PU)-based 
meniscus BGS (Actifit®), pore 
size 150 - 355 µm 
hMSC Continuous  
10 ml/min 
10% strain, 0.5 Hz,  
4 times/day, 2 h/time with 4 
hours of rest; 1 time/day, 8 
h/time 
24 h, 1 week and 2 weeks 
Perfusion: increased proliferation, type 
III procollagen synthesis 
Perfusion + on-off compression: 
increased proliferation, equilibrium 
modulus, type I procollagen 
Chapter 3 
75 
 
In previous studies, most of in vitro mechanical stimulation has shown to increase 
ALP activity, however, there are studies report various effects of mechanical 
stimulation on ALP activity. For example, rat marrow stromal cells and osteoblastic 
cells stimulated by flow induced shear stress were observed to have significantly 
increased ALP activity compared with static culture (Goldstein et al., 2001; Sikavitsas 
et al., 2003; Sikavitsas et al., 2005; Bancroft et al., 2002; Holtorf, Sheffield, et al., 
2005). Du et al observed that the specific ALP activity of MC3T3-E1 cells did not differ 
significantly between the unidirectional perfusion culture and the static culture, and 
was significantly higher in the oscillatory flow perfusion group than in the 
unidirectional flow perfusion group (Du et al., 2009). Rat calvarial osteoblasts 
subjected to fluid flow expressed lower alp mRNA especially under pulsatile fluid flow 
(Roelofsen et al., 1995). In the current study, specific ALP activity was not dependent 
on perfusion or compression, and the specific ALP activity of MG63 cells on SiHA-22 
BGS granules was several magnitude lower than the specific ALP activity of rat 
osteoblastic cells from marrow tissue or osteoblast-like MC3T3-E1 cells reported in 
previous studies (Goldstein et al., 2001; Du et al., 2008). Although MG63 
osteosarcoma cells have some features of osteoblasts, they differ in proliferation 
kinetics and differentiation. The differentiation ability of MG63 cells, particularly 
specific ALP activity and mineralization were then investigated. The results of current 
study showed that the specific ALP activity of MG63 cells was very low and it did not 
increase until 25 days of culture. No extracellular calcium deposition by MG63 cells 
was observed.  
By performing a systematic comparison of MG-63, HOS TE85 and human bone 
derived cells, Clover observed that the ALP activity of MG-63 cells was significantly 
lower than human bone derived cells after 4 days under both basal condition and 
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) administration (Clover and Gowen, 1994). 
Pautke found that no ALP activity could be detected in MG-63 cells (Pautke et al., 
2004). Czekanska also observed that the maximum level of ALP activity of MG-63 by 
day 28, was ~ 26 fold lower compared to human osteoblasts at the same point 
(Czekanska et al., 2014). MG63 cells formed a cell layer with evident nodules after 14 
days of culture, however, no calcium deposition within the extracellular matrix was 
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seen during 28 days of culture. These results together indicated that cell lines could 
be useful for specific studies, but cell lines do not reflect the behaviour of primary 
cells and must be used with caution. MG63 cells were not a very good model in 
investigating the differentiation of cells induced by mechanical stimulation or 
osteoconductivity of BGS. Mesenchymal stem cells (MSCs) are mechanosensitive and 
mechanotransduction in MSCs has been proved to induce trabecular bone formation 
(Curtis et al., 2018). Human bone marrow derived mesenchymal stem cells (hMSCs) 
have been widely used in investigating the cellular response to mechanical 
stimulation (Meinel et al., 2004; Grayson et al., 2008) , and hMSCs based therapy has 
emerged as a novel branch regenerative medicine, with more than 500 registered 
clinical trials worldwide in the last 10 years (Bunpetch et al., 2017). Therefore, hMSCs 
were characterized and used in subsequent in vitro experiment. 
3.5 Conclusion 
The work in this chapter optimized the seeding parameters for seeding MG63 cells 
onto SiHA BGS granules in the perfusion chamber of a 3D bioreactor system, which 
is the first and crucial step for cells growth in a mechanical stimulation environment. 
A 3D bioreactor system which allow the application of shear stress and compression 
at the same time was built, and MG63 cells have been found to respond to both shear 
stress and mechanical loading in terms of proliferation and gene expression. 
However, a 3D bioreactor system that can precisely control compression force on 
BGS granules should be designed and used for future work. Cellular differentiation, 
particularly specific ALP activity is an important indicator in investigating the cellular 
response to mechanical stimulation. However, MG63 cells were found to have very 
low specific ALP activity, and it was not dependent on the environment such as 
mechanical stimulation, chemical stimulation and culture period. Therefore, hMSCs 
were used in subsequent in vitro experiment, considering their differentiation ability, 
response to the environment and potential clinical applications. 
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Chapter 4 Structural Guidance of 3D SiHA BGS on 
hMSCs Proliferation and Differentiation  
4.1 Introduction 
Using three dimensional BGS for the treatment of bone repair is a rapidly emerging 
field (Langer and Vacanti, 1993; Service, 2000; Hutmacher et al., 2007; Shahrezaie et 
al., 2018). So far, highly porous bioceramics represent the standard for generating 
osteoconductive BGS (Gauthier et al., 1998; Boyde et al., 1999; Chang et al., 2000; 
Marcacci et al., 2007; Sweedy et al., 2018), as interconnected macro-pores (>100 µm) 
are necessary for blood vessels invasion and bone matrix deposition in empty space. 
Macro-pore size, macro-porosity (the volume fraction of macro-pores) and the 
interconnectivity of macro-pores have been demonstrated to have a strong impact 
on bone ingrowth. For example, an in vivo study of hydroxyapatite (HA) BGS with 
identical microstructure but different macro-pore structure has demonstrated that 
macro-porosity and pore interconnection of the BGS influenced the amount of 
deposited bone and kinetics of bone formation (Mastrogiacomo et al., 2006).  Based 
on early work (Hulbert et al., 1970), it is widely believed that interconnected size of 
pores larger than 100 µm are necessary due to cell size, migration requirements and 
nutrient transport. The recommended macro-pore size is larger than 300 µm to 
achieve enhanced new bone formation (Gauthier et al., 1998; Kuboki et al., 2001; 
Karageorgiou and Kaplan, 2005). Although high macro-porosity BGS has the potential 
to facilitate bone ingrowth, it should be borne in mind that increasing porosity 
decreases mechanical properties, so the two have to be carefully balanced. 
Incorporation of micro-pores (<30 µm), in the struts or walls of macro-porous BGS 
has been demonstrated to improve osteoblast anchorage and attachment on HA BGS 
surface at the early time points  in vitro experiments (Annaz et al., 2004b). Increased 
levels of micro-porosity (the volume fraction of micro-pores) in HA BGS was found to 
facilitate earlier neovascularization (Hing et al., 2004), thicker trabeculae of new 
bone (Hing et al., 2005), and a greater volume of bone formation (Coathup et al., 
2012) in vivo. One explanation that micro-pore structure promoted BGS performance 
is that micro-pores allow cellular infiltration, which increases biological fixation and 
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thereby results in improved mechanical interlock between the cells and the surface 
of the substrate (Bignon et al., 2003; Annaz et al., 2004a). Another mechanism that 
has been proposed recently is that micro-pores induced capillarity drive of cells, 
blood, or marrow components deep into the BGS pores and therefore enhance bone 
distribution in vivo (Rustom et al., 2016). This is in line with the findings from 
literature that micro-porosity of calcium phosphate - based BGS can result in 
multiscale osteointegration, and thus a composite material (Lan Levengood et al., 
2010). 
In the body, human mesenchymal stem cells (hMSCs) are known to migrate to a 
wound site and become incorporated into certain tissues and assist tissue repair or 
regeneration either through the secretion of chemokines or by differentiation into 
the mature native cell (Parekkadan and Milwid, 2010). hMSCs have the ability to 
differentiate towards the osteogenic lineage, so they have great potential for clinical 
applications for bone regeneration (Koç and Lazarus, 2001). The differentiation of 
hMSCs is likely to be initiated and directed by cues from the local microenvironment, 
such as soluble factors and topography of extracellular matrix. Therefore, the 
response of hMSCs to the geometric structure of a BGS is crucial to evaluate the 
osteoconductivity of that BGS. There are few studies investigating the effect of 
porosity on proliferation and osteogenic differentiation of hMSCs. Gomes found that 
a starch-based mesh BGS with 75% macro-porosity demonstrated significantly 
enhanced MSCs proliferation and higher specific ALP activity under perfusion 
condition compared with the BGS with 50% macro-porosity (Manuela E. Gomes et al., 
2006). Kasten found that specific ALP activity of hMSCs was not dependent on the 
macro-porosity (Kasten et al., 2008). Presence of micro-pores in calcium phosphate 
BGS has been demonstrated to stimulate osteogenic differentiation of stem cells in 
vitro and bone formation in vivo, respectively (Yuan et al., 2010). Enhanced micro-
porosity in silicate-substituted calcium phosphate has proven stimulate osteogenic 
differentiation of hMSCs (De Godoy et al., 2015) 
Multiscale silicate substituted hydroxyapatite (SiHA) BGS, with both micro-pores and 
macro-pores, have excellent biocompatibility (Patel et al., 2002; Hing et al., 2006). 
However, the combined influence of micro-porosity and total porosity (the total 
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volume fraction of macro-pores and micro-pores) in SiHA BGS on hMSCs 
differentiation has not been investigated. The aim of this study was to synthesise and 
characterise a group of SiHA BGS with equivalent levels of total porosity, but different 
levels of micro-porosity and another group of SiHA BGS with equivalent levels of 
micro-porosity but different levels of total porosity. In vitro studies were performed 
to systematically investigate the influence of SiHA BGS structure on the proliferation 
and differentiation of hMSCs in different medium types and to choose the BGS 
structure and medium type in further perfusion study.  
4.2 Materials and Methods 
Irregularly shaped SiHA granules (φ: 1-2 mm) were synthesised using a slip foaming 
technique, as described in Chapter 2.1, which enabled independent control of the 
level of total porosity and the level of micro-porosity. 5 batches of SiHA granules were 
produced to enable investigation of changes in both total porosity and micro-
porosity with designed porosity values as shown in Table 4-1. 
Table 4-1 Designed total porosity and micro-porosity of SiHA BGS. 
 
 
 
 
 
1 million of hMSCs in a 500 µl cell suspension (concentration: 2 × 106 cells/ml) were 
seeded per 1 cm3 (0.47 ± 0.03 g) of SiHA BGS granules in 24 well-plates. After hMSCs 
had attached to BGS granules (2 hours), hMSCs were kept in static condition in 24 
well-plates in 1.5 ml MSC growth medium 2 (PromoCell). After one day, the culture 
medium was replaced with one of 4 types of medium: 1) PM: MSC growth medium 
2; 2) PMO: PM supplemented with osteogenic induction medium (0.1 µM 
dexamethasone, 0.05 mM ascorbic acid and 10 mM β-glycerophosphate (Sigma-
Aldrich); 3) BM: basic cell culture medium (BM, as per Table 2-2) consisting of high 
glucose Dulbecco’s modified Eagle Medium (DMEM) with 10% fetal bovine serum 
 Designed micro-porosity (%) 
 10 20 30 
Designed total 
porosity (%) 
60  ✔  
70  ✔  
80 ✔ ✔ ✔ 
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(FBS) and 1% penicillin-streptomycin (Sigma-Aldrich); 4) BMO: BM supplemented 
with osteogenic induction medium. The medium was changed every 2 days 
thereafter. After 3, 7, and 10 days of culture, total DNA amount and specific ALP 
activity of hMSCs from each BGS were tested as described in Chapter 2.5 and Chapter 
2.6. 
4.3 Results 
4.3.1 BGS Characterisation 
In the group of SiHA BGS with equivalent amount of total porosity (80.9 ± 1.9%), their 
actual micro-porosities were listed in Table 4-2. As depicted in Figure 4-1 (a), (c) and 
(e), BGS SiHA-14, SiHA-22 and SiHA-28 was found to have similar macro-pore 
structure, while the micro-pore volume fraction was varied significantly that SiHA-14 
has nominal micro-porosity of 14% (Figure 4-1 (b)), SiHA-22 has nominal micro-
porosity of 22% (Figure 4-1 (d)), and SiHA-28 has nominal micro-porosity of 28% 
(Figure 4-1 (f)). Phase purity of SiHA-14, SiHA-22 and SiHA-28 after sintering were 
verified using X-ray diffractometry (Figure 4-2). 
Table 4-2 The actual micro-porosity of BGS SiHA-14, SiHA-22 and SiHA-28. 
 
 
 
 SiHA-14 (%) SiHA-22 (%) SiHA-28(%) 
Micro-porosity 13.5 ± 0.7 22.4 ± 0.5  28.2 ± 2.7 
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Figure 4-1 Macro-pore structure (a) and micro-pore structure (b) of SiHA-14; macro-pore 
structure (c) and micro-pore structure (d) of SiHA-22; macro-pore structure (e) and micro-
pore structure (f) of SiHA-28. 
 
Figure 4-2 XRD patterns of SiHA-14, SiHA-22 and SiHA-28 BGS. 
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In the group of SiHA BGS with equivalent amount of micro-porosity (21.5 ± 1.4%), 
their total porosities were listed in Table 4-3. As can be seen in Figure 4-3 (b), (d) and 
(f), BGS SiHA60, SiHA70 and SiHA80 was found to have similar micro-pore structure, 
while the macro-pore volume fraction varied (Figure 4-3 (a), (c) and (e)), which results 
in the total porosity varied that SiHA60 has nominal total porosity of 60%, SiHA70 has 
nominal total porosity of 70% and SiHA80 has nominal total porosity of 80%. Phase 
purity of SiHA60, SiHA70 and SiHA80 after sintering were verified using X-ray 
diffractometry (Figure 4-4).  
Table 4-3 The actual total porosity of BGS SiHA60, SiHA70 and SiHA80. 
 
 
 
 
Figure 4-3 Macro-pore structure (a) and micro-pore structure (b) of SiHA60; macro-pore 
structure (c) and micro-pore structure (d) of SiHA70; macro-pore structure (e) and micro-
pore structure (f) of SiHA80. 
 SiHA60 (%) SiHA70 (%) SiHA80 (%) 
Total porosity 61.8 ± 1.7 70.8 ± 0.4 80.4 ± 0.5 
500μm 500μm 500μm 
20μm 20μm 20μm 
(a) (c) 
(d) (f) 
(e) 
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Figure 4-4 XRD patterns of SiHA60, SiHA70 and SiHA80 BGS. 
4.3.2 DNA and specific ALP Activity of hMSCs on BGS with Equivalent 
Levels of Total Porosity and Different Micro-porosities in Different 
Culture Medium 
To evaluate hMSCs proliferation on BGS with different micro-porosity, total DNA of 
hMSCs from cell lysate was quantified. As can be seen in Figure 4-5 (a), in PM medium, 
at day 3, the DNA content was significantly lower on SiHA-28 as compared to SiHA-
14 and SiHA-22, while at day 7 and day 10, there was no significant difference in DNA 
content on all three types of BGS irrespective of micro-porosity. In PM medium, the 
DNA content of hMSCs increased significantly from day 3 to day 7 on SiHA-28 BGS, 
and there was no significant difference in DNA compared with day 7 to day 3 on both 
SiHA-14 and SiHA-22. In PM medium, at day 10, the DNA content of hMSCs was found 
to be significantly higher compared with day 3 on SiHA-22 and SiHA-28, but not SiHA-
14 BGS. 
As can be seen in Figure 4-5 (b), in PMO medium, at day 3, the DNA content was 
significantly lower on SiHA-28 compared with SiHA-14, while at day 7 and day 10, 
there was no significant difference in DNA content on all three types of BGS 
irrespective of micro-porosity. In PMO medium, there was no significant difference 
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in DNA content at day 7 compared with day 3 on all three types of BGS irrespective 
of BGS micro-porosity. In PMO medium, the DNA content of hMSCs increased 
significantly from day 7 to day 10 on both SiHA-22 and SiHA-28 BGS, but not SiHA-14 
BGS. In PMO medium, at day 10, the DNA content of hMSCs was significantly higher 
compared with day 3 on SiHA-28 BGS, and there was no significant difference in DNA 
compared with day 10 to day 3 on SiHA-14 BGS and SiHA-22 BGS. 
As can be seen in Figure 4-5 (c), in BM medium, at day 3, the DNA content was 
significantly lower on SiHA-28 compared with SiHA-14 and SiHA-22, while at day 7 
and day 10, there was no significant difference in DNA content on all three types of 
BGS irrespective of micro-porosity. In BM medium, there was no significant 
difference in DNA content found at any of the time points, irrespective of BGS micro-
porosity.  
As can be seen in Figure 4-5 (d), in BMO medium, at day 3, the DNA content was 
significantly lower on SiHA-28 compared with SiHA-14 and SiHA-22, while at day 7 
and day 10, there was no significant difference in DNA content on all three types of 
BGS irrespective of micro-porosity. In BMO medium, the DNA content of hMSCs on 
SiHA-14 BGS was found to be significantly decreased at both day 7 and day 10 
compared with day 3. In contrast, in BMO medium, there was significant increase in 
DNA content from day 7 to day 10 on SiHA-28 BGS. 
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Figure 4-5 DNA content of hMSCs on different BGS cultured in (a) PM, (b) PMO, (c) BM and 
(d) BMO medium. Results are presented as mean ± standard deviation (n>=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, 
**p < 0.01, ***p < 0.001, comparison between SiHA-14, SiHA-22 and SiHA-28. +p < 0. 05, 
++p < 0.01, +++p < 0.001, comparison between D3, D7 and D10. 
Specific ALP activity is an early marker of osteoblast differentiation towards 
osteoblastic phenotype. To investigate the response of hMSCs differentiation to BGS 
micro-porosity in different culture medium, specific ALP activity from cell lysate at 
day 3, day 7 and day 10 were tested and normalized by DNA content. As can be seen 
in Figure 4-6 (a), in PM medium, the specific ALP activity was not found to be 
responsive to BGS micro-porosity at any of the three time points. In PM medium, the 
specific ALP activity of hMSCs increased significantly from day 3 to day 7, and then 
further increased significantly from day 7 to day 10, with specific ALP activity being 
the highest at day 10 on any of the three types of BGS. 
As can be seen in Figure 4-6 (b), in PMO medium, the specific ALP activity was not 
found to be responsive to BGS micro-porosity at both day 3 and day 7, whereas at 
day 10, specific ALP activity increased significantly with increasing BGS micro-
porosity. In PMO medium, the specific ALP activity of hMSCs was found to be 
a b 
c d 
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significantly higher at both day 7 and day 10 compared with day 3, irrespective of the 
BGS micro-porosity. In PMO medium, the specific ALP activity of hMSCs was found to 
be significantly higher at day 10 compared with day 7 on both SiHA-22 and SiHA-28, 
but not SiHA-14 BGS. 
 
Figure 4-6 Specific ALP activity of hMSCs on BGS cultured in (a) PM, (b) PMO, (c) BM and 
(d) BMO medium. Results are presented as mean ± standard deviation (n>=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, 
**p < 0.01, ***p < 0.001, comparison between SiHA-14, SiHA-22 and SiHA-28. +p < 0. 05, 
++p < 0.01, +++p < 0.001, comparison between D3, D7 and D10. 
As can be seen in Figure 4-6 (c), in BM medium, the specific ALP activity was not found 
to be dependent on BGS micro-porosity at any of the three time points. In BM 
medium, the specific ALP activity was also found not to be dependent on culture 
period on any of the three types of BGS. 
As can be seen in Figure 4-6 (d), in BMO medium, the specific ALP activity was not 
found to be responsive to BGS micro-porosity at both day 3 and day 7, whereas at 
day 10, specific ALP activity was significantly higher on both SiHA-22 and SiHA-28 as 
a b 
c d 
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compared to SiHA-14 BGS. In BMO medium, the specific ALP activity of hMSCs was 
found to be significantly higher at both day 7 and day 10 compared with day 3 
irrespective of the BGS micro-porosity. In BMO medium, the specific ALP activity of 
hMSCs was found to be significantly higher at day 10 compared with day 7 on both 
SiHA-22 and SiHA-28, but not SiHA-14 BGS. 
4.3.3 DNA and specific ALP Activity of hMSCs on BGS with Equivalent 
Levels of Micro-porosity and Different Total Porosities in Different 
Culture Medium 
In PM medium, at both day 3 and day 7, DNA content of hMSCs was not found to be 
dependent on BGS total porosity (i.e SiHA60, SiHA70 and SiHA80), whereas at day 10, 
the DNA content was significantly higher on SiHA80 BGS than SiHA60 BGS, as can be 
seen in Figure 4-7 (a). In PM medium, the DNA content of hMSCs increased 
significantly from day 3 to day 7 on SiHA70 and SiHA80, but not SiHA60 BGS. In PM 
medium, the DNA content of hMSCs was significantly higher at day 10 compared with 
day 3 on SiHA80 BGS, and there was no significant difference in DNA content at day 
10 compared with day 3 on SiHA60 and SiHA70 BGS. 
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Figure 4-7 DNA content of hMSCs on BGS cultured in (a) PM, (b) PMO, (c) BM and (d) BMO 
medium. Results are presented as mean ± standard deviation (n>=3). Statistical analysis 
was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, **p < 
0.01, ***p < 0.001, comparison between SiHA60, SiHA70 and SiHA80. +p < 0. 05, ++p < 0.01, 
+++p < 0.001, comparison between D3, D7 and D10. 
As can be seen in Figure 4-7 (b), in PMO medium, at both day 3 and day 7, DNA 
content of hMSCs was not found to be dependent on BGS total porosity, whereas at 
day 10, the DNA content was significantly higher on SiHA80 BGS than SiHA60 and 
SiHA70 BGS. In PMO medium, there was no significant difference in DNA content 
from day 3 to day 7, or from day 7 to day 10 irrespective of BGS total porosity. In 
PMO medium, the DNA content of hMSCs was significantly higher at day 10 
compared with day 3 on SiHA80 BGS, however, DNA content of hMSCs was not 
significantly different at day 10 compared with day 3 on SiHA60 and SiHA70 BGS. 
As can be seen in Figure 4-7 (c) and (d), in both BM and BMO medium, the DNA 
content of hMSCs was not dependent on BGS total porosity at any of the three time 
points.  
As can be seen in Figure 4-8 (a), in PM medium, the specific ALP activity was not 
found to be dependent on BGS total porosity at any of the three time points. In PM 
medium, the specific ALP activity of hMSCs increased significantly from day 3 to day 
a b 
c d 
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7, and then further increased significantly from day 7 to day 10, with specific ALP 
activity being the highest at day 10 on any of the three types of BGS. 
As can be seen in Figure 4-8 (b), in PMO medium, at day 3, the specific ALP activity 
was not found to be dependent on BGS total porosity, whereas at both day 7 and day 
10, the specific ALP activity was significantly higher on SiHA80 compared with SiHA60 
and SiHA70 BGS. In PMO medium, the specific ALP activity of hMSCs increased 
significantly from day 3 to day 7, and then further increased significantly from day 7 
to day 10, with specific ALP activity being the highest at day 10 on any of the three 
types of BGS.  
As can be seen in Figure 4-8 (c), in BM medium, the specific ALP activity was not found 
to be dependent on BGS total porosity at any of the three time points. In BM medium, 
the specific ALP activity of hMSCs increased significantly from day 3 to day 7, on 
SiHA60 and SiHA70, but not SiHA80 BGS. In BM medium, there was no significant 
difference in specific ALP activity at day 10 compared with day 7 irrespective BGS 
total porosity. In BM medium, the specific ALP activity of hMSCs was significantly 
higher at day 10 compared with day 3 on SiHA22 BGS, however, there was no 
significant difference in specific ALP activity of hMSCs at day 10 compared with day 
3 on SiHA60 and SiHA70 BGS. 
As can be seen in Figure 4-8 (d), in BMO medium, at both day 3 and day 7, the specific 
ALP activity was not found to be dependent on BGS total porosity, however at day 
10, the specific ALP activity of hMSCs was significantly higher on SiHA-70 and SiHA80 
BGS than SiHA60 BGS. In BMO medium, the specific ALP activity of hMSCs was found 
to be significantly higher at day 7 and day 10 compared with day 3 irrespective of the 
BGS total porosity. In BMO medium, the specific ALP activity of hMSCs was found to 
be significantly higher at day 10 compared with day 7 on both SiHA70 and SiHA80, 
but not SiHA60 BGS. 
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Figure 4-8 Specific ALP activity of hMSCs on BGS cultured in (a) PM, (b) PMO, (c) BM and 
(d) BMO medium. Results are presented as mean ± standard deviation (n>=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, 
**p < 0.01, ***p < 0.001, comparison between SiHA60, SiHA70 and SiHA80. +p < 0. 05, ++p 
< 0.01, +++p < 0.001, comparison between D3, D7 and D10. 
4.4 Discussion 
Cell behaviour is directly affected by the BGS architecture, which provides cues that 
influence the specific integrin-ligand interactions between cells and the surroundings 
and thereby influence cell proliferation or direct cell differentiation (Murphy et al., 
2010; Loh and Choong, 2013). SiHA BGS with equivalent levels of total porosity, 
micro-porosity level altered hMSCs proliferation at day 3, where DNA content was 
significantly higher on SiHA-14 as compared to SiHA-28, in all of the four types of 
culture medium. Ma et al. also observed that the initial cell proliferation rate in the 
low porosity matrix was greater than those in the high porosity matrix (Ma et al., 
2000). One possible explanation is that SiHA-14 BGS has a greater number of small 
size of micro-pores (< 5 µm) compared with SiHA-28 BGS, which provided a more 
a b 
c d 
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suitable substrate for cell anchorage and attachment, leading to earlier hMSCs 
proliferation. This hypothesis is supported by previous study that an affinity was 
observed between the fidopillia of human osteoblasts-like cells and micro-pores in 
vitro (Annaz et al., 2004b), and MC3TE-E1 cells were observed to attach and grow 
into micro-pores in the inner surface (Li et al., 2005), respectively. However, at day 7 
and day 10, hMSCs were not dependent on BGS with different micro-porosities, 
indicating that the micro-porosity level in SiHA BGS did not have an impact on late 
stage cell proliferation.  
At both day 3 and day 7, the specific ALP activity of hMSCs was not altered by micro-
porosity irrespective of the types of culture medium. However, at day 10, in PMO 
and BMO medium, BGS with high micro-porosity (SiHA-22 and SiHA-28) supported 
significantly increased levels of specific ALP activity in hMSCs as compared to the 
SiHA-14 BGS about 22%. This finding demonstrated that SiHA BGS with higher levels 
of micro-porosity had a greater potential to support hMSCs differentiation than 
those with lower levels of micro-porosity, but this needs a longer culture period and 
osteogenic supplements in the culture medium. It is possible that increasing the 
permeability of struts within the porous BGS increased physical accessibility of 
nutrients to support proliferation and differentiation. Higher surface area in SiHA BGS 
with higher levels of micro-porosity may also increase the osteogenic protein binding 
capacity and therefore increase the osteogenic differentiation capacity. It is worth 
mentioning that, in BM medium, the specific ALP activity of hMSCs did not increase 
significantly through the 10 days of culture, whereas in PM medium, the specific ALP 
activity of hMSCs increased significantly from day 3 to day 7 and from day 7 to day 
10 irrespective of the levels of micro-porosity of SiHA BGS, which indicated that there 
might be some growth factors in PM medium that enhance hMSCs osteogenic 
differentiation. Unfortunately, the manufactures would not divulge the component 
of PM medium. 
At both day 3 and day 7, DNA content of hMSCs was not found to be responsive to 
the total porosities of SiHA BGS irrespective the types of culture medium, whereas at 
day 10, in both PM and PMO medium, DNA content of hMSCs was significantly higher 
on SiHA80 BGS compared with SiHA60 BGS. This may be due to the fact that there 
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was greater number of macro-pores in SiHA80 BGS compared with SiHA60 BGS, also, 
macro-pores and pore interconnection in SiHA80 are likely to be bigger, which 
facilitated nutrient transportation and thereby increased hMSCs proliferation. This 
observation is in line with previous study that the absolute volume of bone ingrowth 
was consistently higher on HA BGS with higher total porosity (Hing et al., 2002). 
In both PM and BM medium, the specific ALP activity of hMSCs was not found to be 
responsive to BGS with different total porosities at any of the time points. However, 
in BMO medium, at day 10, the BGS with highest total porosity (SiHA80) was found 
to support significantly increased levels specific ALP activity in hMSCs compared with 
SiHA60, and in PMO medium, at both day 7 and day 10, SiHA80 was again found to 
support significantly increased levels of specific ALP activity of hMSCs as compared 
with SiHA60. The increased surface area or enhanced permeability due to greater 
levels of pore connectivity in SiHA80 BGS enhanced hMSCs proliferation and thereby 
advanced hMSCs proliferation and specific ALP activity. 
4.5 Conclusion 
Porosity influences cell spreading and cell ingrowth in BGS materials. SiHA BGS with 
equivalent level of total porosity but different levels of micro-porosities and SiHA BGS 
with equivalent level of micro-porosity but different levels of total porosities were 
synthesised, characterised and tested in vitro. All SiHA BGS types irrespective of 
micro-porosity and total porosity were found to be suitable for hMSCs to grow and 
differentiate. From all the combinations of micro-porosity and macro-porosity tested, 
it would appear that rapid cell attachment may be favoured on surfaces with lower 
levels of micro-porosity (SiHA-14). However, hMSCs growth and differentiation were 
supported by BGS with greater levels of micro-porosity (SiHA-22 and SiHA-28) and 
the highest levels of total porosity (SiHA80) in osteogenic supplemented culture 
medium. The response of hMSCs differentiation to BGS micro-porosity was found in 
osteogenic medium, especially PMO. To investigate the response of hMSCs 
differentiation to BGS structure and mechanical forces, hMSCs were cultured on BGS 
with different micro-porosity in PMO medium in perfusion bioreactor. 
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Chapter 5 Synergistic Effect of BGS Micro-porosity and 
Perfusion Culture on Differentiation of Human 
Mesenchymal Stem Cells (hMSCs) 
5.1 Introduction 
Synthetic hydroxyapatite (HA) bone substitutes have been increasingly used in bone 
repair due to their excellent biocompatibility (Bowen et al., 1989; Yoshikawa et al., 
1996; Chu et al., 2002; Woodard et al., 2007; Tripathi and Basu, 2012; Xia et al., 2016). 
Silicate substituted hydroxyapatite (SiHA) has proven to be particularly promising 
due to accelerated bone apposition, higher bone ingrowth and bone coverage on 
SiHA as compared to HA (Patel et al., 2002; Hing et al., 2006). There have been 
numerous studies conducted to investigate the effect of the parameters of geometric 
structure of BGS on bone repair, including pore size, total porosity, micro-porosity, 
and pore shape (Hing et al., 2002; Mastrogiacomo et al., 2006; Sweedy et al., 2018). 
Specifically, increasing micro-porosity has been shown to support bone-like apatite 
precipitation, encourage early neovascularization and increase absolute new bone 
volume (Hing et al., 2005; Campion et al., 2013; Campion et al., 2011; Coathup et al., 
2012). 
It is well known that mechanical loading plays an important role in bone remodelling 
and fracture healing (Lanyon and Rubin, 1984; Lanyon, 1993; Robling et al., 2002; 
Boerckel et al., 2012). For example, compression loading of bone during walking 
results in non-uniform strains macroscopically. The associated pressure differences 
within the interconnected canalicular network cause interstitial fluid flow, which 
imparts shear stresses on the cells (Hillsley and Frangos, 1994). As a result, essential 
cellular functions and BGS properties that present in vivo are missing by using 
traditional static culture method. Perfusion culture that mimics the concept of 
mechanical loading has been widely used to improve viability, cell distribution, 
differentiation, matrix synthesis and functionality of tissue engineered constructs 
(Bancroft et al., 2002; Wang et al., 2003; Braccini et al., 2005; Papadimitropoulos et 
al., 2014). It also has the advantage of bridging the gap between static culture and in 
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vivo test with respect to evaluating the bioactivity of the BGS under more relevant 
physiological conditions.  
The cylindrical pore model approach of Goldstein et al. (Goldstein et al., 2001) has 
been widely used to estimate the shear stress (τw) on cells seeded on the BGS (μ: the 
viscosity of the culture medium, d: the mean pore size of the BGS, and Vm: mean 
velocity through the pores). 
𝜏𝑤 = 8𝜇𝑉𝑚/𝑑 
Assuming flow was distributed uniformly across the BGS surface with diameter, 
the mean velocity (Vm) through the pores can be calculated based on flow rate Q, 
diameter of BGS D, and porosity of BGS ∅. 
𝑉𝑚 =
𝑄
∅𝜋(
𝐷
2)
2
 
This model is a massive over simplification, but it is the best compromise that is 
available so far. Compatible shear stress values calculated based on this model (0.001 
- 1 dyn/cm2) have been reported and been demonstrated to activate osteogenic 
differentiation in 3D perfusion culture systems (Goldstein et al., 2001; Bancroft et al., 
2002; Gomes et al., 2003; Sikavitsas et al., 2005; Li et al., 2009; Vance et al., 2005; 
McCoy and O’Brien, 2010) based on increased ALP activity (Goldstein et al., 2001; 
Bancroft et al., 2002; Sikavitsas et al., 2005), PGE2 release (Vance et al., 2005), or 
mineralized matrix deposition (Bancroft et al., 2002; Gomes et al., 2003; Sikavitsas et 
al., 2005; Li et al., 2009). The shear stress value calculated based on this model were 
also in line with shear stress estimated by computational fluid dynamics (CFD) models 
on the BGS surfaces, which was found to induce osteogenic differentiation (Zhao et 
al., 2015; Stephens et al., 2007; Vetsch et al., 2017). In the current study, continuous 
BASAL PERFUSION RATE (BPR) at 0.07 ml/min flow rate was chosen to generate shear 
stress value of 0.0088 dyn/cm2 (μ: 0.01 dyn * s/cm2, d: 265 μm, D: 8 mm and ∅: 80%). 
BPR with a period of HIGH PERFUSION RATE (pHPR) every day at 2.5 ml/min flow rate 
was chosen to generate shear stress value of 0.31 dyn/cm2 (μ: 0.01 dyn * s/cm2, d: 
265 μm, D: 8 mm and ∅: 80%).  
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Although both micro-porosity of BGS and shear stress are both involved in bone 
functional adaption and they have only been investigated independently. The 
combined effect of these two cues has not yet to be studied. The aim of this study 
here was to investigate the synergistic effects of micro-porosity and perfusion on 
hMSCs proliferation, cytoskeleton organisation, ERK1/2 signalling pathway activation 
and differentiation. 
5.2 Materials and Methods 
Irregularly shaped SiHA granules (φ: 1-2 mm) consisting of same total porosity (80.9 
± 1.9%), but different levels of micro-porosity: 13.5 ± 0.7% & 22.4 ± 0.5% & 28.4 ± 
2.7% (SiHA-14 & SiHA-22 & SiHA-28) were synthesised as described in Chapter 2.1 in 
Baxter Inc (Elstree, London) and tested in in vitro experiments. 
1 million of hMSCs in 500 µl cell suspension (concentration: 2 × 106 cells/ml) were 
seeded per 1 cm3 (0.47 ± 0.03 g) of SiHA BGS granules. After hMSCs had attached to 
BGS granules (2 hours), granules were kept under static condition in 24 well-plates in 
1.5 ml medium or moved to a recirculating perfusion bioreactor system consisting of 
16 independent chambers (Figure 5-1) (as described in Chapter 2.4) for further 
incubation. MSC growth medium 2 (PromoCell) from the reservoir was perfused 
through the constructs vertically in a bottom-to-top direction using a peristaltic 
pump (IPC Iamatec, VWR). Two perfusion profiles were applied: 1) continuous BASAL 
PERFUSION RATE (BPR) at 0.7 ml/min flow rate; 2) BPR with a period (one hour daily) 
of HIGH PERFUSION RATE (pHPR) at 2.5 ml/min flow rate in recirculating 
configuration as in Figure 5-1. 
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Figure 5-1 Schematic diagram of recirculating perfusion bioreactor system. 
In Chapter 4, the response of hMSCs differentiation to BGS micro-porosity was found 
in osteogenic medium, but not basic cell culture medium. Previous study also proved 
that flow perfusion culture alone induces osteogenic differentiation of MSCs, while 
osteogenic medium enhanced its response to perfusion (Holtorf, Jansen, et al., 2005). 
To clearly show the response of hMSCs differentiation to BGS micro-porosity and 
perfusion, and to better understand the synergistic effect of BGS micro-porosity and 
perfusion culture, in this study, after cells attached on BGS for a short period (24 
hours), the MSC growth medium 2 was supplemented with osteogenic medium (0.1 
µM dexamethasone, 0.05 mM ascorbic acid and 10 mM β-glycerophosphate) (Sigma-
Aldrich). 1.5 ml medium was used for each BGS under static condition and culture 
medium was exchanged every 2 days thereafter. 100 ml medium was recirculated for 
each BGS during 7 days of perfusion culture, and the bottle of medium was vented in 
normoxic atmosphere. 
After 3 or 7 days, hMSCs on the BGS were fixed, cytoskeleton organization was made 
visible as described in Chapter 2.8. hMSCs on the BGS were lysised, DNA and specific 
ALP activity, ERK1/2 and phosphorylated ERK (pERK1/2) distribution and production, 
gene expression for osteogenic differentiation markers (osx, alp, bmp2, col i, dmp1), 
chondrogenic differentiation markers (sox9, runx2, col ii), myogenic differentiation 
markers (myoD) and integrin subunits (integrin α1, integrin α5, integrin β1) were 
tested as described in Chapter 2.10. 
Cell culture medium (100 ml for each 
construct during culture period) 
Peristaltic pump 
Granules 
packed in 
silicone 
tube  
Silicone 
tubing 
  
Flow direction 
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5.3 Results 
5.3.1 Cytoskeleton Organisation 
Actin cytoskeleton was made visible to determine if the presence or absence of fluid 
shear stress results in cytoskeletal reorganisation after culturing for 3 days (Figure 
5-2 (a)) and 7 days (Figure 5-3 (a)) on different BGS. At both day 3 and day 7, there 
was no observable difference in cytoskeleton organisation of hMSCs irrespective of 
whether they were cultured on SiHA-14, SiHA-22 or SiHA-28 BGS in static 
environment. Under basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR) culture conditions, there were also no significant difference in actin 
organisation with different BGS types. However, significant difference in actin 
organisation was observed to respond to change in culture condition from static to 
dynamic culture. 
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Figure 5-2 At day 3, actin organisation in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS 
under static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions. (a) The actin cytoskeleton was labelled with Alexa 488 conjugated phalloidin 
(green) and nuclei were counterstained with DAPI (blue). Scale bar represents 50 µm. (b) 
Quantitative analysis of cell area by Image J. Results are presented as mean ± standard 
deviation (n=3). Statistical analysis was performed by two-way ANOVA followed by 
Bonferroni post-tests. *p < 0.05, **p < 0.01, ***p < 0.001, comparison between static, basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR) for each BGS. 
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Static 
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pHPR 
a 
b 
Day 3 
50 µm 
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Figure 5-3 At day 7, actin organisation in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS 
under static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions. (a) The actin cytoskeleton was labelled with Alexa 488 conjugated phalloidin 
(green) and nuclei were counterstained with DAPI (blue). Scale bar represents 50 µm. (b) 
Quantitative analysis of cell area by Image J. Results are presented as mean ± standard 
deviation (n=3). Statistical analysis was performed by two-way ANOVA followed by 
Bonferroni post-tests. *p < 0.05, comparison between static, basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR) for each BGS. 
SiHA-14 SiHA-22 SiHA-28 
Static 
BPR 
pHPR 
50µm 
a 
b 
Day 7 
Chapter 5 
100 
 
It is noticeable that majority hMSCs were spread on BGS under static culture 
condition, while most hMSCs were found to have relatively less spread cytoskeleton 
under basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions. This is confirmed by the quantification of the average cellular size, as 
shown in Figure 5-2 (b), which demonstrated that at day 3, cell area was significantly 
larger when cultured in a static environment than cultured in basal perfusion rate 
(BPR) or a period of high perfusion rate (pHPR) environment irrespective of BGS types. 
At day 7, cell area was larger when cultured in a static environment than cultured in 
basal perfusion rate (BPR) or a period of high perfusion rate (pHPR) environment on 
SiHA-14, whereas cell area was significantly larger when cultured in a static 
environment than cultured in basal perfusion rate (BPR) or a period of high perfusion 
rate (pHPR) environment on SiHA-22 and SiHA-28. There was no significant difference 
in cell area irrespective of whether they were cultured under basal perfusion rate 
(BPR) condition or a period of high perfusion rate (pHPR) condition irrespective of 
BGS types. 
5.3.2 Total DNA Quantity 
The quantity of total DNA from the BGS was assumed to be proportional to the 
number of cells on the BGS. So total increases in DNA was quantified to reflect cellular 
proliferation. As can be seen in Figure 5-4 (a), at day 3, cell proliferation was not 
dependent on culture conditions on any of the 3 BGS types. Also, total DNA 
production was not responsive to the BGS micro-porosity under any of the culture 
conditions. 
Total DNA production did not change with time in static environment, whereas, at 
day 7, it was around 1.2 times higher in basal perfusion rate (BPR) and 1.4 times 
higher in a period of high perfusion rate (pHPR) environment respectively (Figure 5-4 
(b)) compared with day 3. As a result, the DNA content of BGS cultured under 
perfusion conditions was significantly higher than under static culture condition at 
day 7. A period of high perfusion rate (pHPR) increased cell proliferation to a greater 
extent than basal perfusion rate (BPR), although there was no significant difference 
in total DNA quantity when culturing under basal perfusion rate (BPR) or a period of 
high perfusion rate (pHPR). 
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Figure 5-4 Total DNA production of hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under 
static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions at 
(a) day 3 and (b) day 7. Results are presented as mean ± standard deviation (n=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, 
**p < 0.01, ***p < 0.001, comparison between static, basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) for each BGS. 
5.3.3 Specific ALP Activity 
Specific ALP activity is an early marker of bone marrow stromal cells differentiating 
towards the osteoblastic phenotype. So, ALP activity normalized by µg DNA (specific 
ALP activity) was measured to evaluate osteogenic differentiation of hMSCs on 
different samples after 3 and 7 days. In Figure 5-5 (a), at day 3, specific ALP activity 
of hMSCs was significantly greater under static culture condition than under basal 
perfusion rate (BPR) condition on SiHA-14 BGS. The specific ALP activity of hMSCs 
was significantly lower under a period of high perfusion rate (pHPR) than both static 
and basal perfusion rate (BPR) conditions on SiHA-28 BGS. The specific ALP activity 
was not found to be dependent on BGS micro-porosity under both static and a period 
of high perfusion rate (pHPR) conditions. However, under basal perfusion rate (BPR) 
condition, the specific ALP activity of hMSCs was significantly higher on SiHA-22 and 
SiHA-28 than SiHA-14 BGS. 
After 7 days, specific ALP activity of hMSCs was significantly lower under basal 
perfusion rate (BPR) than both static and a period of high perfusion rate (pHPR) 
conditions irrespective of BGS types, as shown in Figure 5-5 (b). At day 7, on both 
SiHA-22 and SiHA-28 BGS, specific ALP activity was significantly higher under a period 
of high perfusion rate (pHPR) than static condition. The specific ALP activity was not 
dependent on BGS micro-porosity under both static and basal perfusion rate (BPR) 
conditions. However, under a period of high perfusion rate (pHPR) condition, specific 
a b 
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ALP activity of hMSCs was significantly lower on SiHA-14 compared with on both 
SiHA-22 and SiHA-28 BGS. 
 
Figure 5-5 Specific ALP activity of hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions at (a) day 
3 and (b) day 7. Results are presented as mean ± standard deviation (n=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests.  *p < 0.05, 
**p < 0.01, ***p < 0.001, comparison between static, basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) for each BGS. +++p < 0.001, comparison between 
SiHA-14, SiHA-22 and SiHA-28 under each culture condition.  
5.3.4 ERK and pERK Nuclear Translocation 
When hMSCs seeded BGS were cultured under static condition for 3 days, in some of 
hMSCs, ERK1/2 localised exclusively in the cytoplasm, while for other hMSCs, ERK1/2 
homogeneously distributed in both cytoplasm and nucleus, as can be seen in Figure 
5-6. However, when hMSCs seeded BGS were cultured under basal perfusion rate 
(BPR) or a period of high perfusion rate (pHPR) conditions, strong nuclear 
accumulation of ERK1/2 was detected, as can be seen in Figure 5-7. Under each 
isolated culture condition of static, basal perfusion rate (BPR) or a period of high 
perfusion rate (pHPR), ERK1/2 distribution did not appear to vary on the three types 
of BGS. Interestingly, pERK was found to have the same pattern with ERK, as can be 
seen in Figure 5-8 and Figure 5-9, i.e. pERK also located at nucleus when hMSCs 
seeded BGS were cultured in the basal perfusion rate (BPR) or a period of high 
perfusion rate (pHPR) environment rather than in static environment. 
a b 
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Figure 5-6 ERK1/2 distribution in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under static 
condition after 3 days. ERK1/2 was labelled using an antibody against at ERK1/2 (red), and 
nuclei were counterstained with DAPI (blue), scale bar represents 50 µm. White arrow 
showed ERK1/2 localised exclusively in the cytoplasm. 
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Figure 5-7 ERK1/2 distribution in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions after 3 days. 
ERK1/2 was labelled using an antibody against at ERK1/2 (red), and nuclei were 
counterstained with DAPI (blue), scale bar represents 50 µm. Yellow arrow showed ERK1/2 
was accumulated in nuclear. 
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Figure 5-8 pERK1/2 distribution in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under static 
condition after 3 days. pERK1/2 was labelled using an antibody against at pERK1/2 (red), 
and nuclei were counterstained with DAPI (blue), scale bar represents 50 µm. White arrow 
showed ERK1/2 localised exclusively in the cytoplasm. 
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Figure 5-9 pERK1/2 distribution in hMSCs on SiHA-14, SiHA-22 and SiHA-28 BGS under basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions after 3 days. 
pERK1/2 was labelled using an antibody against at pERK1/2 (red), and nuclei were 
counterstained with DAPI (blue), scale bar represents 50 µm. Yellow arrow showed 
pERK1/2 was accumulated in nuclear. 
 
SiHA-14 SiHA-22 SiHA-28 
pHPR 
BPR 
50µm 
pERK1/2 
Chapter 5 
107 
 
5.3.5 ERK Phosphorylation Levels 
The phosphorylation status of ERK1/2 was examined by Western blot and normalised 
by total ERK1/2 expression. As can be seen in Figure 5-10(b), at day 3, on SiHA-14 and 
SiHA-22, pERK1/2 in hMSCs was found to be significantly lower under basal perfusion 
rate (BPR), compared with both static condition and a period of high perfusion rate 
(pHPR) condition. On SiHA-28, the phosphorylation of ERK1/2 in hMSCs was 
significantly higher under a period of high perfusion rate (pHPR) compared with both 
static and basal perfusion rate (BPR) conditions. The phosphorylation of EKR1/2 at 
day 3 has the similar pattern of the specific ALP activity at day 7, which implies EKR1/2 
is part of the upstream signalling of hMSCs differentiation. 
After 7 days, the phosphorylation of ERK1/2 in hMSCs was significantly higher under 
static culture than basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR) on SiHA-14, as shown in Figure 5-11 (b).  On BGS SiHA-28, the phosphorylation 
of ERK1/2 in hMSCs was not dependent on culture conditions. It is worth mentioning 
that the phosphorylation of ERK1/2 in hMSCs was significantly higher on SiHA-14 
than on SiHA-22 and SiHA-28 under static condition, while it increased with 
increasing in BGS micro-porosity under basal perfusion rate (BPR) condition. 
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Figure 5-10 (a) At day 3, the phosphorylation of ERK1/2 (pERK1/2) and ERK protein 
expression on SiHA-14, SiHA-22 and SiHA-28 under static, basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) conditions. (b) Quantitative analysis of pERK1/2 
expression. Results are presented as mean ± standard deviation (n=3). Statistical analysis 
was performed by two-way ANOVA followed by Bonferroni post-tests.  *p < 0.05, **p < 
0.01, ***p < 0.001, comparison between static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) for each BGS. 
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Figure 5-11 (a) At day 7, the phosphorylation of ERK1/2 (pERK1/2) and ERK protein 
expression on SiHA-14, SiHA-22 and SiHA-28 under static, basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) conditions. (b) Quantitative analysis of pERK1/2 
expression. Results are presented as mean ± standard deviation (n=3). Statistical analysis 
was performed by two-way ANOVA followed by Bonferroni post-tests. *p < 0.05, **p < 
0.01, ***p < 0.001, comparison between static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) for each BGS. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison 
between SiHA-14, SiHA-22 and SiHA-28 under each culture condition.  
5.3.6 Relative Gene Expression 
5.3.6.1 Expression of Osteogenic Gene Markers 
mRNA levels of osteogenic markers: osterix (osx), alkaline phosphatase (alp), bone 
morphogenetic protein 2 (bmp2), collagen I (col i) and dentin matrix acidic 
phosphoprotein (dmp1) of hMSCs were measured by quantitative real-time PCR to 
evaluate how BGS micro-porosity and shear stress influences the expression of 
markers of osteogenic differentiation. osx is a transcription factor that has been 
demonstrated to be critical for osteoblast differentiation and bone formation 
(Nakashima et al., 2002; Tu et al., 2006). At day 3, the expression of osx was 
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significantly higher when BGS were cultured under basal perfusion rate (BPR) than 
both a period of high perfusion rate (pHPR) and static conditions, with osx expression 
under static condition being significantly lower than under a period of high perfusion 
rate (pHPR) condition, irrespective of BGS types (Figure 5-12 (a)). At day 3, under 
basal perfusion rate (BPR) condition, osx gene expression increased significantly with 
increasing in BGS micro-porosity. At day 7, there was no significant difference in osx 
gene expression with time under static condition irrespective of BGS types, whereas 
there was a significant decrease in osx expression under basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR) conditions, compared with day 3 (Figure 
5-12 (a) and (b)). The decrease under basal perfusion rate (BPR) condition was more 
prominent on SiHA-22 and SiHA-28 than on SiHA-14. However, at day 7, the 
expression of osx was still significantly higher under basal perfusion rate (BPR) than 
both static and a period of high perfusion rate (pHPR) conditions on any of the 3 BGS 
types.  
ALP is a transient early marker of bone marrow stromal cells differentiating towards 
the osteoblastic phenotype (Datta et al., 2005). At day 3, on both SiHA-14 and SiHA-
28, alp gene expression was significantly higher under static condition than either 
type of perfusion conditions, while on SiHA-22, alp gene expression was significantly 
higher under basal perfusion rate (BPR) than both static and a period of high 
perfusion rate (pHPR) conditions (Figure 5-12(c)). At day 3, alp gene expression was 
significantly higher on SiHA-22 BGS than SiHA-14 and SiHA-28 BGS under basal 
perfusion rate (BPR) condition. alp gene expression tended to increase with time 
from day 3 to day 7 under all conditions. At day 7, alp gene expression was 
significantly higher under static condition compared with basal perfusion rate (BPR) 
condition on SiHA-14 BGS, whereas it was significantly higher under basal perfusion 
rate (BPR) than both static and a period of high perfusion rate (pHPR) conditions on 
SiHA-22 BGS, as can be seen in Figure 5-12 (d). At day 7, under basal perfusion rate 
(BPR), alp gene expression was found to be significantly higher on SiHA-22 BGS than 
both SiHA-14 and SiHA-28 BGS. Specific ALP activity at day 7 (in section 5.3.3) did not 
match with gene expression of alp at day 7. One possible explanation is that specific 
ALP activity reaches the highest levels under a period of high perfusion rate (pHPR) 
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at day 7, but it is ready to decrease after day 7 according its gene expression levels 
at day 7. Arpornmaeklong  also found that ALP activity increased to reach the highest 
levels then decreased during osteogenic differentiation (Arpornmaeklong et al., 
2009).  
 
Figure 5-12 Expression of osx and alp genes in hMSCs cultured on SiHA-14, SiHA-22 and 
SiHA-28 BGS under static, basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR) conditions after 3 and 7 days.  Results are presented as mean ± standard deviation 
(n=3). Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-
tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison between static, basal perfusion rate 
(BPR) and a period of high perfusion rate (pHPR) for each BGS. +p < 0.05, ++p < 0.01, +++p 
< 0.001, comparison between SiHA-14, SiHA-22 and SiHA-28 under each culture condition. 
BMP2 plays a critical role in bone formation and regeneration (Reddi, 1998). The 
short-term expression of bmp2 was demonstrated to be necessary and sufficient for 
osteochondral differentiation of MSCs in vivo (Noel et al., 2008). At day 3, both basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR) facilitated the 
expression of bmp2, as compared to static culture on SiHA-22 and SiHA-28 BGS 
(Figure 5-13 (a)). With increasing in BGS micro-porosity, expression of bmp2 
decreased irrespective of culture conditions. Interestingly, expression of bmp2 
a b 
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decreased with time from day 3 to day 7 irrespective of culture conditions, as shown 
in Figure 5-13  (b). The decrease in bmp2 expression was less marked under basal 
perfusion rate (BPR), with bmp2 expression under basal perfusion rate (BPR) 
condition being consistently the highest at day 7, and there no longer being any 
response in bmp2 expression to BGS micro-porosity under any of 3 culture conditions 
used in this study. 
col i has been reported to be expressed early during the commitment to the 
osteoblastic phenotype (Rodan and Noda, 1991). At day 3, the gene expression of col 
i was significantly higher under basal perfusion rate (BPR) than both static and a 
period of high perfusion rate (pHPR) conditions for both SiHA-14 and SiHA-22 BGS, 
while it was the highest under a period of high perfusion rate (pHPR) on SiHA-28 BGS. 
At day 3, col i gene expression was found to be significantly lower on SiHA-28 than 
on SiHA-14 and SiHA-22 under basal perfusion rate (BPR), as can be seen in Figure 
5-13 (c). The expression of col i was found to have an obvious decrease with time 
from day 3 to day 7 under a period of high perfusion rate (pHPR) condition 
irrespective of BGS types. At day 7, expression of col i (Figure 5-13 (d)) was the highest 
under basal perfusion rate (BPR) than static and a period of high perfusion rate (pHPR) 
irrespective of BGS types. At day 7, the pattern of col i expression was similar to day 
3, with the expression of col i was found to be significantly lower on SiHA-28 than on 
SiHA-14 under basal perfusion rate (BPR). 
dmp1 has been found to be highly expressed in osteocytes and can be classed as a 
pro-osteogenic factor (Kalajzic et al., 2004). At both day 3 and day 7, the expression 
of dmp1 was significantly higher under basal perfusion rate (BPR) than both static 
and a period of high perfusion rate (pHPR) conditions irrespective of BGS types, as 
can be seen in Figure 5-13 (e) and (f). dmp1 expression was not found to be 
responsive to micro-porosity of BGS at either time point or under any of 3 culture 
conditions used in this study. 
 
Chapter 5 
113 
 
 
Figure 5-13 Expression of bmp2, col i and dmp1 genes in hMSCs cultured on SiHA-14, SiHA-
22 and SiHA-28 BGS under static, basal perfusion rate (BPR) and a period of high perfusion 
rate (pHPR) conditions after 3 and 7 days.  Results are presented as mean ± standard 
deviation (n=3). Statistical analysis was performed by two-way ANOVA followed by 
Bonferroni post-tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison between static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) for each BGS. +p < 
0.05, ++p < 0.01, +++p < 0.001, comparison between SiHA-14, SiHA-22 and SiHA-28 under 
each culture condition.  
5.3.6.2 Expression of Chondrogenic Gene Markers 
SRY-box 9 (sox9) and runt-related transcription factor 2 (runx2) have been identified 
as important transcriptional regulators of early and late chondrogenic differentiation, 
respectively (Karsenty, 2008). At day 3, basal perfusion rate (BPR) significantly 
increased the expression of sox9 compared with static culture, and a period of high 
e 
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perfusion rate (pHPR) increased it even further irrespective of BGS types, as can be 
seen in Figure 5-14 (a). At day 3, sox9 expression was significantly lower on SiHA-28 
than on SiHA-22 under a period of high perfusion rate (pHPR) condition. From day 3 
to day 7, the expression of sox9 increased under basal perfusion rate (BPR) condition, 
while it decreased under static and a period of high perfusion rate (pHPR) conditions. 
At day 7, sox9 expression was found to be significantly higher under either type of 
perfusion culture conditions than under static condition irrespective of BGS types. At 
day 7, expression of sox9 was not found to be responsive to micro-porosity of BGS 
irrespective of culture conditions. 
At day 3, there was no significant difference in runx2 expression when culturing 
under static or basal perfusion rate (BPR), while in comparison with static and basal 
perfusion rate (BPR), a period of high perfusion rate (pHPR) enhanced expression of 
runx2 significantly irrespective of BGS types, as can be seen in Figure 5-14 (c). At day 
3, under a period of high perfusion rate (pHPR), runx2 expression was significantly 
lower on SiHA-28 than both on SiHA-14 and SiHA-22. But there was no response of 
runx2 expression to BGS micro-porosity under static or basal perfusion rate (BPR) 
conditions. Under static condition there was no significant difference in expression 
of runx2 with time, in contrast, under either type of perfusion conditions, it increased 
significantly from day 3 to day 7 (Figure 5-14 (d)). As a result, at day 7, runx2 
expression was significantly higher under a period of high perfusion rate (pHPR) as 
compared to static and basal perfusion rate (BPR) conditions, with runx2 expression 
under basal perfusion rate (BPR) being higher than static condition. At day 7, under 
a period of high perfusion rate (pHPR) condition, the expression of runx2 was higher 
on SiHA-22 BGS than on SiHA-14 and SiHA-28 at day 7. 
Collagen II (COL II) is the major structural component of cartilage, so it is one of the 
commonly used markers of chondrogenesis (Ng et al., 1997). At day 3, there was no 
significant difference between static and basal perfusion rate (BPR) on any of the 
three BGS types. At day 3, there was significant increase in the expression of col ii 
under a period of high perfusion rate (pHPR) as compared static condition on SiHA-
14, SiHA-22 and SiHA-28, Figure 5-14 (e). At day 3, col ii expression was found to be 
higher under a period of high perfusion rate (pHPR) as compared to basal perfusion 
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rate (BPR) on SiHA-14 and SiHA-22 BGS. At day 3, under a period of high perfusion 
rate (pHPR), the expression of col ii was found to be significantly lower on SiHA-28 
than on either SiHA-14 or SiHA-22. At day 7, col ii expression was found to be 
significantly higher under a period of high perfusion rate (pHPR) condition as 
compared to static condition on any of the three BGS types. At day 7, col ii expression 
was found to be significantly higher under a period of high perfusion rate (pHPR) as 
compared to basal perfusion rate (BPR) on SiHA-14 and SiHA-28. col ii expression was 
not found to be responsive to micro-porosity of BGS at day 7 under any of 3 culture 
conditions used in this study. 
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Figure 5-14 Expression of sox9, runx2 and col ii genes in hMSCs cultured on SiHA-14, SiHA-
22 and SiHA-28 BGS under static, basal perfusion rate (BPR) and a period of high perfusion 
rate (pHPR) conditions after 3 and 7 days.  Results are presented as mean ± standard 
deviation (n=3). Statistical analysis was performed by two-way ANOVA followed by 
Bonferroni post-tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison between static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) for each BGS. +p < 
0.05, ++p < 0.01, +++p < 0.001, comparison between SiHA-14, SiHA-22 and SiHA-28 under 
each culture condition.  
5.3.6.3 Expression of Myogenic Gene Marker 
Myoblast determination protein (myoD) is a myogenic transcriptional regulatory 
factor that activate a number of muscle-specific structural genes and transcription 
factors to drive myogenesis (Rao et al., 2006). On day 3, there was no significant 
difference in myoD expression under basal perfusion rate (BPR) compared with static 
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culture irrespective of BGS types. At day 3, the expression of myoD was found to be 
significantly lower under a period of high perfusion rate (pHPR) than under either 
static or basal perfusion rate (BPR) conditions on SiHA-14 and SiHA-22, Figure 5-15 
(a). At day 3, under both static and basal perfusion rate (BPR) conditions, the 
expression of myoD was significantly lower on SiHA-28 than on SiHA-14. 
 
Figure 5-15 The gene expression of myoD in hMSCs cultured on SiHA-14, SiHA-22 and SiHA-
28 BGS under static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions after 3 and 7 days.  Results are presented as mean ± standard deviation (n=3). 
Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-tests.  
*p < 0.05, **p < 0.01, ***p < 0.001, comparison between static, basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR) for each BGS. +p < 0.05, ++p < 0.01, comparison 
between SiHA-14, SiHA-22 and SiHA-28 under each culture condition.  
By day 7, the expression of myoD was found to be significantly decreased (Figure 5-15 
(b)) compared with day 3, regardless of BGS micro-porosity and culture condition. At 
day 7, myoD expression was found to be significantly lower under a period of high 
perfusion rate (pHPR) as compared to static condition on SiHA-14. At day 7, the 
expression of myoD was significantly higher under basal perfusion rate (BPR) 
condition than either static or a period of high perfusion rate (pHPR) conditions on 
SiHA-22 and SiHA-28. At day 7, under static condition, myoD expression was 
significantly higher under on SiHA-14 than on SiHA-28. At day 7, under basal 
perfusion rate (BPR), there was a significant increase in myoD expression when 
hMSCs were cultured on either SiHA-22 or SiHA-28 compared with SiHA-14. 
5.3.6.4 Expression of Integrin Subunits 
At day 3, either type of perfusion culture significantly increased integrin α1 
expression compared with static culture when hMSCs were cultured on SiHA-22 and 
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SiHA-28 BGS, Figure 5-16 (a). For SiHA-14 BGS, basal perfusion rate (BPR) significantly 
increased the integrin α1 expression as compared to static culture and a period of 
high perfusion rate (pHPR). At day 3, under static condition, higher micro porosity 
(SiHA-22 or SiHA-28) suppressed integrin α1 expression compared with SiHA-14, 
whereas under either type of perfusion conditions, there was no obvious difference 
in expression of integrin α1 with respect to BGS micro-porosity. By day 7, integrin α1 
expression under basal perfusion rate (BPR) condition was significantly higher as 
compared to static and a period of high perfusion rate (pHPR) on SiHA-14 and SiHA-
28 BGS, as can be seen in Figure 5-16 (b). At day 7, on BGS SiHA-22, integrin α1 
expression was significantly higher on either type of perfusion conditions than static 
condition. At day 7, under basal perfusion rate (BPR) condition, the expression of 
integrin α1 was found to be significantly higher on SiHA-28 than on SiHA-14, whereas, 
under a period of high perfusion rate (pHPR), the expression of integrinα1 was 
significantly higher on SiHA-22 compared with on SiHA-14. 
At day 3, basal perfusion rate (BPR) significantly increased integrin α5 expression 
compared with static culture, and a period of high perfusion rate (pHPR) further 
increased integrin α5 expression significantly irrespective of BGS types, Figure 5-16 
(c). At day 3, under basal perfusion rate (BPR) condition, the expression of integrin 
α5 was significantly higher on SiHA-28 than on SiHA-14, however, under a period of 
high perfusion rate (pHPR) condition, integrin α5 expression was found to be 
significantly lower on SiHA-28 than SiHA-14 and SiHA-22. By day 7, the expression of 
integrin α5 significantly decreased (Figure 5-16 (d)) under a period of high perfusion 
rate (pHPR) compared with day 3 on SiHA-14 and SiHA-22. At day 7, under a period 
of high perfusion rate (pHPR) condition, the expression of integrin α5 was 
significantly higher compared with static condition on any of the three BGS types, 
and the expression of integrin α5 was also significantly higher compared with basal 
perfusion rate (BPR) on SiHA-28. At day 7, under a period of high perfusion rate 
(pHPR), the expression of integrin α5 increased significantly on SiHA-28 compared 
with both SiHA-14 and SiHA-22. At day 3, there was no significant difference in the 
expression of integrin β1 when comparing basal perfusion rate (BPR) with static 
culture condition, while a period of high perfusion rate (pHPR) significantly increased 
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integrin β1 expression compared with static culture irrespective of BGS types, as 
shown in Figure 5-16 (e). At day 3, integrin β1 expression was significantly higher 
under a period of high perfusion rate (pHPR) than basal perfusion rate (BPR) 
condition on both SiHA-14 and SiHA-22 BGS. At day 3, under static and basal 
perfusion rate (BPR) conditions, there was no response to BGS type in expression of 
integrin β1, however, under a period of high perfusion rate (pHPR) condition, 
expression of integrin β1 was downregulated on SiHA-28 than on SiHA-14 and SiHA-
22. By day 7, the expression of integrin β1 did not vary significantly compared with 
day 3 under static and basal perfusion rate (BPR) conditions, while it increased 
significantly under a period of high perfusion rate (pHPR) on SiHA-22 and SiHA-22 
compared with day 3 (Figure 5-16 (f)). At day 7, under static and basal perfusion rate 
(BPR) conditions, the expression of integrin β1 was not dependent on BGS micro-
porosity, while under a period of high perfusion rate (pHPR), the expression of 
integrin β1 was significantly higher on SiHA-22 than SiHA-28, which is in turn 
significantly higher than on SiHA-14. 
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Figure 5-16 Expression of integrin α1, integrin α5 and integrin β1 genes in hMSCs cultured 
on SiHA-14, SiHA-22 and SiHA-28 BGS under static, basal perfusion rate (BPR) and a period 
of high perfusion rate (pHPR) conditions after 3 and 7 days.  Results are presented as mean 
± standard deviation (n=3). Statistical analysis was performed by two-way ANOVA 
followed by Bonferroni post-tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison 
between static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) for 
each BGS. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison between SiHA-14, SiHA-22 and 
SiHA-28 under each culture condition.  
5.4 Discussion 
In this study, SiHA BGS granules with different micro-porosities were seeded with 
hMSCs then cultured in static, basal perfusion rate (BPR) or a period of high perfusion 
rate (pHPR) environment. Responses of hMSCs, for example proliferation, 
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cytoskeleton organisation, integrin activation and differentiation, were analysed to 
investigate the synergistic effect of BGS geometry (micro-porosity) and perfusion.  
The cytoskeleton is composed of a network of microfilaments and microtubules that 
link extracellular matrix to the cell nucleus and could play an important role in sensing 
mechanical forces and transforming mechanical forces into biochemical signals. Actin 
filamentous network is highly dynamic, and it can rearrange in response to 
mechanical stimulation, substrate stiffness or topography (Pavalko et al., 1998; Lee 
et al., 2015; Park et al., 2011). To investigate the synergistic effect of micro-structure 
of BGS and shear stress on cytoskeleton organisation, F-actin of hMSCs cultured on 
SiHA-14, SiHA-22 and SiHA-28 BGS at different condition was studied in vitro and 
shown in Figure 5-2 (a). Cytoskeleton responded to both basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR) culture. Cytoskeleton was found to be less 
spread under both basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR) conditions, i.e. when cells differentiate to osteogenic lineage or chondrogenic 
lineage, compared with under static condition. Similar findings were also reported in 
the literature that cells become more rounded, when the expression of chondrogenic 
markers (sox9 and col ii) are upregulated (Zhang et al., 2006). Under In vivo condition, 
osteoblasts were also found to adopt a cuboidal morphology when actively secreting 
matrix (Franz-Odendaal et al., 2006). 
Cell proliferation is crucial for bone tissue regeneration. However, traditional static 
culture may lead to the death of seeded cells on 3D BGS, due to limited nutrients and 
oxygen transport (Volkmer et al., 2008; Yeatts and Fisher, 2011). This can be 
overcome by using dynamic 3D perfusion bioreactors with constant replacement of 
fresh medium. In this study, at day 3, there was no significant difference in hMSCs 
proliferation irrespective of culture conditions on any of the three types of BGS. 
However, at day 7, either type of perfusion conditions was found to significantly 
increase hMSCs proliferation, especially a period of high perfusion rate (pHPR), which 
provides more efficient nutrients and oxygen exchange as well as increased shear 
stress. 
The mitogen-activated protein kinase (MAPK) pathways have been found to respond 
to various extracellular stimuli and control a large number of fundamental cellular 
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processes including cell survival, growth, proliferation, differentiation, motility, 
stress response and apoptosis. ERK1/2 is one of the members of MAP Kinase, which 
has been widely recognised as a latent integrin-related pathway and can facilitate 
osteogenic differentiation of hMSCs in response to mechanical stimulation (Liu et al., 
2011; Ward Jr. et al., 2007; Liu et al., 2009). However, the role of ERK appears to be 
more complex in chondrogenesis. Some researchers reported that ERK signalling 
represses chondrogenesis (Yoon et al., 2000; Appleton et al., 2010), whereas others 
demonstrated the requirement of ERK activation for induction of the chondrogenic 
master gene sox9 or precartilage condensation in the early stage of chondrogenesis 
(Zhang et al., 2014; Li et al., 2010; Murakami et al., 2000). 
In order to execute its functions, MAP kinase was required to translocate into the 
nucleus, where MAP kinase phosphorylates a large number of substrates (Roskoski, 
2012; Plotnikov et al., 2011; Brunet et al., 1999). Studies have demonstrated that 
ERK1/2 was localized in the cytoplasm of resting cells due to interaction with 
anchoring proteins. Following stimulation, most ERK1/2 molecules were observed to 
enter the nucleus rapidly (in 15 min), and remain there persistently (Lenormand et 
al., 1993). The main activity of ERK1/2 in the nucleus is to regulate transcription 
factors, which can in turn induce various physiological processes. In this study, both 
ERK1/2 and pEKR1/2 were mostly located in the nucleus under both basal perfusion 
rate (BPR) and a period of high perfusion rate (pHPR). One explanation may be that 
ERK1/2 translocated from the cytoplasm to nucleus in response to shear stress and 
phosphorylated in nucleus. It is worth mentioning that, at day 3, the phosphorylated 
ERK1/2 amount was significantly lower under basal perfusion rate (BPR) condition 
compared with under static condition. However, pERK1/2 was mostly observed in the 
nucleus, indicating that it could regulate transcription factors more efficiently than 
static culture.  
The significant upregulation of osx expression under basal perfusion rate (BPR) 
suggested that it can induce osteogenic differentiation of hMSCs. The enhancement 
of alp, bmp2, dmp1 and col i expression under basal perfusion rate (BPR) condition 
consolidated the differentiation towards the osteogenic lineage. In this study, when 
hMSCs seeded BGS were subjected to a period of high perfusion rate (pHPR), the 
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expression of osteogenic markers was lower compared with basal perfusion rate 
(BPR). This demonstrated that a period of high perfusion rate (pHPR) diminished the 
advantage of basal perfusion rate (BPR) in terms of osteogenic differentiation. 
However, the expression of certain osteogenic genes, like osx and bmp2, and specific 
ALP activity were higher compared with static culture. This demonstrated that a 
period of high perfusion rate (pHPR) could still support osteogenic differentiation to 
some extent. Taken together, these findings agree with previous research that, in 3D 
perfusion culture bioreactor, shear stress in the range of 0.001 – 1 dyn/cm2 
generated by flow induces osteogenic differentiation (Bancroft et al., 2002; Gomes 
et al., 2003; Sikavitsas et al., 2005; Li et al., 2009; Vance et al., 2005; McCoy and 
O’Brien, 2010). In this study, although hMSCs seeded BGS were cultured in 
osteogenic medium, it is surprising to notice that a period of high perfusion rate 
(pHPR) significantly increased the expression of chondrogenic markers, like sox9, 
runx2 and col ii, throughout 7 days of culture compared with static condition. 
Interestingly, cyclic tensile strain was also proved to play a role in directing both 
intramembranous and endochondral ossification of mesenchymal stem cells (Carroll 
et al., 2017).  
In a previous study, continuous flow rate of 0.1 ml/min was demonstrated to favour 
chondrogenic potential of goat MSCs on 3D biodegradable polymeric BGS (Gonçalves 
et al., 2011). Another study showed decreased chondrogenic gene expression and 
matrix production of pellet hMSCs mounted in porous BGS that were exposed to a 
1.22 ml/min flow (Kock et al., 2014). Although the flow rate of 1.22 ml/min is more 
than 10 times higher compared to flow rate of 0.1 ml/min, shear stress is affected by 
the dimension of flow chamber and structure of the BGS, as well as flow rate. So, the 
interference of shear stress level and chondrogenic differentiation cannot be 
concluded by comparing directly the levels of flow rate between previous studies 
using different experimental setups. Basal perfusion rate (BPR) culture also elevated 
the expression of chondrogenic gene markers compared static condition. This finding 
suggested that in a 3D perfusion environment, higher shear stress enhanced 
chondrogenic differentiation, and this finding is in line with a previous study that, 
rabbit chondrocytes cultured in a 3D bioreactor at increased flow rate (0.8 ml/min) 
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were found to have significantly higher production of chondrogenic markers, like 
glycosaminoglycan (GAG) and matrix deposition, compared with chondrocytes that 
were cultured at low flow rate (0.05 ml/min) (Dror et al., 1996). The models that are 
used in shear stress evaluation in 3D perfusion culture were different from that are 
used in monolayer cell culture models. The quantified shear stress value in 
monolayer cell culture is usually 2 to 4 orders of magnitude higher. For example, in 
monolayer cell culture model, Yourek et al. and Juhasz et al. found that the shear 
stresses of 9 dyn/cm2 and 50 dyn/cm2 could enhance osteogenic and chondrogenic 
differentiation, respectively (Yourek et al., 2010; Juhász et al., 2014). The evidence of 
higher shear stress induced chondrogenic differentiation from previous studies was 
in chondrogenic media. The current study showed that higher shear stress induced 
chondrogenic differentiation in osteogenic medium for the first time. It is widely 
accepted that hypoxia can promote chondrogenesis. However, it is unlikely that the 
perfusion conditions in the current study cause or change hypoxia, because the 
bottle of medium was vented in normoxic atmosphere. 
The findings in this study reveal a clear dependence of hMSCs response on perfusion 
flow rate: hMSCs cultured in basal perfusion rate (BPR) environment differentiate 
towards the osteogenic lineage, while a period of high perfusion rate (pHPR) induces 
hMSCs differentiate towards the chondrogenic lineage. This may explain the results 
that low strain led to the intramembranous bone formation, whereas higher strain 
additionally provoked endochondral ossification with respect to fracture healing in 
trabecular metaphyseal bone (Claes et al., 2011). The first stage of 
endochondral ossification is the aggregation of MSCs to form cellular aggregates, 
after which the cells undergo chondrogenic differentiation to form the cartilaginous 
template (Mackie et al., 2008), and mechanical stimuli have been found to have an 
important effect on the rate of endochondral ossification during this early stage 
(Lacroix and Prendergast, 2002; Isaksson et al., 2006; Lacroix et al., 2002). In a SiCaP 
bone substitute graft materials used in an in vivo ectopic model, bone formation 
were observed by both intramembranous and endochondral ossification, often 
within close proximity to one another, illustrated differences in the local mechanical 
environment (Chan et al., 2012). The findings in this study may explain the possible 
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mechanism for this observation, with the different pathways of bone formation 
potentially illustrating differences in the local mechanical environment. Mechanical 
stimulus was distributed differently in BGS, and areas that receive low level of 
stimulus form bone by intramembranous ossification, while areas that receive 
excessive mechanical stimulus form bone by endochondral ossification. Rough 
surface causes a higher shear pressure gradient and leads to the early transition from 
laminar to turbulent flow, therefore SiHA-28 has a higher possibility to create 
turbulent flow. However, its unknown whether micro-porosity creates local 
turbulent flow and how micro-porosity affects shear stress, as the transition from 
laminar to turbulent flow also depends on flow rate, friction factor of the surface and 
dimension of the micro-pores. A previous study demonstrated that chondrogenic 
priming of hMSCs could improve vessel invasion within bioengineered constructs 
(Farrell et al., 2009). Therefore, this finding also demonstrated a possible approach 
in tissue engineering in terms of controlling shear stress to optimize hMSCs 
chondrogenic differentiation and achieve bone regeneration. 
It has been postulated that MSCs commit to myogenic lineage when cultured on 
relatively soft muscle-like substrates, and to osteogenic lineage when cultured on 
rigid bone-like substrates (Engler et al., 2006; Pek et al., 2010). The expression of 
myoD on SiHA BGS under static culture decreased with time significantly possibly due 
to the high stiffness of SiHA dominantly induce osteogenic differentiation over 
myogenic differentiation. The effect of perfusion on myogenesis was also 
investigated in this study. At day 3, there was no significant difference in myogenic 
differentiation of hMSCs under basal perfusion rate (BPR) compared with static 
culture. At both day 3 and day 7, a period of high perfusion rate (pHPR) significantly 
suppressed myogenic differentiation of hMSCs compared with static culture, as 
demonstrated by the downregulation of myoD expression. 
Integrins play important roles in adhesion, cell survival, regulating matrix metabolism 
and responding to mechanical stimuli (Desgrosellier and Cheresh, 2010; Kasten et al., 
2010; Lee et al., 2015). Previous study demonstrated that integrin β1 plays 
predominant roles in shear induced signalling and gene expression in osteoblast like 
cells (Lee et al., 2008). Yan also showed that the knockdown of integrin β1 led to the 
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inhibition of ERK activity and cell proliferation (Yan et al., 2012). The mechanism 
proposed was that integrin β1 in hMSCs acts as mechanoreceptors, which can 
activate signalling proteins such as focal adhesion kinase (FAK), and then activate the 
MAP kinase pathway (Friedland et al., 2009; Young et al., 2009; Lal et al., 2007; 
Pommerenke et al., 2002; Yang et al., 2014). On the other hand, fluid shear stress has 
been demonstrated to upregulate the expression of integrin β1 and this upregulation 
depended on FSS activated ERK1/2 (Liyue Liu et al., 2012). In this study, the gene 
expression of integrin β1 was upregulated up to 4 times during “chondrogenesis” 
under a period of high perfusion rate (pHPR). This finding strengthened previous 
research that β1 integrins play important roles in triggering the outside-in signalling 
and condensing precartilage during chondrogenesis of MSCs (Raghothaman et al., 
2014; Jin et al., 2007; Zhang et al., 2015), and blocking β1 integrins with blocking 
antibodies abolished proteoglycan synthesis response to mechanical stimuli (Chai et 
al., 2010). 
α integrins were widely recognised to be involved in stem cell lineage specification. 
This study demonstrated that integrin α5 increased significantly while chondrogenic 
gene markers were upregulated under a period of high perfusion rate (pHPR), which 
is in line with previous research showing that the level of integrin α5 increased during 
the early stage of chondrogenic differentiation (Jin et al., 2007; Chang et al., 2009). 
Combing the upregulation of integrin β1 under a period of high perfusion rate (pHPR) 
condition, these results agreeing with previous research that the fibronectin receptor 
(integrin α5β1) was expressed and rose during chondrogenic differentiation of MSCs 
(Goessler et al., 2008). Results from this study also indicate that the expression of 
integrin α5 was upregulated significantly while the expression of osteogenic markers 
was enhanced under basal perfusion rate (BPR). However, there are conflicting 
results in the literature regarding the role of integrin α5 in osteogenesis. Some 
studies have reported that integrin α5 was downregulated during osteogenesis (Chen 
et al., 2016; Lu and Zreiqat, 2010); whereas others have suggested that integrin α5 
was upregulated during osteogenesis (Frith et al., 2012) and downregulated with 
shRNA blocking osteogenic differentiation (Hamidouche et al., 2009).  
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The expression profile of integrin α1 was different to integrin α5, i.e. it was 
upregulated to a great extent during osteogenesis under basal perfusion rate (BPR). 
This is in line with findings from previous research that combined effects of 
mechanical stimulation and nanotopography led to significant upregulation of gene 
expression for integrin α1, as well as runx2 in osteoblast like cells (Prodanov et al., 
2010). Previous research also demonstrated that COL I receptor integrin α1β1 played 
important roles in promoting osteogenesis, and it was consistently enhanced 
following BMP-2 treatment induced osteoblast differentiation (Jikko et al., 1999; 
Salasznyk et al., 2004).   
Under static condition, hMSCs proliferation, cytoskeleton reorganisation, specific 
ALP activity, and most of the differentiation markers like osx, alp, col i, dmp1, sox9, 
runx2 and col ii were not found to be responsive to BGS with different micro-
porosities. On the contrary, when basal perfusion rate (BPR) was introduced to cell 
culture, at day 3, specific ALP activity and expression of osx were found to be 
significantly higher on BGS with higher micro-porosities like SiHA-22 and SiHA-28, 
compared with SiHA-14. At day 7, the phosphorylation of ERK1/2, and the expression 
of myoD were also significantly higher on BGS SiHA-22 and SiHA-28, compared with 
SiHA-14 under basal perfusion rate (BPR). At both day 3 and day 7, the expression of 
alp was found to be significantly higher on BGS SiHA-22 than both BGS SiHA-14 and 
SiHA-28 under basal perfusion rate (BPR).  
Under a period of high perfusion rate (pHPR), the expression of markers and integrin 
subunits related to chondrogenic differentiation were also found to be responsive to 
micro-porosity of BGS. For example, at day 3, the expression of runx2, col ii, integrin 
α5 and integrin β1 were found to be significantly higher on SiHA-14 and SiHA-22, 
compared with SiHA-28 under a period of high perfusion rate (pHPR). At day D7, the 
expression of runx2 and integrin β1 was significantly higher on SiHA-22, compared 
with SiHA-14 and SiHA-28 under a period of high perfusion rate (pHPR). This 
demonstrates that traditional static culture is not enough to screen BGS with 
different micro-porosities. Basal perfusion rate (BPR) was not only able to induce 
osteogenic differentiation, but also screen the osteoconduction capability of BGS 
with different micro-porosities. A period of high perfusion rate (pHPR) was not only 
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able to induce chondrogenic differentiation, but also screen the chondroconduction 
capability of BGS with different micro-porosities.  
5.5 Conclusion 
In summary, results in this study have demonstrated a strong interaction between 
perfusion shear stress and BGS micro-porosity, with perfusion culture facilitated 
proliferation, activated signalling pathways and being able to differentiate the 
bioactivity of BGS in vitro even with a small geometric difference. Furthermore, this 
study showed a clear dependence of hMSCs fate on the perfusion flow rate applied. 
Basal perfusion rate (BPR) led to upregulation of osteogenic differentiation markers, 
whereas a period of high perfusion rate (pHPR) induced upregulation of 
chondrogenic differentiation markers. Therefore, these findings provide valuable 
guidance for the future research and design of testing protocols in terms of 
investigating the behaviour of hMSCs towards different lineage commitment in 
combination with different BGS structures and chemistries.
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Chapter 6 L-type Voltage Sensitive Calcium Channels 
(VSCCs) Modulate Fluid Shear Stress Induced 
Differentiation of hMSCs Cultured on 3D SiHA BGS 
6.1 Introduction 
Mechanical stimuli have been reported to produce a variety of biological signals in 
bone cells, and one of the earliest events was the activation of calcium channels. 
Under physiological conditions, Ca2+ concentrations are reported to be 20,000 - 
100,000 times higher in the extracellular space than in the cell cytoplasm (around 
100 nM) (Clapham, 2007; Matta et al., 2015; Demaurex and Nunes, 2016). With the 
activation of calcium channels, intracellular calcium ([Ca2+]i) levels increase rapidly.  
For example, rat calvarial bone cells subjected to a hydrostatic pressure (6.9 x 104 
dyn/cm2, 1 Hz) were observed to have a significant increase in the concentration of 
[Ca2+]i after 25 s from the onset of mechanical strain (Brighton et al., 1996). By 
monitoring flow induced [Ca2+]i changes in intact bone of embryonic chicks, 
researchers have also proved that the percentage of responsive cells was increased 
in both osteoblasts and osteocytes under flow compared with static condition 
(Ishihara et al., 2013).  
L-type voltage-sensitive calcium channels (VSCCs) are one of the best characterized 
type of calcium channel. Much study has been conducted investigating the 
participation of L-type VSCCs in responding to mechanical load by using L-type VSCCs 
inhibitor, like nifedipine. For example, researchers have reported L-type VSCCs 
mediate load-induced bone formation in vivo (Li et al., 2002; Li et al., 2003), and they 
are critical components actively involved in the early long bone skeletal development 
(Shao et al., 2005). 
The early response of rat osteoblasts to bone loading was found to be associated 
with L-type VSCCs (Rawlinson et al., 1996). Whereas the responsiveness of L-type 
VSCCs to loading is conflicting in osteocytes. Rawlinson reported osteocytes’ 
response to bone loading did not involve ion channels dependent on nifedipine 
(Rawlinson et al., 1996), however, Miyauchi found that hypotonic stretch induced 
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rapid [Ca2+]i increase in isolated osteocytes, which required the expression of L-type 
Ca2+ channel subunit α1C (Miyauchi et al., 2000). One possible reason of these 
conflicting results is that osteocytes were cultured in different environments, i.e. in 
situ in bone loading experiment (Rawlinson et al., 1996), or isolated osteocytes 
stimulated by hypotonic stretch (Miyauchi et al., 2000). This suggests that 
experiment should be carefully evaluated when conducting comparison between 
different findings. Only a few studies have been conducted to investigate the 
presence or function of L-type VSCCs in MSCs. Li demonstrated that L-type VSCCs 
were presented in a small portion of undifferentiated rat MSCs (Li et al., 2006). Wen 
reported that L-type VSCCs play a crucial role in the proliferation, expression of 
osteogenic markers in rat MSCs (Wen et al., 2012). Kearney demonstrated that L-
type VSCCs coupled tensile strains of 7.5% or greater activated calpain and JNK, which 
lead to apoptosis of rat MSCs through DNA fragmentation (Kearney et al., 2008). 
Application of stretch via an expandable membrane resulted in immediate increase 
in [Ca2+]i in rat femur-derived osteoblast cells, which in turn modulated the increased 
production of OPN and OC proteins. Presence of nifedipine, L-type VSCCs blocker, 
blocked increases in [Ca2+]i and these matrix proteins production (Walker et al., 2000). 
However, there are conflicting results in the literature regarding involvement of L-
type VSCCs in response to fluid flow. Oscillatory fluid flow (20 to -20 dyn/cm2, 1 Hz, 
2 h) was found to induce [Ca2+]i mobilization within 1 min, then p38 and ERK1/2 
activation and opn mRNA upregulation in MC3T3-E1 cells, with L-type VSCCs playing 
an important role in this process (You et al., 2001). Liu reported that steady fluid flow 
(12 dyn/cm2, 30 min) also induced ERK1/2 phosphorylation in MC3T3-E1 cells, which 
was dependent on L-type VSCCs activation and ATP release (Liu et al., 2008). 
However, Chen demonstrated that MC3T3-E1 cells responded to steady fluid flow 
(12 dyn/cm2, 1 h) by showing [Ca2+]i increase within 20 s of onset, cytoskeletal 
reorganisation and c-fos and COX-2 activation, but these responses were 
independent of L-type VSCCs (Chen et al., 2000). This may indicate that steady flow 
(12 dyn/cm2) or oscillatory fluid flow (20 to -20 dyn/cm2) induced L-type VSCCs play 
an important role in MAP kinase activation, but L-type VSCCs were not involved in 
steady flow (12 dyn/cm2) induced cytoskeletal reorganisation. Ryder found that 
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steady fluid shear (12 dyn/cm2 or 25 dyn/cm2, 3 min) induced [Ca2+]i increase in 
MC3T3-E1 cells, but it was independent of L-type VSCCs, although in the same study, 
L-type VSCCs were found to be involved in parathyroid hormone (PTH) enhanced the 
[Ca2+]i response to shear (Ryder and Duncan, 2001). It should be borne in mind that 
all of these studies investigating the involvement of L-type VSCCs in response to fluid 
flow were conducted in monolayer cell culture model, and shear stress in these 
studies (12 - 25 dyn/cm2) are several magnitudes higher than the shear stress (0.001 
- 1 dyn/cm2) in 3D bioreactor system that have been reported to be able to activate 
signalling pathways and osteogenic differentiation (Goldstein et al., 2001; Bancroft 
et al., 2002; Gomes et al., 2003; Sikavitsas et al., 2005; Li et al., 2009; Vance et al., 
2005; McCoy and O’Brien, 2010). It has not been investigated how L-type VSCCs 
regulate shear stress induced biological signals in a 3D perfusion culture model. 
Findings in a previous chapter (Chapter 5) demonstrated that fluid flow induced 
expression of osteogenic differentiation or chondrogenic differentiation markers of 
hMSCs cultured on SiHA BGS was dependent on the flow profile and micro-porosity 
of SiHA BGS. The aim of this study was to investigate the role of L-type VSCCs in these 
processes. 
 
 
 
 
 
 
 
 
 
Chapter 6 
132 
 
6.2 Materials and Methods 
hMSCs seeded on either SiHA-14 or SiHA-28 BGS granules were cultured under static 
condition, basal perfusion rate (BPR) or a period of high perfusion rate (pHPR) as 
described in Chapter 5.2, hereafter cited as “control group”, or in control medium 
supplemented with 10 µM nifedipine for 3 days, hereafter cited as “nifedipine group”. 
100 ml medium was recirculated for each BGS during 3 days of perfusion culture, and 
the bottle of medium was vented in normoxic atmosphere. Composition of cell 
culture medium can be seen in Table 6-1. All analytical methods are same for control 
group and nifedipine group, which can be seen in Chapter 5, and all data are from 3 
days of culture. 
Table 6-1 Cell culture medium in control group and nifedipine group in CO2 atmosphere. 
 Control group Nifedipine group 
Day 1 PM PM + 10 µM nifedipine 
Day 2 - Day 3 PMO PMO + 10 µM nifedipine 
* PM and PMO are defined in Chapter 4.2. 
6.3 Results 
6.3.1 Cytoskeleton Organisation 
Changes in actin cytoskeleton were monitored to determine if L-type VSCCs 
mediated the shear stress induced cytoskeletal organisation on SiHA-14 (Figure 6-1) 
and SiHA-28 (Figure 6-2) BGS. The presence of nifedipine was not found to change 
the cytoskeleton of hMSCs noticeably compared with control group on both SiHA-14 
and SiHA-28 BGS, irrespective the culture conditions. This was confirmed by the 
quantification of the average cellular size, as shown in Figure 6-3, which 
demonstrated that the presence of nifedipine did not change cellular size 
significantly compared with control group on both SiHA-14 (Figure 6-3 (a)) and SiHA-
28 BGS (Figure 6-3 (b)), irrespective of culture conditions. On SiHA-14, cell area was 
significantly larger when cultured in a static environment compared with cultured in 
a period of high perfusion rate (pHPR) environment in control group. However, there 
was no significant difference in cell area on SiHA-14 in nifedipine group, irrespective 
the culture conditions. On SiHA-28, cell area was significantly larger when cultured in 
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a static environment than cultured in basal perfusion rate (BPR) or a period of high 
perfusion rate (pHPR) environment in both control group and nifedipine group.  
 
Figure 6-1 Influence of nifedipine on actin organisation in hMSCs on SiHA-14 under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. The actin 
cytoskeleton was labelled with Alexa 488 conjugated phalloidin (green) and nuclei were 
counterstained with DAPI (blue). Scale bar represents 50 µm.  
SiHA-14 
Static 
BPR  
pHPR 
Nifedipine 
50µm 
Control 
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Figure 6-2 Influence of nifedipine on actin organisation in hMSCs on SiHA-28 under static 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. The actin 
cytoskeleton was labelled with Alexa 488 conjugated phalloidin (green) and nuclei were 
counterstained with DAPI (blue). Scale bar represents 50 µm.  
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Figure 6-3 Influence of nifedipine on cellular size of hMSCs on (a) SiHA-14 and (b) SiHA-28 
BGS under static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions. Results are presented as mean ± standard deviation (n=3). Statistical analysis 
was performed by two-way ANOVA followed by Bonferroni post-tests.  +p < 0. 05, ++p < 
0.01, +++p < 0.001, comparison between static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR). 
6.3.2 Total DNA and Specific ALP Activity  
Total DNA was quantified to determine whether L-type VSCCs modulated cellular 
proliferation on SiHA BGS. As can be seen in Figure 6-4 (a), on SiHA-14, under static 
culture and basal perfusion rate (BPR) conditions, total DNA production was not 
significantly influenced by adding nifedipine into medium, however, under a period 
of high perfusion rate (pHPR) condition, total DNA production increased significantly 
with the presence of nifedipine compared with control group. On BGS SiHA-14, total 
DNA production was not responsive to culture conditions in control group. However, 
with the presence of nifedipine, total DNA production was significantly higher when 
BGS were cultured under a period of high perfusion rate (pHPR) condition compared 
with under basal perfusion rate (BPR) and static condition, with total DNA production 
under basal perfusion rate (BPR) condition being significantly higher than under static 
condition. Figure 6-4 (b) showed adding nifedipine into medium did not affect total 
DNA on SiHA-28 BGS under any culture conditions. On SiHA-28, total DNA production 
was found to be significantly higher under both basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) conditions compared with static condition, 
irrespective whether nifedipine was added into medium. In both control group and 
nifedipine group, total DNA production was not found to be dependent on BGS 
micro-porosity, irrespective of culture condition. 
a b 
SiHA-14 SiHA-28 
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Figure 6-4 Total DNA content of hMSCs on (a) SiHA-14 and (b) SiHA-28 BGS under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. Results 
are presented as mean ± standard deviation (n=3). Statistical analysis was performed by 
two-way ANOVA followed by Bonferroni post-tests. ***p < 0.001, the comparison between 
control group and nifedipine group. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison 
between static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR). 
ALP activity was measured and normalized by total DNA content (i.e. specific ALP 
activity) to examine how L-type VSCCs mediated the specific ALP activity of hMSCs 
on SiHA BGS. As can be seen in Figure 6-5 (a), on SiHA-14 BGS, specific ALP activity 
was not found to be dependent on the presence of nifedipine irrespective of culture 
conditions. On SiHA-14 BGS, specific ALP activity was found to be significantly higher 
under static condition than both basal perfusion rate (BPR) and a period of high 
perfusion rate (pHPR) conditions, irrespective whether nifedipine was added into 
medium.  
As can be seen in Figure 6-5 (b), on SiHA-28, under basal perfusion rate (BPR) 
condition, specific ALP activity was significantly decreased by adding nifedipine into 
medium compared with control group. On SiHA-28, under static and a period of high 
perfusion rate (pHPR) conditions, specific ALP activity was reduced with the presence 
of nifedipine in medium compared with control group. When SiHA-28 BGS was 
incubated in control medium, specific ALP activity was significantly lower under a 
period of high perfusion rate (pHPR) condition than static condition, however, with 
the presence of nifedipine, specific ALP activity was not found to be dependent on 
culture conditions.  
As can be seen in Figure 6-5, in control medium, under basal perfusion rate (BPR) 
condition, specific ALP activity increased significantly on SiHA-28 compared with 
a b 
SiHA-14 SiHA-28 
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SiHA-14, whereas under static condition and a period of high perfusion rate (pHPR) 
condition, specific ALP activity was not responsive to BGS type. When nifedipine was 
added into medium, specific ALP activity was not found to be responsive to BGS 
micro-porosity irrespective of culture conditions.  
 
Figure 6-5 Specific ALP activity of hMSCs on (a) SiHA-14 and (b) SiHA-28 BGS under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. Results 
are presented as mean ± standard deviation (n=3). Results are presented as mean ± 
standard deviation (n=3). Statistical analysis was performed by two-way ANOVA followed 
by Bonferroni post-tests. *p < 0.05, comparison between control group and nifedipine 
group. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison between static, basal perfusion rate 
(BPR) and a period of high perfusion rate (pHPR). $$$p < 0.001, comparison between SiHA-
14 and SiHA-28. 
6.3.3 ERK Distribution  
ERK1/2 distribution followed similar pattern on SiHA-14 (Figure 6-6) and SiHA-28 
(Figure 6-7) BGS. In control medium, ERK1/2 localised mostly in the cytoplasm 
(showed by white arrows in Figure 6-6 and Figure 6-7) under static condition, 
whereas strong nuclear accumulation of ERK1/2 was detected under both basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions (showed 
by yellow arrows in Figure 6-6  and Figure 6-7). However, with the addition of L-type 
VSCCs blocker nifedipine in medium, ERK1/2 was found to be homogeneously 
distributed in both cytoplasm and nucleus, irrespective of culture conditions (showed 
by green arrows in Figure 6-6  and Figure 6-7). 
a b 
SiHA-14 SiHA-28 
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Figure 6-6 Influence of nifedipine on ERK1/2 distribution in hMSCs on SiHA-14 under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. ERK1/2 
was labelled using an antibody against at ERK1/2 (red), and nuclei were counterstained 
with DAPI (blue), scale bar represents 50 µm. White arrow showed ERK1/2 localised 
exclusively in the cytoplasm, yellow arrow showed ERK1/2 was accumulated in nuclear, 
green arrow showed ERK1/2 was homogeneously distributed in both cytoplasm and 
nuclear.  
SiHA-14 
Control 
Static BPR pHPR 
Nifedipine 
50µm 
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Figure 6-7 Influence of nifedipine on ERK1/2 distribution in hMSCs on SiHA-28 under static, 
basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions. ERK1/2 
was labelled using an antibody against at ERK1/2 (red), and nuclei were counterstained 
with DAPI (blue), scale bar represents 50 µm. White arrow showed ERK1/2 localised 
exclusively in the cytoplasm, yellow arrow showed ERK1/2 was accumulated in nuclear, 
green arrow showed ERK1/2 was homogeneously distributed in both cytoplasm and 
nuclear.  
SiHA-28 
Control 
Static BPR pHPR 
Nifedipine 
50µm 
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6.3.4 Western Blot 
 
Figure 6-8 (a) Influence of nifedipine on pERK1/2 protein expression on SiHA-14 and SiHA-
28 under static, basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) 
conditions. (b)(c) Quantitative analysis of pERK1/2 expression. Results are presented as 
mean ± standard deviation (n=3). Statistical analysis was performed by two-way ANOVA 
followed by Bonferroni post-tests. *p < 0.05 comparison between control group and 
nifedipine. ++p < 0.01, +++p < 0.001, comparison between static, basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR). 
The phosphorylated ERK1/2 was tested and normalised by total ERK1/2 to evaluate 
if L-type VSCCs mediated ERK1/2 activation. As can be seen in Figure 6-8 (b), on BGS 
SiHA-14, under basal perfusion rate (BPR), the presence of nifedipine significantly 
increased phosphorylation of ERK1/2 compared with control group. On BGS SiHA-14, 
in control medium, the phosphorylation of ERK1/2 was found to be significantly 
lower under basal perfusion rate (BPR) condition than both static and a period of high 
perfusion rate (pHPR) conditions, however, with the presence of nifedipine in 
ERK1/2 
SiHA-14 
pERK1/2 
Control 
SiHA-28 
Static   BPR     pHPR 
GAPDH 
ERK1/2 
pERK1/2 
Nifedipine 
GAPDH 
a 
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medium, the phosphorylation of ERK1/2 was not found to be dependent on the 
culture conditions. 
As can be seen in Figure 6-8 (c), on BGS SiHA-28, under basal perfusion rate (BPR) 
condition, the presence of nifedipine significantly increased phosphorylation of 
ERK1/2 compared with control group. On BGS SiHA-28, in control medium, the 
phosphorylation of ERK1/2 was found to be significantly higher under a period of high 
perfusion rate (pHPR) condition than both static and basal perfusion rate (BPR) 
conditions, however, with the addition of nifedipine into medium, the 
phosphorylation of ERK1/2 was not found to be dependent on the culture conditions. 
In both control group and nifedipine group, the phosphorylation of ERK1/2 was not 
found to be responsive to BGS micro-porosity irrespective of culture conditions. 
6.3.5 Relative Gene Expression 
6.3.5.1 Expression of Osteogenic Gene Markers 
hMSCs seeded BGS were cultured in static, basal perfusion rate (BPR) or a period of 
high perfusion rate (pHPR) environment in control medium or in medium 
supplemented with nifedipine for 3 days, and mRNA levels of osterix (osx), alkaline 
phosphatase (alp), bone morphogenetic protein 2 (bmp2), type I collagen (col i) and 
dentin matrix acidic phosphoprotein (dmp1) were measured by quantitative real-
time PCR. osx is a transcription factor that has been demonstrated to be critical for 
osteoblast differentiation and bone formation (Nakashima et al., 2002; Tu et al., 
2006). As can be seen from Figure 6-9 (a) and (b), on both BGS SiHA-14 and BGS SiHA-
28, blocking L-type VSCCs with nifedipine significantly downregulated the expression 
of osx under basal perfusion rate (BPR) condition compared with control group, while 
significantly upregulated the expression of osx under a period of high perfusion rate 
(pHPR) condition, compared with control group. On BGS SiHA-14, in control medium, 
the expression of osx was significantly higher under basal perfusion rate (BPR) 
condition compared with static and a period of high perfusion rate (pHPR) conditions, 
with the expression of osx under a period of high perfusion rate (pHPR) condition 
being significantly higher than static condition. On BGS SiHA-14, with the addition of 
nifedipine in medium, the expression of osx was significantly higher under either type 
of perfusion conditions compared with static condition. On BGS SiHA-28, in control 
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medium, the expression of osx was significantly higher under basal perfusion rate 
(BPR) condition than both static and a period of high perfusion rate (pHPR) conditions, 
with the expression of osx under a period of high perfusion rate (pHPR) condition 
being significantly higher than static condition. On BGS SiHA-28, when nifedipine was 
added into medium, the expression of osx was significantly higher under a period of 
high perfusion rate (pHPR) condition than both basal perfusion rate (BPR) and static 
conditions, with the expression of osx under basal perfusion rate (BPR) condition 
being significantly higher than static condition. In control medium, under basal 
perfusion rate (BPR) condition, the expression of osx was significantly upregulated 
on SiHA-28 compared with SiHA-14, whereas, the expression of osx was not found 
responsive to BGS micro-porosity under static and a period of high perfusion rate 
(pHPR) condition. With the presence of nifedipine, the expression of osx was not 
found to be responsive to BGS micro-porosity irrespective of culture conditions. 
ALP is a transient early marker of bone marrow stromal cells differentiating towards 
the osteoblastic phenotype (Datta et al., 2005). On BGS SiHA-14, the addition of 
nifedipine into medium did not alter the expression of alp compared with control 
group, irrespective of culture conditions, as can be seen in Figure 6-9 (c). On BGS 
SiHA-14, the expression of alp was significantly higher under static condition than 
either type of perfusion conditions, irrespective whether nifedipine was added into 
medium. As can be seen in Figure 6-9 (d), on BGS SiHA-28, the expression of alp was 
significantly downregulated with the presence of nifedipine in the medium compared 
with control group under both static and basal perfusion rate (BPR) conditions, but 
not a period of high perfusion rate (pHPR) condition. On BGS SiHA-28, in control 
medium, the expression of alp was significantly higher under static condition than 
both basal perfusion rate (BPR) and a period of high perfusion rate (pHPR) conditions, 
whereas with the addition of nifedipine into medium, the expression of alp was 
significantly higher under both static and a period of high perfusion rate (pHPR) 
conditions compared with basal perfusion rate (BPR) condition. In control medium, 
the expression of alp was not found to be dependent on BGS micro-porosity 
irrespective of culture conditions. When medium was supplemented with nifedipine, 
under static condition, the expression of alp was found to be significantly 
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downregulated on SiHA-28 compared with SiHA-14, while under both basal perfusion 
rate (BPR) and a period of high perfusion rate (pHPR) conditions, the expression of 
alp was not found to be dependent on BGS micro-porosity. 
 
Figure 6-9 Influence of nifedipine on expression of osx and alp genes in hMSCs cultured on 
SiHA-14 and SiHA-28 under static, basal perfusion rate (BPR) and a period of high perfusion 
rate (pHPR) conditions. Results are presented as mean ± standard deviation (n=3). 
Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-tests. 
**p < 0.01, ***p < 0.001, comparison between control group and nifedipine group. +p < 
0.05, ++p < 0.01, +++p < 0.001, comparison between static, basal perfusion rate (BPR) and 
a period of high perfusion rate (pHPR). $$$p < 0.001, comparison between SiHA-14 and 
SiHA-28. 
BMP2 plays a critical role in bone formation and regeneration (Reddi, 1998). On both 
BGS SiHA-14 and BGS SiHA-28, under a period of high perfusion rate (pHPR) condition, 
the expression of bmp2 was significantly upregulated with the presence of nifedipine 
compared with control group, whereas under both static and basal perfusion rate 
(BPR) conditions, the expression of bmp2 was not responsive to the addition of 
nifedipine into medium compared with control group, as can be seen in Figure 6-10 
SiHA-14 SiHA-28 
a b 
c d 
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(a) and (b). On BGS SiHA-14, in control medium, the expression of bmp2 was 
significantly higher under either type of perfusion conditions compared with under 
static condition. On BGS SiHA-14, with the addition of nifedipine into medium, the 
expression of bmp2 under a period of high perfusion rate (pHPR) condition was 
significantly higher than both static and basal perfusion rate (BPR) conditions. On BGS 
SiHA-28, in control medium, the expression of bmp2 was not found to be dependent 
on culture conditions, whereas when adding nifedipine into medium, the expression 
of bmp2 was significantly higher under a period of high perfusion rate (pHPR) 
condition compared with both static and basal perfusion rate (BPR) conditions. In 
both control group and nifedipine group, under static condition, the expression of 
bmp2 was significantly downregulated on SiHA-28 compared with SiHA-14, however, 
under either type of perfusion conditions, the expression of bmp2 was not found to 
be responsive to BGS micro-porosity. 
col i has been reported to be expressed early during the commitment to the 
osteoblastic phenotype (Rodan and Noda, 1991). On BGS SiHA-14, under basal 
perfusion rate (BPR) condition, the expression of col i was significantly 
downregulated with the presence of nifedipine in medium compared with control 
group, whereas under both static and a period of high perfusion rate (pHPR) 
conditions, the expression of col i was not dependent on the addition of nifedipine 
into medium compared with control group, as can be seen in Figure 6-10 (c). On BGS 
SiHA-14, in control medium, the expression of col i was significantly higher under 
basal perfusion rate (BPR) condition compared with both a period of high perfusion 
rate (pHPR) and static conditions, with the expression of col i under a period of high 
perfusion rate (pHPR) condition being significantly higher than under static condition. 
In medium supplemented with nifedipine, the expression of col i was not found to be 
dependent on culture conditions. On BGS SiHA-28, the expression of col i was not 
dependent on the presence of nifedipine compared with control group irrespective 
the culture conditions. On BGS SiHA-28, in control medium, the expression of col i 
was significantly higher under a period of high perfusion rate (pHPR) condition, 
compared with both basal perfusion rate (BPR) and static conditions, with the 
expression of col i under basal perfusion rate (BPR) being significantly higher than 
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static condition. On BGS SiHA-28, in medium supplemented with nifedipine, the 
expression of col i was significantly higher under either type of perfusion conditions 
compared with static condition. In control medium, under basal perfusion rate (BPR) 
condition, the expression of col i was significantly downregulated on SiHA-28 
compared with SiHA-14, whereas under static and a period of high perfusion rate 
(pHPR) conditions, the expression of col i was not responsive to BGS micro-porosity. 
With the addition of nifedipine into medium, the expression of col i was not found to 
be responsive to BGS micro-porosity, irrespective of culture conditions. 
dmp1 has been found to be highly expressed in osteocytes and can be classed as a 
pro-osteogenic factor (Kalajzic et al., 2004). On both BGS SiHA-14 and BGS SiHA-28, 
under basal perfusion rate (BPR) condition, the expression of dmp1 was significantly 
downregulated with the presence of nifedipine in medium compared with control 
group, whereas under both static and a period of high perfusion rate (pHPR) 
conditions, the expression of dmp1 was not responsive to the addition of nifedipine 
into medium compared with control group, as can be seen in Figure 6-10  (e) and (f). 
On BGS SiHA-14, the expression of dmp1 was found to be significantly higher under 
basal perfusion rate (BPR) condition than both static and a period of high perfusion 
rate (pHPR) conditions, irrespective whether nifedipine was added into culture 
medium. On BGS SiHA-28, in control medium, the expression of dmp1 was found to 
be significantly higher under basal perfusion rate (BPR) condition than both static and 
a period of high perfusion rate (pHPR) conditions, with the expression of dmp1 under 
a period of high perfusion rate (pHPR) being significantly higher than under static 
condition. On BGS SiHA-28, with the addition of nifedipine into medium, the 
expression of dmp1 was significantly higher under a period of high perfusion rate 
(pHPR) condition than under static condition. In control medium, the expression of 
dmp1 was not found to be dependent on BGS micro-porosity, irrespective of culture 
conditions. With the presence of nifedipine in medium, under basal perfusion rate 
(BPR) condition, the expression of dmp1 was significantly downregulated on SiHA-28 
compared with SiHA-14, whereas under a period of high perfusion rate (pHPR) 
condition, the expression of dmp1 was significantly upregulated on SiHA-28 
compared with SiHA-14. 
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Figure 6-10 Influence of nifedipine on expression of bmp2, col i and dmp1 in hMSCs 
cultured on SiHA-14 and SiHA-28 under static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) conditions. Results are presented as mean ± standard deviation 
(n=3). Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-
tests. **p < 0.01, ***p < 0.001, comparison between control group and nifedipine group. 
+p < 0.05, ++p < 0.01, +++p < 0.001, comparison between static, basal perfusion rate (BPR) 
and a period of high perfusion rate (pHPR). $$p < 0.01, $$$p < 0.001, comparison between 
SiHA-14 and SiHA-28. 
SiHA-14 SiHA-28 
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6.3.5.2 Expression of Chondrogenic Gene Markers 
SRY-box 9 (sox9) and runt-related transcription factor 2 (runx2) have been identified 
as important transcriptional regulators of early and late stage chondrogenic 
differentiation, respectively (Karsenty, 2008). On BGS SiHA-14, the expression of sox9 
was not dependent on the addition of nifedipine into medium, irrespective of culture 
conditions, as can be seen in Figure 6-11 (a). On BGS SiHA-14, in both control medium 
and medium with the presence of nifedipine, the expression of sox9 was significantly 
higher under a period of high perfusion rate (pHPR) condition compared with both 
basal perfusion rate (BPR) and static conditions, with the expression of sox9 under 
basal perfusion rate (BPR) being significantly higher than under static condition. On 
BGS SiHA-28, under a period of high perfusion rate (pHPR) condition, sox9 expression 
was significantly upregulated by the presence of nifedipine compared with control 
medium, whereas under both static and basal perfusion rate (BPR) conditions, sox9 
expression was not dependent on the presence of nifedipine in medium compared 
with control medium, as can be seen in Figure 6-11 (b). On BGS SiHA-28, in control 
medium, sox9 expression was significantly higher under either type of perfusion 
conditions compared with under static condition. On BGS SiHA-28, in medium 
supplemented with nifedipine, sox9 expression was significantly higher under a 
period of high perfusion rate (pHPR) condition compared with both basal perfusion 
rate (BPR) and static conditions, with sox9 expression under basal perfusion rate (BPR) 
condition being significantly higher than under static condition. In both control 
medium and medium supplemented with nifedipine, sox9 expression was not found 
to be dependent on BGS micro-porosity, irrespective of culture conditions. 
On BGS SiHA-14, runx2 expression was significantly upregulated with the presence of 
nifedipine in medium compared with control medium under both basal perfusion 
rate (BPR) and a period of high perfusion rate (pHPR) conditions, but not static 
condition, as can be seen in Figure 6-11 (c). On BGS SiHA-14, in control medium, runx2 
expression was significantly higher under a period of high perfusion rate (pHPR) 
condition than both basal perfusion rate (BPR) and static conditions. On BGS SiHA-
14, with the addition of nifedipine into medium, runx2 expression was significantly 
higher under a period of high perfusion rate (pHPR) condition than both basal 
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perfusion rate (BPR) and static conditions, with runx2 expression under basal 
perfusion rate (BPR) being significantly higher than static condition. On BGS SiHA-28, 
under static and basal perfusion rate (BPR) conditions, the expression of runx2 was 
not dependent on the presence of nifedipine in medium, whereas under a period of 
high perfusion rate (pHPR), the expression of was significantly upregulated by the 
addition of nifedipine into medium compared with control medium, as can be seen 
in Figure 6-11 (d). On BGS SiHA-28, in control medium, the expression of runx2 was 
not dependent on culture conditions. On BGS SiHA-28, in medium supplemented 
with nifedipine, the expression of runx2 was significantly higher under a period of 
high perfusion rate (pHPR) condition than both basal perfusion rate (BPR) and static 
conditions, with the expression of runx2 under basal perfusion rate (BPR) condition 
being significantly higher than static condition. In control medium, under a period of 
high perfusion rate (pHPR) condition, runx2 expression was significantly 
downregulated on SiHA-28 compared with on SiHA-14, whereas under basal 
perfusion rate (BPR) and static conditions, runx2 expression was not responsive to 
the BGS micro-porosity. In medium supplemented with nifedipine, the expression of 
runx2 was not found to be dependent on BGS micro-porosity irrespective of culture 
conditions. 
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Figure 6-11 Influence of nifedipine on expression of chondrogenic gene markers in hMSCs 
cultured on SiHA-14 and SiHA-28 under static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) conditions. Results are presented as mean ± standard deviation 
(n=3). Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-
tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison between control group and 
nifedipine group. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison between static, basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR). $p <0.05, $$p < 0.01, 
comparison between SiHA-14 and SiHA-28. 
Type II collagen (COI II) is the major structural component of cartilage, so it is one of 
the commonly used markers of chondrogenesis (Ng et al., 1997). On BGS SiHA-14, col 
ii expression was not responsive to the presence of nifedipine in medium irrespective 
SiHA-14 SiHA-28 
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of culture conditions (Figure 6-11 (e)). On BGS SiHA-14, in both control medium and 
medium with the addition of nifedipine, the expression of col ii was significantly 
higher under a period of high perfusion rate (pHPR) condition than both static and 
basal perfusion rate (BPR) conditions. On BGS SiHA-28, under both static and basal 
perfusion rate (BPR) conditions, col ii expression was not responsive to the presence 
of nifedipine in medium, whereas under a period of high perfusion rate (pHPR) 
condition, col ii expression was significantly upregulated with the presence of 
nifedipine in medium compared with control medium (Figure 6-11 (f)). On BGS SiHA-
28, in control medium, col ii expression was significantly higher under a period of 
high perfusion rate (pHPR) condition than under static condition, whereas in medium 
with the addition of nifedipine, col ii expression was significantly higher under a 
period of high perfusion rate (pHPR) condition than both basal perfusion rate (BPR) 
and static conditions. In control medium, under both static and a period of high 
perfusion rate (pHPR) conditions, the expression of col ii was significantly 
downregulated on SiHA-28 compared with on SiHA-14. In medium with the presence 
of nifedipine, the expression of col ii was not dependent on BGS micro-porosity 
irrespective of culture conditions. 
6.3.5.3 Expression of Myogenic Gene Marker 
Myoblast determination protein (myoD) is a myogenic transcriptional regulatory 
factor that activates a number of muscle-specific structural genes and transcription 
factors to drive myogenesis (Rao et al., 2006). As shown in Figure 6-12 (a), on SiHA-
14 BGS, blocking L-type VSCCs with nifedipine significantly downregulated the gene 
expression of myoD compared with in control medium under both static and basal 
perfusion rate (BPR) conditions, but not under a period of high perfusion rate (pHPR) 
condition. On BGS SiHA-14, in control medium, the expression of myoD was 
significantly higher under both static and basal perfusion rate (BPR) conditions 
compared with under a period of high perfusion rate (pHPR) condition. On BGS SiHA-
14, in medium supplemented with nifedipine, myoD expression was significantly 
higher under static condition than both basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) conditions. On BGS SiHA-28, under basal perfusion rate 
(BPR) condition, the expression of myoD was significantly downregulated by the 
Chapter 6 
151 
 
presence of nifedipine in the medium compared with control medium, whereas 
under both static and a period of high perfusion rate (pHPR) conditions, the 
expression of myoD was not dependent on the addition of nifedipine into medium, 
as can be seen in Figure 6-12 (b). On BGS SiHA-28, in control medium, myoD 
expression was significantly higher under basal perfusion rate (BPR) condition 
compared with under a period of high perfusion rate (pHPR) condition. On BGS SiHA-
28, in medium with the addition of nifedipine, myoD expression was significantly 
higher under static condition compared than both basal perfusion rate (BPR) and a 
period of high perfusion rate (pHPR) conditions. In control medium, the expression 
of myoD was significantly downregulated on BGS SiHA-28 than SiHA-14 under both 
static and basal perfusion rate (BPR) conditions, but not a period of high perfusion 
rate (pHPR) condition. In medium with the addition of nifedipine, the expression of 
myoD was not found to be dependent on BGS micro-porosity irrespective of culture 
conditions. 
 
Figure 6-12 Influence of nifedipine on gene expression of myoD in hMSCs cultured on SiHA-
14 and SiHA-28 under static, basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR) conditions. Results are presented as mean ± standard deviation (n=3). Statistical 
analysis was performed by two-way ANOVA followed by Bonferroni post-tests. ***p < 
0.001, comparison between control group and nifedipine group. ++p < 0.01, +++p < 0.01, 
comparison between static, basal perfusion rate (BPR) and a period of high perfusion rate 
(pHPR). $p <0.05, $$p < 0.01, comparison between SiHA-14 and SiHA-28. 
6.3.5.4 Expression of Integrin Subunits 
On BGS SiHA-14, the expression of integrin α1 was significantly downregulated under 
either type of perfusion conditions (Figure 6-13 (a)) by the presence of nifedipine in 
a b 
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culture medium compared with control medium. On BGS SiHA-14, in control medium, 
the expression of integrin α1 was significantly higher under basal perfusion rate (BPR) 
condition than both static and a period of high perfusion rate (pHPR) conditions, with 
integrin α1 expression under a period of high perfusion rate (pHPR) being 
significantly higher than under static condition. On BGS SiHA-14, with the presence 
of nifedipine in the medium, the expression of integrin α1 was significantly higher 
under a period of high perfusion rate (pHPR) than basal perfusion rate (BPR) 
condition. On BGS SiHA-28, under basal perfusion rate (BPR) condition, the 
expression of integrin α1 was significantly downregulated by the addition of 
nifedipine into medium, whereas under both static and a period of high perfusion 
rate (pHPR) conditions, the expression of integrin α1 was not responsive to the 
presence of nifedipine in the medium compared with control medium, as can be seen 
in Figure 6-13  (b). On BGS SiHA-28, in control medium, the expression of integrin α1 
was significantly higher under either type of perfusion condition compared with 
under static condition. On BGS SiHA-28, in medium supplemented with nifedipine, 
the expression of integrin α1 was significantly higher under a period of high perfusion 
rate (pHPR) condition than both static and basal perfusion rate (BPR) conditions. In 
control medium, the expression of integrin α1 was significantly downregulated on 
SiHA-28 than SiHA-14 under static condition, but not either type of perfusion culture 
conditions. With the addition of nifedipine into medium, the expression of integrin 
α1 was not dependent on BGS micro-porosity irrespective of culture conditions. 
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Figure 6-13 Influence of nifedipine on gene expression of integrin subunits in hMSCs 
cultured on SiHA-14 and SiHA-28 under static, basal perfusion rate (BPR) and a period of 
high perfusion rate (pHPR) conditions. Results are presented as mean ± standard deviation 
(n=3). Statistical analysis was performed by two-way ANOVA followed by Bonferroni post-
tests.  *p < 0.05, **p < 0.01, ***p < 0.001, comparison between control group and 
nifedipine group. +p < 0.05, ++p < 0.01, +++p < 0.001, comparison between static, basal 
perfusion rate (BPR) and a period of high perfusion rate (pHPR). $p <0.05, $$p < 0.01, $$$p 
< 0.001, comparison between SiHA-14 and SiHA-28. 
On both BGS SiHA-14 and SiHA-28, the expression of integrin α5 increased 
significantly with the addition of nifedipine into medium compared with control 
medium under either type of perfusion culture conditions, as shown in Figure 6-13 
a b 
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(c) and (d). On BGS SiHA-14, in both control medium and medium supplemented with 
nifedipine, the expression of integrin α5 was significantly higher under a period of 
high perfusion rate (pHPR) condition than both basal perfusion rate (BPR) and static 
conditions, with integrin α5 expression under basal perfusion rate (BPR) being 
significantly higher than under static condition. On BGS SiHA-28, in control medium, 
the expression of integrin α5 was significantly higher under either type of perfusion 
culture conditions compared with under static condition. On BGS SiHA-28, in medium 
supplemented with nifedipine, the expression of integrin α5 was significantly higher 
under a period of high perfusion rate (pHPR) condition than both basal perfusion rate 
(BPR) and static conditions, with integrin α5 expression under basal perfusion rate 
(BPR) being significantly higher than under static condition. In control medium, under 
basal perfusion rate (BPR) condition, the expression of integrin α5 was significantly 
upregulated on SiHA-28 compared with SiHA-14, whereas under a period of high 
perfusion rate (pHPR) condition, the expression of integrin α5 was significantly 
downregulated on SiHA-28 compared with SiHA-14. In medium with the presence of 
nifedipine, the expression of integrin α5 was not found to be dependent on BGS 
micro-porosity irrespective of culture conditions. 
On BGS SiHA-14, presence of nifedipine in the medium downregulated the 
expression of integrin β1 compared with control medium under either type of 
perfusion conditions, but not static condition (Figure 6-13 (e)). On BGS SiHA-14, in 
both control medium and medium supplemented with nifedipine, the expression of 
integrin β1 was significantly higher under a period of high perfusion rate (pHPR) than 
both basal perfusion rate (BPR) and static conditions.  On BGS SiHA-28, under a 
period of high perfusion rate (pHPR) condition, presence of nifedipine in the medium 
significantly upregulated the expression of integrin β1 compared with control 
medium, whereas under static and basal perfusion rate (BPR) conditions, the 
expression of integrin β1 was not dependent on the presence of nifedipine in the 
medium, as can be seen in Figure 6-13 (f). On BGS SiHA-28, in control medium, the 
expression of integrin β1 was not dependent on the culture conditions. On BGS SiHA-
28, with the addition of nifedipine into medium, the expression of integrin β1 was 
significantly higher under a period of high perfusion rate (pHPR) condition than both 
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static and basal perfusion rate (BPR) conditions. In both control medium and medium 
with the presence of nifedipine, integrin β1 expression was not s responsive to BGS 
micro-porosity under both static and basal perfusion rate (BPR) conditions. Under a 
period of high perfusion rate (pHPR) condition, in control medium, the expression of 
integrin β1 was downregulated on SiHA-28 than on SiHA-14, whereas in medium 
supplemented with nifedipine, the expression of integrin β1 was upregulated on 
SiHA-28 than on SiHA-14. 
6.4 Discussion 
In this study, SiHA BGS granules were seeded with hMSCs then cultured under static, 
basal perfusion rate (BPR) or a period of high perfusion rate (pHPR) conditions in 
control medium or medium supplemented with the L-type VSCCs blocker, nifedipine. 
Responses of hMSCs, i.e. cytoskeleton organisation, proliferation, specific ALP 
activity, ERK1/2 activation and expression of gene markers for differentiation were 
analysed to investigate the modulation by L-type VSCCs on shear stress induced 
differentiation of hMSCs. 
The cytoskeleton has been well-recognised as a  responder to mechanical stimuli, 
such as stretch  (Xu et al., 2012), shear stress (Ajubi et al., 1996), hydrostatic pressure 
(Knight et al., 2006) and compression (Zhang et al., 2015). Current research agrees 
with previous results showing that, with the stimulation of fluid shear stress, 
cytoskeleton exhibited a less spread morphology and smaller cellular size compared 
with static culture. However, this process was independent of L-type VSCCs. This 
result agrees with previous findings demonstrating that flow activated stress fibre 
formation was dependent on [Ca2+]i release, not extracellular Ca2+ entry (Chen et al., 
2000).  
Proliferation and specific ALP activity of rat MSCs were reported to be significantly 
decreased after nifedipine treatment (Wen et al., 2012). However, in the current 
study, treatment with nifedipine was not observed to decrease either proliferation 
or specific ALP activity under static culture on both SiHA-14 and SiHA-28 BGS. One 
possible explanation is that hMSCs were cultured on SiHA BGS, instead of well-plates, 
in osteogenic medium, which maintained hMSCs proliferation and specific ALP 
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activity robustly and they were not dependent on L-type VSCCs. Previous research 
has reported that any enhanced proliferation by stretch in chicken chondrocytes was 
blocked by nifedipine treatment (Wu and Chen, 2000). In the current study, enhanced 
proliferation by shear stress was not observed to be blocked by nifedipine treatment, 
indicating that shear stress induced proliferation on SiHA BGS was independent of L-
type VSCCs.  
Interestingly, L-type VSCCs were demonstrated to be involved in the distribution of 
ERK1/2 in response to shear stress. Distribution of ERK1/2 was dependent on culture 
conditions and this dependence was blocked by adding nifedipine into culture 
medium. On both BGS SiHA-14 and SiHA-28, the production of pERK was significantly 
different under basal perfusion rate (BPR) compared with a period of high perfusion 
rate (pHPR) condition in control medium, and treatment with nifedipine inhibited 
this difference. This inhibition of response to different perfusion culture conditions 
by nifedipine treatment was also observed in the expression of genes like osx, col i 
and myoD. Previous studies also reported that L-type VSCCs were involved in the 
activation of the ERK phosphorylation (Dolmetsch et al., 2001; Nakayama et al., 2008). 
Findings in the current study agreed with previous research, indicating that L-type 
VSCCs play a role in modulating shear stress induced activation of ERK pathway of 
hMSCs on SiHA BGS. 
Ca2+ is the most widely used second messenger in cell biology and calcium channels 
fulfil a lot of essential cell functions. One such function is the involvement in the 
regulation of gene expression (Barbado et al., 2009). The regulation of L-type VSCCs 
blocker, nifedipine, on the expression of osteogenic genes was similar on SiHA-14 
and SiHA-28 BGS. Osteogenic gene makers like osx, bmp2, col i and dmp1 were 
significantly upregulated under basal perfusion rate (BPR) compared with under 
static condition. This upregulation was diminished by L-type VSCCs blocker, 
nifedipine, indicating that L-type VSCCs were compulsory in osteogenic 
differentiation induced by basal perfusion rate (BPR).  This agreed with previous 
research reported that L-type VSCCs mediate load-induced bone formation (Li et al., 
2003). Under a period of high perfusion rate (pHPR), the expression of some 
osteogenic genes, like alp, col i and dmp1 was not affected by the presence of 
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nifedipine in the medium, however, the expression of osx and bmp2 was upregulated 
by nifedipine treatment. These findings demonstrated that under a period of high 
perfusion rate (pHPR) condition, the regulation of L-type VSCCs on osteogenic 
differentiation was more complicated compared with under basal perfusion rate 
(BPR) condition, and different pathways might be involved in the regulation process. 
It is interesting to notice that integrin α1 expression followed the same pattern with 
osteogenic gene expression, i.e it was upregulated under basal perfusion rate (BPR), 
and this upregulation was dependent on L-type VSCCs. Under a period of high 
perfusion rate (pHPR), the expression of integrin α1 was downregulated by nifedipine 
treatment on SiHA-14 but not SiHA-28, indicating that BGS SiHA-28 protected against 
the downregulation effect by the addition of nifedipine in medium. 
The expression of chondrogenic gene markers like sox9, runx2 and col ii was not 
dependent on the blocking of L-type VSCCs by nifedipine under static condition. This 
finding was confirmed by previous research, in a high density chondrifying MSCs 
culture model, blocking L-type VSCCs did not interfere with the mRNA expression of 
sox9 (Fodor et al., 2013). Basal perfusion rate (BPR) upregulated chondrogenic gene 
markers as compared to static condition, and a period of high perfusion rate (pHPR) 
further increased their expression significantly. Under either type of perfusion 
culture conditions, the expression level of chondrogenic markers was further 
increased with the addition of nifedipine into medium, indicating that active L-type 
VSCCs regulates the extent of perfusion induced chondrogenic differentiation. It is 
unknown how silica enters hMSCs and whether blocking L-type VSCCs affects silica 
entering hMSCs. It is also unknown whether silica has a pro-chondrogenic effect 
when calcium is deficient. Shear stress induced chondrogenic differentiation and its 
regulation by L-type VSCCs has received little attention to date. The upregulation of 
an endochondral bone formation mediator (parathyroid hormone (PTH) related 
peptide) in rat chondrocyte by cyclic mechanical strain was found to be dependent 
on L-type VSCCs activation (Tanaka et al., 2005). It is understandable that the role of 
L-type VSCCs in shear stress induced chondrogenic differentiation was distinct from 
in cyclic mechanical strain induced chondrogenic differentiation. Integrin α5 was 
upregulated significantly while chondrogenic markers were upregulated significantly 
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under a period of high perfusion rate (pHPR). Adding nifedipine into medium further 
enhanced expression of integrin α5, as well as chondrogenic markers under either 
type of perfusion culture conditions. These results indicated that integrin α5 was 
closely related to chondrogenesis process. 
Under basal perfusion rate (BPR) condition, the expression of osx, col i and myoD was 
responsive to BGS micro-porosity. Under a period of high perfusion rate (pHPR) 
culture condition, the expression of runx2, col ii and integrin α5 was dependent on 
BGS micro-porosity. The response of these gene expression to BGS micro-porosity 
was blocked by adding L-type VSCCs nifedipine into medium, indicating that fully 
functional L-type VSCCs were necessary when evaluating BGS performance. 
6.5 Conclusion 
In summary, current research results have demonstrated that L-type VSCCs play 
important roles in activating ERK pathway and regulating flow activated hMSCs 
differentiation. Basal perfusion rate (BPR) induced osteogenic differentiation was 
dependent on L-type VSCCs. L-type VSCCs also regulated shear stress activated 
chondrogenic differentiation. Integrin subunits showed a strong preference in stem 
cell lineage specification. Integrin α1 was proved to be closely related to osteogenesis 
process, whereas integrin α5 was demonstrated to be more involved in 
chondrogenesis process.
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Chapter 7 Conclusions and Future Work 
7.1 Conclusions 
Cells in the human body are exposed to shear stress and other mechanical forces, 
which are known to influence cellular response, bone regeneration and bone 
remodelling (Lanyon and Rubin, 1984; Boerckel et al., 2012). The evaluation of how 
cells response to BGS in a static environment usually cannot be translated to 
subsequent in vivo studies and clinical trials. Therefore, a 3D bioreactor that allows 
cell-seeded SiHA BGS granules to be applied with both shear stress and compression 
was built. A specific perfusion chamber which hosts BGS granules and can be fitted 
into the 3D bioreactor was designed, and parameters of seeding MG63 cells on BGS 
granules in this chamber were optimized. Results demonstrated that osteoblast-like 
cells on BGS was dependent on both shear stress and mechanical loading, showing 
different proliferation and gene expression profiles, which is in line with previous 
studies (Bancroft et al., 2002; Chen et al., 2017; Bolgen et al., 2008; David et al., 2008; 
C X Liu et al., 2012). However, after careful characterization, MG63 cells were found 
to lack the capacity to reflect the pattern of specific ALP activity demonstrated 
primary osteoblast cells, which is an important indicator in investigating the cellular 
response to mechanical stimulation. hMSCs were then characterized and used for 
the rest of the study. Perfusing cell culture medium through BGS requires tight fit 
between construct chamber and tubing, which creates friction resistance for 
compression and results in the compression force on BGS granules becoming 
unquantifiable. Therefore, perfusion in isolation with two different perfusion profiles 
was employed for the rest of the study.  
The structure of BGS has been demonstrated to have a strong impact on cellular 
response and bone regeneration in vivo (Manuela E. Gomes et al., 2006; Hing et al., 
2005; Campion et al., 2011; Coathup et al., 2012). SiHA BGS with defined total 
porosity and micro-porosity were synthesised and characterised. The proliferation 
and osteogenic differentiation of hMSCs on different BGS were preliminarily tested 
in a static environment. The composition and hierarchical structure of SiHA were 
found to be beneficial for the growth of hMSCs, however under static conditions the 
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structural differences between BGS did not have a significant influence on hMSCs at 
day 3. However, in culture medium with osteogenic supplements, SiHA BGS with high 
micro-porosity (SiHA-28) was demonstrated to be more beneficial in enhancing 
hMSCs proliferation and differentiation after 7 days. Therefore, it was decided to 
further investigate the response of hMSCs to variation in micro-porosity under 
perfusion conditions. 
Two perfusion patterns were employed in the study, as perfusion parameters 
including flow type, magnitude, duration, insertion of rest periods were found to 
influence cell responses (Bancroft et al., 2002; Grayson et al., 2008; Yang et al., 2010; 
Jaasma and O’Brien, 2008). Results demonstrated that hMSCs on SiHA BGS were 
dependent on basal perfusion rate (BPR), showing significantly increased 
proliferation and osteogenic differentiation compared with static culture, with the 
involvement of cytoskeleton and ERK1/2 signalling pathway. The response of hMSCs 
was not consistently dependent on BGS micro-porosity under static condition. While 
basal perfusion rate (BPR) revealed the response of hMSCs to BGS micro-porosity, 
with the expression of osteogenic marker osx increased significantly with increasing 
BGS micro-porosity. On the other hand, a period of high perfusion rate (pHPR) 
significantly increased the gene expression of chondrogenic markers, and SiHA-22 
was demonstrated to be more supportive in terms of chondrogenic markers 
expression compared with SiHA-14 and SiHA-28. Since perfusion condition is more 
relevant to physiological in vivo situation, the future evaluation of porous BGS 
bioactivity should be conducted under carefully selected perfusion conditions, and 
the results of this thesis suggest that chondrogenic markers should also be used as 
one of the indicators for BGS performance in addition to conventional osteogenic 
markers, as early chondrogenic activity may denote the onset of osteochondral bone 
formation.  This would also argue for longer term culture to further monitor cell fate 
and the development of any ECM produced. 
Many studies have demonstrated that L-type voltage-sensitive calcium channels 
(VSCCs) were activated in response to mechanical stimulation, which then initiate a 
variety of biological signals in bone cells and also mediate bone formation (Rawlinson 
et al., 1996; Li et al., 2002). The regulation of L-type VSCCs on shear stress induced 
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hMSCs response were also examined in this study. Results demonstrated that shear 
stress induced osteogenic and chondrogenic differentiation of hMSCs on SiHA BGS 
was modulated by L-type VSCCs, possibly through ERK1/2 signalling pathways. The 
results of this study underline the importance of evaluating BGS performance 
especially when investigating the mechanisms behind response to variation in BGS 
structure and chemistry under well understood perfusion conditions. 
7.2 Future Work 
Although it is encouraging that perfusion culture can result in improved 
differentiation and disclose the cellular response to small BGS architectural 
differences, this is only a small step towards a physiological-mimicking bioreactor 
system.  
• Future work is required to prolong culturing period and investigate the effect 
of SiHA BGS micro-porosity on cell proliferation and differentiation under 
perfusion conditions at 14 days, 21 days and 28 days. 
• Future work is required to investigate the effect of SiHA BGS macro-porosity 
on cell proliferation and differentiation under mechanical stimulated 
conditions. 
• Inhibitors of ERK1/2 and cytoskeletal drugs can be used in the experiment to 
examine their role in the synergistic effect of perfusion and BGS structure on 
hMSCs response. 
• Future work is required to simulate/investigate how micro-porosity affects 
type of flow, shear stress and strain field, which could contribute to explain 
the response of hMSCs to SiHA with different micro-porosity under perfusion 
condition. 
• Future work is required to investigate the cellular response to HA and SiHA 
with equivalent structure under perfusion condition to study the role of silica 
on osteogenic and chondrogenic effect. Cellular response to HA and SiHA 
when L-type VSCC channels are blocked should also be investigated to 
examine the role of silica on osteogenic and chondrogenic effect when 
calcium is deficient. 
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• A more advanced bioreactor which can apply both compression and perfusion 
in an accurate manner should be developed. 
• The final goal of bioreactor system is carrying out real time monitored, 
automated control over relevant parameters during the cultivation. Also, 
studies using bioreactor system should be preferably completed in 
conjunction with µCT scan and computational fluid dynamics (CFD) to 
characterise the fluid shear stress field. Then the fluid shear stress from 
studies using different BGS or flow with different configurations can be 
compared. A thorough network of studies of using bioreactors can be built, 
which will provide valuable guidance for tissue engineering in clinical practice. 
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Appendix 1: DNA and specific ALP activity of hMSCs in 24 well-plates (5000 
cells/well) after 7 days 
 
Appendix 2: Cell culture and molecular analysis chemicals used in this PhD 
research. 
Chemicals Supplier 
CatLog 
number 
MG-63 cell line human Sigma 86051601 
Dulbecco’s Phosphate Buffered Saline (PBS) Sigma D8537 
Trypsin-EDTA solution Sigma T3824 
High glucose Dulbecco's  
Modified Eagles Medium (DMEM) 
(contains NaHCO3 buffer) 
Sigma D6429 
High glucose Dulbecco’s  
Modified Eagle’s Medium (DMEM)  
(without NaHCO3 buffer) 
Sigma D7777 
Fetal bovine serum (FBS) Sigma F9665 
HEPES solution Sigma H0887 
Penicillin-Streptomycin Sigma P4333 
Human Mesenchymal Stem Cells from Bone 
Marrow (hMSC-BM), Lot: 403Z003.2. 
PromoCell C-12974 
Mesenchymal Stem Cell (MSC) Growth 
Medium 2  
PromoCell C-28009 
Accutase-Solution PromoCell C-41310 
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Dexamethasone Sigma D4902 
β-Glycerophosphate disodium salt hydrate Sigma G9422 
L-Ascorbic acid 2-phosphate 
sesquimagnesium salt hydrate 
Sigma A8960 
Bovine Serum Albumin Sigma A2058 
Triton® X-100 (Polyethylene glycol tert-
octylphenyl ether) 
VWR 437002A 
Quant iT PicoGreen dsDNA Assay Kit Life Technologies  P11496 
UltraPure™ DNase/RNase-Free Distilled 
Water 
Life Technologies 10977035 
Alkaline Phosphatase Assay Kit Abcam ab83369 
4-Nitrophenol solution Sigma N7660 
Alizarin Red S Sigma A5533 
Paraformaldehyde solution, 4%(w/v) in PBS Thermo Fisher Scientific J19943 
RIPA Lysis and Extraction Buffer Life Technologies 89900 
Halt™ Protease and Phosphatase Inhibitor 
Cocktail (100X) 
Life Technologies 78440 
Pierce™ BCA Protein Assay Kit Thermo Fisher Scientific 23227 
4x Laemmli Sample Buffer Bio Rad 1610747 
2-Mercaptoethanol Sigma M6250 
Precision Plus Protein™ WesternC™ Blotting 
Standards 
Bio Rad 1610376 
4–20% Mini-PROTEAN® TGX™ Precast Protein 
Gels 
Bio Rad 4561094 
Tris/Glycine/SDS Bio Rad 1610732 
Trans-Blot® Turbo™ RTA Mini LF PVDF 
Transfer Kit 
Bio Rad 1704274 
Tris Buffered Saline Bio Rad 1706435 
TWEEN® 20 Sigma P2287 
TRI Reagent® Solution Life Technologies AM9738 
Chloroform, pure Acros Organics 38376025 
RNeasy Mini Kit Qiagen 74104 
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GoScript™ Reverse Transcription System Promega  A5000 
KAPA SYBR® FAST Sigma KK4618 
Nifedipine Sigma N7634 
Glutaraldehyde Agar Scientific AGR1011 
Sodium cacodylate Sigma C0250 
Osmium tetroxide TAAB O015/1 
Tannic acid Sigma T0125 
Ethyl alcohol Sigma 459836 
Hexamethyldisilazane Sigma 52619 
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